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Abstract
Despite the success of GWASs in the recent years, the genetic architecture
of complex diseases, such as primary open-angle glaucoma is yet to be
understood. The purpose of this thesis is to gain a better understanding
of primary open-angle glaucoma using genetic association studies on
several quantitative traits, such as intraocular pressure and optic nerve
measurements. Collaborative efforts through extensive meta-analysis will
help to increase the power of genetic association studies to identify novel
variants for intraocular pressure and optic nerve parameters. In addition,
gene-set enrichment analysis on the results of these meta-analyses may also
help to shed a light on the mechanisms underlying glaucoma pathogenesis.
Intraocular pressure and optic nerve cupping are not independent and
they act together to determine the disease. Genetic association studies
that combine information from different quantitative traits may help to
identify novel genes affecting glaucoma susceptibility. In addition, epistatic
interactions may also play a role in determining glaucoma endophenotypes
variation and may help to identify novel loci affecting primary open-angle
glaucoma susceptibility. Finally, primary open-angle glaucoma has been
also associated with Alzheimer’s disease, particularly the decrease of retinal
ganglion cells. Elucidating the genetic underlying retinal nerve fibre layer
and its relationship with Alzheimer’s disease may help to discover and
understand neurodegenerative mechanisms affecting primary open-angle
glaucoma.
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CHAPTER 1
Introduction
Here I review the previous work in the genetic epidemiology of
glaucoma and present the aim and objectives of my thesis.
1.1 Introduction to primary open-angle glaucoma (POAG)
Glaucoma is one of the leading causes of irreversible blindness worldwide
(Quigley 1996). It is a heterogeneous group of degenerative disorders that
have in common a degeneration of retinal ganglion cells, a characteristic
excavation of the optic disc and irreversible visual field loss (Foster et al.
2002). There are many types of glaucoma, but the most common include
primary open-angle glaucoma (POAG), chronic angle-closure (ACG),
and exfoliation glaucoma (XFG). Primary open-angle glaucoma (POAG)
is the predominant form of glaucoma (Weinreb & Khaw 2004) and is
characterised by an open angle without a secondary explanatory cause
(Leske 2007).
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1.1.1 Anatomy and physiology
Intraocular pressure is regulated by a balance between the secretion and
drainage of aqueous humour, which provides nutrients to the iris, lens and
cornea. The fluid is secreted posterior to the iris by the ciliary body and
then flows anteriorly to the anterior chamber.
Axons of retinal ganglion cells comprise the retinal nerve fibre layer, the
innermost layer of the retina. These axons converge on the optic disc and
form the optic nerve. The optic disc is about 1-5 mm in diameter and
vertically oval. The convergence of the axons forms a central depression
in the disc, known as the cup.
Glaucoma is characterised by the slow, progressive degeneration of retinal
ganglion cells leading to an enlargement of the optic disc cup. The
pathophysiology is not fully understood. The level of intraocular pressure
may be related to the death of retinal ganglion cells and optic nerve
fibres in some patients. Although no obstruction can be seen with
clinical examination, resistance to aequous outflow through the trabecular
meshwork is increased in patients with this form of glaucoma. When
pressure increases the pressure gradient across the lamina cibrosa also
increases. As a result, the lamina cibrosa and the retinal ganglion cell axons
undergo deformation and mechanical stress (Weinreb & Khaw 2004).
Figure 1.1: The figure shows a summary of the pathophysiology of POAG
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1.1.2 Epidemiology of glaucoma
Studies report prevalence estimates of around 1-3% in Europe, 1-4% in
Asia and 2-3% in Australia (Rudnicka et al. 2006; Quigley & Broman
2006). Prevalence is much higher in Africa, with prevalence estimates
varying from 1% in Nigeria (Murdoch et al. 2001) to over 8% in Ghana
(Ntim-Amponsah et al. 2004). High prevalence of 7-9% were found
in African-Caribbean populations, originating from West Africa where
prevalence is also very high (Mason et al. 1989) (see Figure 1.2). As
a consequence of this variability, the public health impact of glaucoma
blindness also differs across ancestral groups. Glaucoma is the second most
common cause of blindness in the world (responsible for 12% of the global
blindness (Resnikoff et al. 2004)), however it is the commonest cause
in African-descent populations, with one-third of blindness due to POAG
(Hyman et al. 2001; Congdon et al. 2004), probably also due to health
care deficiencies. The incidence of POAG is about 0.1 to 0.2% per year in
populations of European origin (Leske 2007). A higher incidence of 0.5%
per year was found in black participants of the Barbados Eye Studies (Leske
et al. 2007).
Figure 1.2: Primary open-angle glaucoma global prevalence estimates: this figure shows
the POAG global prevalence estimates for adult older than 40 years old. This
figure has been published elsewhere (Leske 2007).
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Risk factors for POAG include demographic, ocular and systemic factors.
Age is a well known risk factor for POAG. The disease rarely occurs before
40 years old and the risk doubles after age 60 as compared with the 40 to
49 years old age group (Leske et al. 2008). In a meta-analysis, prevalence
rose steadily with age, especially in European-derived populations: for
each decade increase in age, the odds ratio was 2.05 (CI: 1.91-2.18, 95%)
in European population, 1.61 (1.53 to 1.70) in African and 1.57 (1.46 to
1.68) in Asian populations (Rudnicka et al. 2006).
An elevated intraocular pressure (IOP) is a strong and established
risk factor for POAG. In the Barbados nine-year study, results showed that
elevated IOP is a major contributor to POAG development, with IOP levels
≥ 21 mmHg increasing the 9-year relative risk to at least 5 as shown
in Figure 1.3 (Nemesure et al. 2007). IOP level remains the only major
POAG risk factor that is known to be modifiable. For that reason, there
has been long-standing interest in IOP-lowering treatment to decrease
risk and progression of POAG (Czudowska et al. 2010; Kass et al. 2002).
Several clinical trials have demonstrated the effectiveness of lowering IOP
to reduce visual field loss and a meta-analysis treatment is associated with
approximately a 40% decreased risk of glaucoma progression (Maier et al.
2005). However, IOP has limitations as predictor of POAG. An estimated
20-50% of all patients with all the symptoms of the disease have IOP within
the normal range (normal tension glaucoma), whereas many individuals
with elevated IOP do not have any sign of POAG (this condition is referred
to as ocular hypertension) (Leske 2007).
Another ocular risk factor has been identified in thinner central corneal
thickness (CCT) (Leske et al. 2008). The mechanisms for an association
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Figure 1.3: Incidence of POAG and IOP: this figure graphically represents the relationship
between incidence of POAG (y axis) and baseline IOP (x axys) in the Barbados
Eye Studies. Overall, when IOP was evaluated as a continuous variable, the
risk of OAG increased by 12% with each 1-mmHg increase in IOP. This figure
has been published elsewhere (Nemesure et al. 2007).
between CCT and POAG have yet to be determined. The association was
initially reported in the Ocular Hypertension Treatment Study, where
thin CCT was a strong factor predicting the development of POAG in
individuals with ocular hypertension (Gordon et al. 2002). While CCT has
a well-known effect on IOP measurement (a thin central cornea may lead
to an underestimation of IOP), the relationship between CCT and POAG
remains unclear.
Associations with spherical error (SE) have been reported in several
studies that report myopia is likely to increase POAG risk (Leske 2007).
For example, myopic individuals in the Blue Mountains Eye study had
a twofold to threefold increased risk of glaucoma compared with those
non myopic (Mitchell et al. 1999). In particular, high myopia has been
correlated with glaucomatous optic nerve damage, for instance in the
Beijing Study high myopic eyes, defined as -6D had a higher correlation
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with glaucomatous damage (Xu et al. 2007).
Large optic discs are mentioned as another risk factor, however larger discs
are associated with larger optic cups, which could be identified as an early
sign of disease(Leske 2007).
Several systemic and metabolic conditions are known to have profound
effects on the structure of the eye. Vascular dysregulation has been
suspected as a risk factor for glaucoma (Flammer et al. 2002). A vascular
role is suggested by the reported associations with vasospasm, migraine
headaches, and with abnormalities in ocular blood flow and circulatory
auto-regulation (Grieshaber & Flammer 2005). Blood pressure has been
associated with IOP, however neither systolic nor diastolic blood pressure
has been related to POAG (Tielsch et al. 1995a; Bonomi et al. 2000).
Diabetes has also a well known association with higher IOP (Tielsch et al.
1995b), but the relationship with POAG remains unclear (Leske 2007).
Neurological conditions have been associated with POAG, for instance
higher prevalence of glaucoma in Alzheimer’s patients in comparison to
the general population has been reported (Bayer et al. 2002). It has been
hypothesised that POAG and Alzheimer’s disease may share common
pathophysiological mechanisms or risk factors i.e. neuro-inflammation
(Tsilis et al. 2014). In addition, the brain has the same embryonic origin
than the retina and interestingly, a thicker retinal nerve fibre layer was
associated with better cognitive performance in healthy young individuals
(Koolwijk et al. 2009).
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1.2 Review of previous work on genetics of POAG
Genetics may also represent a risk factor for developing and progressing
POAG. Research in the last decade has shown that genes have a key role in
the pathogenesis of POAG. The identification of disease causing genes for
POAG is important for at least two main reasons. First, the identification of
genes and their biological pathways may elucidate the pathophysiological
mechanisms that are presently little understood. This may then provide
new directions for the development of POAG therapy. Second, knowing
the genes altering risk of onset or progression of POAG may enable to
create diagnostic and prognostic DNA based tests. This may be especially
valuable for POAG, as many patients are diagnosed only after significant
and irreversible visual field damage has occurred. Early diagnosis and
treatment may prevent or delay this damage. In addition, many suspects
who repeatedly attend the glaucoma clinic unnecessarily might be spared
the burden of regular surveillance based on their DNA test. In the last two
decades important progress has been made in unravelling the genetics of
POAG through advanced in genetic epidemiology. Genetic epidemiology
investigates how genes influence disease risk in human populations.
It differs from classical epidemiology by its explicit consideration of
genetic factors and it differs from medical genetics by its emphasis on
population-based studies.
1.2.1 Genetic susceptibility of POAG
In broad terms, common eye diseases, including POAG, are caused
by environmental exposures in genetically predisposed individuals.
Complex diseases are caused by a combination of genetic, environmental
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and lifestyle factors, most of which have not yet been identified.
Epidemiological studies have shown a generally high prevalence in African
individuals, together with an earlier age of presentation (Rudnicka et al.
2006; Mitchell et al. 1996; Leske et al. 1994; Foster et al. 2000). Ancestral
differences, even though they might reflect different environmental
exposure (i.e. lack of health system in African countries), suggest that
POAG onset and progression may be affected by genetic factors.
In addition, family history is another well-known risk factor for POAG, with
family members clearly having increased risk across populations (Wolfs
et al. 1998). Up to 50% glaucoma patients have a positive family history
(Tielsch JM et al. 1994). More over, first degree relatives of an affected
individual have a 22% risk of developing POAG compared with 2.3% risk
in family members of controls (Wolfs et al. 1998). The overall risk of
developing POAG amongst first degree relatives of an affected individual is
increased 3-9 fold (Wolfs et al. 1998; Tielsch JM et al. 1994).
Despite the evidence that family history plays a role in POAG onset
and progression, only one study (in 1987) determined the heritability
for POAG (Teikari 1987). Heritability is defined as the proportion of the
overall variation in a population that is ascribable to genetic variation
amongst individuals (Sanfilippo et al. 2010). Generally, when estimating
heritability, genetic effects are assumed to be additive and this is called
”narrow sense” heritability. Additive genetic effects occur when alleles at a
locus on a chromosome add up to constitute a phenotype (Sanfilippo et al.
2010). Heritability can be calculated in different ways. The classical twin
model is a well-known way to calculate heritability. In this approach, we
determine whether identical twins (monozygotic, MZ) raised together are
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more similar to each other for a given trait than non identical (dizygotic
twins, DZ) raised together. The rationale is that if a genetic basis exists we
would expect MZ twins to be more similar as they share 100% of their DNA,
compared with DZ twins who share only 50% on average. Family studies
could also include analysis of phenotypic similarity to familial relationship
of greater complexity.
Other methods to calculate heritability are based on regression and
correlation of intrapair trait values. For instance, with parent-child data
we could regress the trait value of the child on the average value of the
parents and the regression coefficient (or the slope) provides an estimate
of the narrow-sense heritability (Sanfilippo et al. 2010). Alternatively,
in sibling and twin study designs it is possible to calculate the intrapair
correlations and twice of the residual correlation provides an estimate of
the narrow-sense heritability (Sanfilippo et al. 2010).
POAG heritability, calculated using twin concordance ratio (correlation
method), was estimated to be 13% (Teikari 1987), however, this is
likely to be an underestimation, as a large proportion of glaucoma goes
undiagnosed and the concordances were calculated from national registries
rather than individual screening and ascertainment.
Studying familial aggregation and heritability in POAG has some
limitations. Ascertainment of age-related condition, such as POAG, is
complicate in families as parents are usually not alive when an individual is
diagnosed. Younger siblings may not have the disease, however cannot be
considered unaffected as they may develop POAG later in life. Recruiting
a large number of cases is expensive and it can be used only for that
Chapter 1. Introduction 23
particular disease. Moreover categorising an individual as affected or
non-affected is arbitrary and therefore susceptible to misclassification. An
important strategy for gene discovery in POAG is to dissect the disease into
its constituent parts or ”endophenotypes”. An endophenotype has been
described as a quantitative biological trait that is associated with the disease
(it should be associated with the causes rather than effects of disorders),
it is heritable and it should vary continuously in the general population
(Cannon & Keller 2006). Within families, endophenotype and disease
co-segregate (Gottesman & Gould 2003). Rather than studying POAG, a
better approach is to study POAG endophenotypes that are cup-to-disc
ratio (CDR) or vertical cup-to-disc ratio (VCDR), rim area, retinal nerve
fibre layer (RNFL) thickness, intraocular pressure (IOP) and central corneal
thickness (CCT). These intermediate traits are thought to have a simpler
genetic architecture, can be measured on a continuous or quantitative
scale, and may be more sensitive measures of important aspects of the
disease process (Sanfilippo et al. 2010). Moreover, quantitative traits
can also be studied in individuals without POAG, which means that this
approach greatly increases the number of individuals available for genetic
studies. Quantitative traits studies are also cost-efficient since you can have
many phenotypes for each individual.
Much effort has gone into investigating IOP variation as it is considered
the most important risk factor for POAG. Heritability estimates range
from 0.29 to 0.67 for IOP (see Figure 1.4) with a pooled estimate of
0.55 (Sanfilippo et al. 2010). Thinner central corneal measurements may
increase the risk for POAG, so much attention has been dedicated to
understand CCT variation. CCT showed a heritability estimate of 0.95,
which suggests that 95% of its variance is explained by the effects of genes
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(Hougaard et al. 2003; Toh et al. 2005). Heritability estimates for CCT
are comparable to other highly heritable human traits such as fingerprint
(Sanfilippo et al. 2010). However, CCT may not represent a true POAG
endophenotype as poor genetic correlation has been found between CCT
and POAG, compared with IOP (Charlesworth et al. 2010). Evaluation of
structural integrity of the optic nerve is important for the assessment of
POAG. Heritability estimates for CDR range from 0.48 to 0.79 and from
0.48 to 0.82 for RNFL thickness (Hougaard et al. 2003; Koolwijk et al.
2007; Chang et al. 2005; Haines et al. 2005; Levene et al. 1970)(see Figure
1.5).
Figure 1.4: Heritability estimates for IOP: this graph shows the heritability estimates for
IOP in different studies. Colours in the bars represent different methods:
black bars represent heritability determined by structural equation modelling
(i.e.classical twins studies) and white bars by regression/correlation methods.
This graph has been published elsewhere (Sanfilippo et al. 2010).
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Figure 1.5: Heritability estimated for optic nerve head parameters: this graph shows
heritability estimates for optic disc parameters in different studies. Colours
in the bars represent different methods: black bars represent heritability
determined by structural equation modelling (i.e. classical twins studies) and
white bars by regression/correlation methods. This graph has been published
elsewhere (Sanfilippo et al. 2010).
1.2.2 Linkage analysis
Identifying genes that affect common disorders, such as POAG, is
challenging. The most commonly used method to identify genes that
are transmitted in a Mendelian pattern is genetic linkage analysis. This
method uses families where multiple members are affected. The power
to detect linkage is proportional to the number of individuals affected
within families and the total number of families. Once linkage to a specific
chromosomal locus has been identified, analysis of the genes within that
region is conducted. The rationale is that two loci lying close together have
a higher probability of being inherited together. The further apart two loci
are, the higher the chance of a recombination event occurring between
them during meiosis. Therefore, the probability of two loci segregating
Chapter 1. Introduction 26
together is a measure of the genetic distance between them. Thus, the
probability of a genetic marker and the disease segregating together is a
measure of the distance between the marker and the disease gene.
Before the advent of current large-scale genotyping platforms, family-based
linkage studies have traditionally played an important role to locate genes
altering disease of phenotypic trait susceptibility. Linkage analysis provide
a tool to identify the chromosomal location (locus) of a disease without
prior knowledge of the biological mechanisms.
Traditionally linkage analysis has been performed to study monogenic
diseases in large families with multiple affected members. This approach is
called parametric or model-based linkage analysis. The aim is to discover
how often two loci are separated by meiotic recombination. The rationale
is that two loci lying close together have a higher probability of being
inherited together. The further apart two loci are, the higher the chance of
a recombination event occurring between them during meiosis. Therefore,
the probability of two loci segregating together is a measure of the genetic
distance between them. Thus, the probability of a genetic marker and the
disease segregating together is a measure of the distance between the
marker and the disease gene.
This approach requires an assumption of the genetic model, in which
the mode of inheritance, the disease and marker allele numbers and
frequencies, and the penetrance of the disease genotype need to be
specified. As long as an adequate model can be assumed, parametric
linkage provides a powerful method to locate a disease gene. However, it
has failed to find the more common genes underlying complex diseases,
for which a valid gene model cannot be specified. The shift towards the
genetics of complex diseases has therefore led to the development of new
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methods of linkage analysis that are nonparametric or model-free. Both
parametric and nonparametric linkage approaches have been used to
identify the chromosomal locations of POAG susceptibility genes.
Fourteen chromosomal loci for POAG (GLC1A-N) are listed in HUGO
Genome Nomenclature Committee. Three genes associated with glaucoma
have been identified within these loci, including myocilin on chromosome
1 (Sheffield et al. 1993), optineurin (Rezaie et al. 2002) on chromosome 10
and WDR36 (Monemi et al. 2005) on chromosomes 5 (see Figure 1.6).
Myocilin (MYOC), on chromosome 1, was the first gene identified for POAG
in the GLC1A locus (Sheffield et al. 1993). It is transmitted as an autosomal
dominant Mendelian trait and mutations in the gene have been found in
patients with juvenile or early-adult forms of POAG. These patients have a
severe clinical phenotype including elevated IOP (Fingert et al. 1999). How
mutations in MYOC gene lead to POAG is still unclear. It has been proposed
that these mutations may alter protein function and promote an increase
of IOP and loss of retinal ganglion cells. However, studies using mouse
model with the Tyr437His mutation have produced conflicting results:
one study reported a normal phenotype (Gould et al. 2006), whereas
other studies reported an increase of the IOP and loss of retinal ganglion
cells (Senatorov et al. 2006; Zhou et al. 2008). MYOC protein is normally
released into the aqueous humour from inside of the cells and release of
MYOC protein into the extracellular space in the presence of glaucoma
mutations is significantly reduced (Jacobson et al. 2001).
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Figure 1.6: Chromosomal regions linked to POAG: this figure has been published
elsewhere (Venturini et al. 2014a). The red lines represent linkage regions that
have been identified by analyses in single, large pedigrees. Line boundaries
have been determined by haplotype analyses. Red dots represent maximum
LOD scores from population based (family) studies.
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OPTN, on chromosome 10, was the second gene identified for POAG
through linkage analysis (Rezaie et al. 2002). OPTN associated POAG
is characterised by normal IOP as seen in patients with normal tension
glaucoma (Rezaie et al. 2002). The main mutation in OPTN gene linked
with POAG is E50 K (Allingham et al. 2009). Patients carrying this particular
mutation have more severe POAG phenotype, such as earlier onset and
more advanced optic nerve cupping. The molecular mechanisms related to
OPTN mutations are still unclear, however it has been hypothesised that the
OPTN protein may exert an effect on retinal ganglion cells by increasing
their susceptibility to premature cell death (apoptosis) (Allingham et al.
2009).
WDR36 is another gene identified for POAG though linkage analysis
(Monemi et al. 2005). Hauser et al. have suggested that WDR36 mutations
may influence susceptibility to POAG rather than cause the disease (Hauser
et al. 2006). WDR36 mutations may directly affect axon growth of the
retinal ganglion cells and lead to progressive retinal degeneration with
normal IOP in transgenic mice (Chi et al. 2010).
Mutations in NTF4 gene were reported in 1.7% of POAG patients in the
European population through linkage analysis (Pasutto et al. 2009). It was
hypothesised that these mutations may affect either NTF4 dimer stability
or the interaction between NTF4 dimer and its receptor TrkB (Pasutto et al.
2009). However, the role of NTF4 gene in POAG remains unclear as other
studies have failed to replicate this result (Liu & Allingham 2011).
Chapter 1. Introduction 30
1.2.3 Association studies
In the last decade, population-based association studies have become
increasingly popular in different medical fields, including eye research.
In principle linkage and association are two different phenomena. As
previously described, linkage is a specific genetic relationship between
loci, on the other hand association is simply a statistical statement about
the co-occurrence of alleles or phenotypes. Allele A is associated with the
disease D if the individuals with D also have A more often (or less often)
than would be expected from the individual frequencies of D and A in the
population. Linkage creates association within families, but it does not
itself produce any association in the general population where individuals
are unrelated. For example, if a locus X is linked to a disease locus, within
a family where the disease mutations is segregating, we would expect
affected people to have the same allele A for the X locus, but over the whole
population the distribution of X alleles is just the same in people with the
disease or not. However, if two ”unrelated” individuals with the disease
D have actually inherited it from a distant common ancestor, they may
well also tend to share particular ancestral alleles at loci closely linked to D.
Association studies in comparison with linkage design are generally
more powerful for complex disease influenced by multiple genes and
they allow a more precise localisation of the region of interest. Originally,
association studies were conceived around the ”common disease-common
variants” (CDCV) hypothesis stating that if a heritable disease/trait is
common in the population (greater than 1-5%), then the causative genetic
factors are also likely to be common (Lander 1996). As a ramification, the
total genetic risk must be spread across multiple common genetic factors
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with small effect.
Initially, association studies were performed for candidate regions that
were selected for their biological interest and understanding of the disease.
Here I review the literature for candidate and in particular genome-wide
association analysis performed for POAG and endophenotypes.
1.2.3.1 Candidate gene analyses
Many candidate genetic association studies for POAG have been performed.
Candidate genes have been selected through different strategies such as
genes involved in mechanisms that are assumed to be involved in POAG
pathogenesis, genes identified with linkage studies and genes involved
in the pathogenesis of related diseases. Many of these studies have had
inconsistent results and the role of these genes in the aetiology of POAG is
still controversial.
In the first category, association studies of genes regulating ocular blood
flow (nitric oxide synthase and endothelin-1 related genes) (Ishikawa et al.
2005; Logan et al. 2005; Motallebipour et al. 2005), aqueous humour
outflow (renin-angiotensin system genes) (Bunce et al. 2005; Hashizume
et al. 2005), apoptosis (tumour-protein P53 gene) (Dimasi et al. 2005; Lin
et al. 2002), immune system (interleukin 1β and tumour necrosis factor
α genes) (Lin et al. 2003, 2003), and neurodegeneration (apolipoprotein
E gene) (Copin et al. 2002; Lam et al. 2006; Mabuchi et al. 2005;
Vickers et al. 2002) were performed. Given the identification of MYOC
as a disease-causing gene, Mukhopadhyay et al. used a bio-informatics
approach to search for myocilin-related proteins that had a conserved
olfactomedin domain and were expressed in the eye (Mukhopadhyay
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et al. 2004). They thus identified the Noelin 1 and 2 genes as potential
candidates for POAG. One association study has since been performed
for the Noelin 2 gene (OLFM2) in Japanese subjects (Funayama et al.
2006). A possible disease causing mutation was identified and common
genetic variants were suggested to contribute to the glaucoma phenotype
by interacting with the optineurin gene.
For the last category, genetic association studies were conducted for
OPA1, the gene responsible for autosomal dominant optic atrophy (Delettre
et al. 2000; Alexander et al. 2000). Like glaucoma, optic atrophy is a
progressive optic neuropathy caused by degeneration of retinal ganglion
cells. Due to the absence of raised IOP, OPA1 was hypothesised to be most
likely associated with normal tension glaucoma. Genetic variants in the
OPA1 gene have indeed been associated with normal tension glaucoma,
but not with high tension glaucoma in Caucasian patients (Aung et al.
2002; Powell et al. 2003). A study in Japanese subjects confirmed this,
but showed that within the group of high tension glaucoma patients an
OPA1 variant was significantly related to the age at the time of diagnosis
(Mabuchi et al. 2005). The association between OPA1 variants and normal
tension glaucoma could not be replicated in Korean and African American
subjects (Woo et al. 2004; Yao et al. 2006).
1.2.3.2 Genome-wide association analyses
In a genome-wide association study (GWAS), a dense set of markers along
the whole genome is assessed for association with a disease or quantitative
trait.
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In 2007, the first GWAS of glaucoma yielded two common exonic variants
in LOXL1 that explained a significant proportion of the cases of exfoliation
glaucoma in a European population (Thorleifsson et al. 2007). Exfoliation
glaucoma is a form of secondary glaucoma in which aqueous humour
outflow is obstructed by fibrillar extracellular (exfoliative) material.
The data suggested that LOXL1 was particularly associated with the
accumulation of microfibrillar deposits in the anterior segment of the eye
(exfoliation syndrome) rather than with the consequent onset of secondary
glaucoma. Subsequent studies in populations of Caucasian, African and
Asian ancestry confirmed the association of LOXL1 with exfoliation
glaucoma and did not support any association with other subtypes of
glaucoma, such as primary open-angle glaucoma (Williams et al. 2010;
Chen et al. 2009; Challa et al. 2008).
A study in 1,263 affected cases and 34,877 controls identified a common
variant near CAV1 and CAV2 genes (Thorleifsson et al. 2010) associated
with POAG. Both genes are expressed in the trabecular meshwork as well
as in retinal ganglion cells. A recent study in a US Caucasian population
confirmed the association of the CAV1-CAV2 gene region with POAG and
further suggested that this association predominated in women (Wiggs
et al. 2011).
Burdon et al. conducted a GWAS in a cohort of patients with severe
glaucomatous visual field loss and identified susceptibility loci for POAG at
TMCO1 and CDKN2B-AS1 genes (Burdon et al. 2011). They replicated their
findings in an independent cohort of patients with advanced POAG, and
also in two cohorts of patients with less severe disease, suggesting that the
approach of selecting extreme phenotypes may be effective in identifying
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susceptibility genes for complex diseases.
In addition to these case-control studies, population-based GWASs
have identified chromosomal regions for POAG-related quantitative traits
(Table 1.1). Two GWASs in Caucasian populations independently identified
a locus for optic disc size near the ATOH7 gene at chromosome 10
(Macgregor et al. 2010; Ramdas et al. 2010). Although ATOH7 had already
been implicated in retinal ganglion cell formation in animal studies, the
study by Macgregor et al. was the first to associate this gene with optic
nerve pathology in humans (Macgregor et al. 2010). A subsequent GWAS
in 4,445 Singaporean individuals of Indian and Malay ancestry confirmed
the association of ATOH7 with optic disc area, suggesting that there are
shared genetic pathways which determine optic disc size across different
ethnicities (Khor et al. 2011).
Another chromosomal region of interest is the CDKN2Bas locus which
was associated with VCDR by Ramdas et al. (Ramdas et al. 2010). Both
genes are involved in the cell cycle regulation. This locus was replicated by
a GWAS in patients with severe glaucomatous visual field loss, indicating
that the same gene may influence both the normal variance in VCDR
and the risk of developing severe glaucoma (Burdon et al. 2011). These
findings support the hypothesis that studies of quantitative traits, such
as VCDR, in healthy individuals may assist in identifying susceptibility
genes for glaucoma. To assess whether the genetic variants identified for
optic disc parameters were associated with glaucoma, a meta-analysis
of 6 case-control studies (total N = 3,161 glaucoma cases and 42,837
controls) was performed (Ramdas et al. 2011). Of the 8 variants evaluated,
statistically significant associations with glaucoma were found for
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CDKN2Bas (identified for VCDR), SIX1/SIX6 (identified for VCDR), and
ATOH7 (identified for both optic disc area and VCDR). A subsequent
study in a US Caucasian sample of 539 glaucoma cases and 336 controls
confirmed these associations for CDKN2Bas and SIX1/6 (Fan et al. 2011).
For IOP, two loci were initially identified by a GWAS (van Koolwijk et al.
2012). The first locus overlapped with the TMCO1 locus, also identified
in cases with severe glaucomatous visual field loss. This finding again
indicated that the same genetic factors may be responsible for both
IOP variation and POAG, supporting the use of quantitative traits to
identify genes for POAG. The second locus was GAS7, a gene previously
implicated in cell remodelling. TMCO1 and GAS7 genes were associated
with glaucoma in a meta-analysis of 4 case-control studies in populations
of European ancestry. Both genes were found to be highly expressed in
the ocular tissues involved in glaucoma and to functionally interact with
known glaucoma disease genes.
A recent meta-analysis of GWAS of CCT involving more than 20,000
individuals of European and Asian ancestry, identified 16 new loci (Cirulli
& Goldstein 2010). The genes involved are COL5A1, AVGR8, FOX01,
AKAP13, ZNF469, FNDC3B and LRRK1-CHSY1 for the European ancestry
populations and COL5A1, AKAP13 and ZNF469 for the Asian ancestry
groups. The loci associated with CCT in European and Asian populations
together explained 8.3% of the variance in Europeans and 7% in Asians.
The relevance of CCT-associated loci for glaucoma was evaluated, using
independent case-control sets, showing that FNDC3B locus was associated
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also with POAG.
Gene region Location Associated trait Reference
CDC7 / TGFBR3 1p22.1 Optic disc size Ramdas WD, PLoS Genet 2010;6:e1000978
Optic disc size Khor CC, Hum Mol Genet 2011;20:1864-1872
TMCO1 1q24.1 Advanced POAG Burdon KP, Nat Genet 2011;43:574-578
IOP Van Koolwijk LME, PLoS Genet 2012
ZP4 1q43 POAG Nakano M, Proc Natl Acad Sci USA 2009;106:12838-12842
SRBD1 2p21 NTG Meguro A, Ophthalmology 2010;117:1331-1338
FNDC3B 3q26.31 central corneal thickness Lu Y, Nat Genet 2013; 45:155-163
POAG Lu Y, Nat Genet 2013; 45:155-163
ELOVL5 6p21.1-p12.1 NTG Meguro A, Ophthalmology 2010;117:1331-1338
CAV1 / CAV2 7q31 POAG Thorleifsson G, Nat Genet 2010;42:906-909
CDKN2A / CDKN2B / CDKN2B-AS1 9p21.3 VCDR Ramdas WD, PLoS Genet 2010;6:e1000978
Advanced POAG Burdon KP, Nat Genet 2011;43:574-578
COL5A1 9q34.2 central corneal thickness Vitart V, Hum Mol Genet 2010;19:4304-4311
central corneal thickness Lu Y, Nat Genet 2013; 45:155-163
PLXDC2 10p12.31 POAG Nakano M, Proc Natl Acad Sci USA 2009;106:12838-12842
ATOH7 10q21.3-q22.1 Optic disc size and VCDR Ramdas WD, PLoS Genet 2010;6:e1000978
Optic disc size Macgregor S, Hum Mol Genet 2010;19:2716-2724
Optic disc size Khor CC, Hum Mol Genet 2011;20:1864-1872
SCYL1 / LTBP3 11q13.1 VCDR Ramdas WD, PLoS Genet 2010;6:e1000978
DKFZp762A217 12q21.31 POAG Nakano M, Proc Natl Acad Sci USA 2009;106:12838-12842
AVGR8 13q12.11 central corneal thickness Vitart V, Hum Mol Genet 2010;19:4304-4311
central corneal thickness Lu Y, Nat Genet 2013; 45:155-163
DCLK1 13q13.3 VCDR Ramdas WD, PLoS Genet 2010;6:e1000978
FOXO1 13q14.1 central corneal thickness Lu Y, PLoS Genet 2010;6:e1000947
central corneal thickness Lu Y, Nat Genet 2013; 45:155-163
SIX1 / SIX6 14q23.1 VCDR Ramdas WD, PLoS Genet 2010;6:e1000978
LOXL1 15q24.1 Exfoliation glaucoma Thorleifsson G, Science 2007;317:1397-1400
AKAP13 15q25.3 central corneal thickness Vitart V, Hum Mol Genet 2010;19:4304-4311
central corneal thickness Lu Y, Nat Genet 2013; 45:155-163
LRRK1-CHSY1 15q26.3 central corneal thickness Lu Y, Nat Genet 2013; 45:155-163
SALL1 16q12.1 Optic disc size Ramdas WD, PLoS Genet 2010;6:e1000978
ZNF469 16q24.2 central corneal thickness Lu Y, PLoS Genet 2010;6:e1000947
central corneal thickness Vitart V, Hum Mol Genet 2010;19:4304-4311
central corneal thickness Lu Y, Nat Genet 2013; 45:155-163
GAS7 17p13.1 IOP Van Koolwijk LME, PLoS Genet 2012
BCAS3 17q23.2 VCDR Ramdas WD, PLoS Genet 2010;6:e1000978
CHEK2 22q12.1 VCDR Ramdas WD, PLoS Genet 2010;6:e1000978
CARD10 22q13.1 Optic disc size Khor CC, Hum Mol Genet 2011;20:1864-1872
Table 1.1: Genome-wide association studies of POAG and related quantitative traits: the
tables shows a summary of the genes identified for POAG and POAG-related
traits
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1.3 Limits in existing knowledge and aims of this thesis
GWAS represent a powerful tool and have identified hundreds of
genetic variants associated with several complex diseases, including
POAG, providing valuable insights into the complexities of their genetic
architecture (Hindorff et al. 2009). However, most variants identified so
far confer a small increment of in risk and explain only a small proportion
of heritability. Many explanations for this missing heritability have been
suggested, including limitations in the design of early GWAS (i.e. imprecise
phenotypes), much larger number of variants of smaller effect yet to
be found, rarer and structural variants with larger effect sizes that are
poorly detectable in genotyping arrays, low power to detect gene-gene
interactions and inadequate accounting for shared environment among
relatives (Manolio et al. 2009; Maher 2008). Consensus is however lacking
on approaches to research to examine the ”dark matter” of GWAS (dark
matter because we know it exists, we can detect its influence, but we
cannot ”see” it).
GWAS have shown that complex diseases cannot be explained by a
limited number of common variants of moderate effects. However, GWAS
will probably remain an efficient way of investigating missing heritability,
because their signals may define the genomic regions where rare and
structural variants are likely to cluster. The value of future studies
could be enhanced in various ways, including the increase of sample
sizes through meta-analyses of comparable data, expanding studies to
non-European ancestry populations, improving phenotyping and including
more quantitative and precise phenotypes. Other approaches may also
include investigating gene-gene and gene-environment interactions and
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enhancing the investigation of the X chromosome (Manolio et al. 2009).
Following the previous considerations, the main purpose of my PhD
project is to gain insight into the genetic aetiology of POAG and related
endophenotypes, using GWAS techniques. The rationale is to make the
most out of existing GWAS data and samples using different approaches.
The specific questions are:
• Which are the genetic variants underlying POAG endophenotypes in
the general population and the biological mechanisms underlying
them??
• Are POAG endophenotypes correlated with each other and if so is it
possible to combine POAG endophenotypes in order to unravel novel
shared genetic loci?
• Are genetic variants for POAG endophenotypes interacting with other
loci or between each other to determine IOP and VCDR?
• Is RNFL thickness correlated with other POAG endophenotypes? Are
there genetic variants affecting RNFL thickness? Do RNFL thickness
and Alzheimer’s disease have a shared genetics?
CHAPTER 2
Materials and methods
Here I describe materials and methods used in my PhD project.
2.1 Populations
To achieve the objectives of this thesis two cohorts have been used: the Blue
Mountains Eye Study (BMES) and the TwinsUK.
2.1.1 The Blue Mountains Eye Study
The BMES is a population-based survey of vision and common eye diseases
in the Blue Mountains region, Australia. This area has a stable and
homogeneous population, representative of Australians for income and
other socioeconomic status measurements. This study was approved by the
Western Sydney Area Health Service Human Ethics Committee. Written,
informed consent was obtain from all participants. A door-to-door census
of the study region was conducted using maps developed by the Australian
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Bureau of Statistics. All residents with birth-dates before January 1, 1943,
were invited to attend a detailed eye examination at the local clinic. Of
the 4433 eligible people, 3654 participated in the study between January
1992 and January 1994, of which 57% were male and 43% females, all
aged 49-97 years old (BMES-1). The second BMES study followed up
participants from the original cohort, five years later, from 1997-1999.
From the original 3,654 people who participated at baseline, 2,334
attended eye examinations for the second data collection period. The third
BMES study followed up participants from the baseline cohort, ten years
after the original data collection, in 2002-2004. From the 3,654 people
who participated at baseline, 1,952 attended interviews for the third data
collection period.
2.1.1.1 Phenotyping in the BMES cohort
At the clinic visit, a detailed questionnaire was administered including
demographic data, medications, family history, and medical history
of systemic disorders. Problems with vision, past eye disease or eye
treatment, and ocular symptoms were included. Applanation tonometry
using a Goldmann tonometer (Haag-Streit, Bern, Switzerland) was
performed using a drop of Fluress (Barnes-Hind). A single measurement
was taken, but repeated if judged unreliable. After pupil dilation with
tropicamide 1.0% and phenylephrine 10%, stereoscopic retinal and optic
disc photographs were taken using a Zeiss fundus camera (FF3 - Carl
Zeiss, Oberkochen, Germany) and Kodachrome 25 film processed by Kodak
(Eastman Kodak, Rochester, NY). Each participant had stereotopic 30◦
colour retinal photographs taken centred on the optic disc, macula, and
nonstereo photographs of modified lateral macula, upper temporal arcade
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and lower temporal arcade. Thirty-five millimetre slide transparencies were
mounted in clear plastic sheets, allowing close apposition of the stereo
pairs. Stereoscopic assessment of the optic disc in all participants was then
conducted by an ophthalmologist, who assessed the disc and field results.
Optic disc parameters subsequently were measured from the stereo optic
disc photographs using a Donaldson stereoviewer with a plastic template
placed under one the stereo pair. Vertical cup-disc ratios were calculated
from disc measurements, excluding the peripapillary halo. In measuring
vertical diameters, the longest diameter in a range between clock hours
of 11 and 1 to 5 and 7 was taken and then used to measure both disc
and optic cup. The optic cup was determined by its contour. The path of
vessels helped to define the contour of the neuroretinal rim. The presence
of rim thinning and extension of the cup to the superior or inferior rim of
the disc was noted. Other signs recorded included presence and extent of
peripapillary atrophy, hemorrhage crossing the disc margin, or a notch in
the cup. All photographs were graded by one or two graders. A summary
of the characteristics of the BMES population is shown in Table 2.1
For the BMES cohort, retinal nerve fibre layer thickness (RNFL)
measurements for the right eye was available. Several technologies
allow the measurements of the retinal ganglion layers and in particular
of RNFL layer. For instance, HRT (Heildenberg Retina Tomograph) is a
confocal scanning laser that takes images of serial sections of the optic
nerve to create a map of topographical sections of the optic nerve head and
the surrounding retina. HRT can measure the changes and loss of RNFL
(Belyea et al. 2014). Subjective refraction results were used to set initial
scan focus. The HRT cylindrical lenses were adapted for subjects with
astigmatism > −1.0 diopter (D). In brief, a 3-dimensional topographic
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image was constructed from multiple focal planes arranged axially along
the ONH. An average of 3 consecutive scans were obtained and aligned
to compose a single mean topography for analysis. The disc margin was
defined as the inner edge of the Elschnig ring and an experienced examiner
outlined the optic disc contour on the topographic and reflectance images.
ONH parameters were analysed by HRT 3 software automatically. Eyes
with a topography standard deviation (TSD) higher than 50 mm were
excluded from analysis because of the unreliability of measurement. Only
subjects with eligible HRT scans for right eyes were included in the study.
2.1.1.2 Genetic data in the BMES cohort
During the first follow-up, BMES, DNA was collected for 2,983 individuals
and sent to the Wellcome Trust Sanger Institute to be genotyped on the
Illumina Human 660-W Quad array platform as part of the Wellcome Trust
Case Control Consortium 2 (WTCC2). This is a custom chip designed by
WTCCC2 comprising Human 550. 2765 samples passed quality control
tests for DNA concentration (Invitrogen PicoGreen) and quality (X-Y
intensity analysis).
2.1.2 The TwinsUK registry cohort
The TwinsUK adult twin registry based at St.Thomas’ Hospital in London
is a volunteer cohort of over 12,000 twins from the general population
(Spector & Williams 2006; Moayyeri et al. 2013). Twins largely volunteered
unaware of the eye studies, gave fully informed consent under a protocol
reviewed by the St.Thomas’ Hospital Local Research Ethics Committee.
About 83% of the registry is female (mean age of 55 years). It contains
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now 51% MZ and 49% DZ twins. The majority of twins have been seen in
a clinical research unit where clinical tests are performed and blood, urine,
DNA and adipose tissue (in a subset) are collected and stored at -80◦C.
2.1.2.1 Phenotyping in the TwinsUK cohort
Intraocular pressure (IOP) was measured with a non-contact air-puff
tonometer. The Ocular Response Analyser (ORA, Reichert, Buffalo, NY)
ejects an air impulse in order to flatten the cornea, which is detected
by an electro-optical collimation system. The mean IOP was calculated
from 4 readings (2 from each eye) for each participant. VCDR in the
subjects was measured from stereo disc photographs using the Nidek-3DX
stereo camera, with digitised images scanned from Polaroid images and
StereoDx stereoscopic planimetric software (StereoDx) using a Z-screen
(StereoGraphics Corp) and software obtained from James Morgan from
Cardiff University software, Wales.
2.1.2.2 Genetic data in the TwinsUK cohort
Subjects were genotyped in two different batches of approximately the
same size, using two genotyping platforms from Illumina: 300K Duo
for and HumanHap610-Quad arrays. Whole genome imputation of the
genotypes was performed using HapMap2 (www.hapmap.org) haplotypes.
Stringent quality control (QC) measures were implemented, including
minimum genotyping success rate (>95%), Hardy-Weinberg equilibrium
(P>E-06), minimum MAF (>1%) and imputation quality score (>0.7).
Subjects of non Caucasian ancestry were excluded from the analysis.
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Pheno BMES TwinsUK
Age 66.19 (± 9.77),49-97 56.5(± 11.8), 16-83
Disc size 150.3 mm (± 16.35), 66.5-219mm (diameter) 2.58 mm2 (± 0.6 mm2),0.58-5.3 mm2 (area)
CDR 0.42 (± 0.13), 0.09-0.94 0.33(± 0.1), 0.035-0.7
IOP 18.04 (± 2.63), 8.00-34.5 mmHg 15.55 (± 3.18), 6.5-37 mmHg
Gender (% men) 57% 2%
Table 2.1: Characteristics of the BMES and TwinsUK cohorts: the table shows the
characteristics of the BMES and TwinsUK cohort
2.1.3 The International Glaucoma Genetics Consortium
Both BMES and TwinsUK cohorts are part of the International Glaucoma
Genetics Consortium (IGGC) which puts together the efforts of several
studies in order to unravel the genetic of POAG and associated quantitative
traits. For these cohorts, the summary statistics for several analysis were
available, however all raw phenotypic and genotypic data were analysed
separately by each group. I will describe briefly the main characteristics of
each cohort:
ALIENOR
The Alienor study is a population-based study in residents of Bordeaux,
France. The 963 participants, aged 73 years or more, were recruited
from an ongoing population-based study (3C Study). They underwent an
ophthalmological examination, including a recording of ophthalmological
history, measures of visual acuity, refraction, two 45 non mydriatic colour
retinal photographs (one centred on the macula, the other centred on the
optic disc), measures of intraocular pressure and central corneal thickness
and break-up time test. This research followed the tenets of the Declaration
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of Helsinki. Participants gave written consent for the participation in
the study. Individuals were genotyped at the French national centre for
genotyping (CNG) using Illumina Human 610-Quad BeadChip and then
imputed up to Hapmap2 CEU release 22 as reference panel.
Australian Twin Studies (BATS and TEST)
The Australian Twin Eye Study comprises participants examined as
part of the Twins Eye Study in Tasmania (TEST) or the Brisbane
Adolescent Twins Study (BATS) (Mackey et al. 2009). The Australian
cohorts were genotyped on the Illumina Human Hap610W Quad array,
with part of the sample typed alongside the TwinsUK cohort and the
remainder typed as a separate contract with DeCODE genetics. Imputation
was done with reference to HapMap release 22 CEU using MACH
(http://www.sph.umich.edu/csg/abecasis/MACH/). In BATS data from
1,152 people, from 517 families, were included in the analyses. For TEST,
686 individuals from 350 families were included. The mean IOP of both
eyes was used as outcome variable.
Beijing Eye Study
The Beijing Eye Study (BES) is a population-based cohort of Han Chinese
in the rural region and in the urban region of Beijing in North China
(Xu et al. 2005, 2008).The Medical Ethics Committee of the Beijing
Tongren Hospital approved the study protocol and all participants gave
informed consent, according to the Declaration of Helsinki. At baseline
in 2001, 4,439 individuals out of 5,324 eligible individuals aged 40
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years or older participated (response rate: 83.4%). In the year 2006,
the study was repeated by re-inviting all participants from the survey
from 2001 to be re-examined. Out of the 4,439 subjects examined in
2001, 3,251 (73.2%) subjects returned for the follow-up examination
in 2006. All study participants underwent an ophthalmic examination
including refractometry, pneumotonometry, slit-lamp biomicroscopy and
photography of the cornea, lens, optic disk and macula. Genotyping was
performed in 2,929 individuals using Illumina Human610-Quad BeadChip
in 988 subjects. Imputation was performed using IMPUTE v2.2.2 7 on
post-QC SNPs. The HapMap Phase II panel (build36, release 22 db126
JPT+CHB HapMap panel) was used for the imputation.
Erasmus Rucphen Family Study (ERF)
The Erasmus Rucphen Family (ERF) Study is a family-based cohort in a
genetically isolated population in the southwest of the Netherlands with
over 3,000 participants aged between 18 and 86 years (Aulchenko et al.
2004; Pardo et al. 2005). Cross-sectional examination took place between
2002 and 2005. The IOP was measured with Goldmann applanation
tonometry (Haag-Streit, Bern, Switzerland). All measurements in these
studies were conducted after the Medical Ethics Committee of the Erasmus
University had approved the study protocols and all participants had given
a written informed consent in accordance with the Declaration of Helsinki.
DNA was genotyped on one of four different platforms (Illumina 610k,
Illumina 300K, Illumina 370K and Affymetrix 250K) and then imputed up
to HapMap 2 build 36.
Chapter 2. Materials and methods 47
Framingham Eye Study
The Framingham Eye Study (FES) was nested within the Framingham
Heart Study (FHS, http://www.framinghamheartstudy.org), which began
its first round of extensive physical examinations in 1948 by recruiting
5,209 men and women from the town of Framingham, MA, USA (Hm et al.
1979). Surviving participants from the original cohort returned for biennial
exams, which continue to the present. A total of 2,675 FHS participants
were also examined as part of the FES between 1,973 and 1,975. The FES
was designed to evaluate ocular characteristics of examinees such as: senile
cataract, age-related macular disease, glaucoma, and retinopathy. Between
1989 and 1991, 1,603 offspring of original cohort participants also received
ocular examinations. Genotyping was conducted as part of the NHLBI
Framingham SNP Health Association Resource (SHARe). This sub-study
contains genotype data for approximately 550000 SNPs (Affymetrix
500K mapping arrays [Mapping250kNsp and Mapping250KSty] plus
Affymetrix 50K supplemental human gene-focused array) in over 9200
FHS participants. Genotype imputation to the HapMap-II reference panel
(CEU population release 22, NCBI build 36) was carried out in a two-step
process using the Markov Chain Haplotyping (MACH version 1.0.16.a)
software.
Gutenberg Health Studies (GHS I, GHS II)
The GHS is a population-based, prospective, observational cohort study
in the Rhine-Main Region in midwestern Germany with a total of 15,010
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participants and follow-up after five years. The study sample is recruited
from subjects aged between 35 and 74 years at the time of the exam. The
sample was drawn randomly from local governmental registry offices and
stratified by gender, residence (urban and rural) and decade of age. Within
GHS, DNA was extracted from buffy-coats from EDTA blood samples.
Genetic analysis was conducted in the first 5,000 study participants. For
these, 3,463 individuals were genotyped in 2008 (GHS I) and further
1,439 individuals in 2009 (GHS II). Genotyping was performed for GHS
I and GHS II using the Affymetrix Genome-Wide Human SNP Array
6.0. Genotypes were called using the Affymetrix Birdseed-V2 calling
algorithm.Imputation of missing genotypes was performed using IMPUTE
software v2.1.012 and HapMap release 24, NCBI Build 36.
Orkney Complex Disease Study (ORCADES)
The Orkney Complex Disease Study (ORCADES) is a population-based,
cross-sectional study in the Scottish archipelago of Orkney, including
1,285 individuals with eye measurements. The study received approval
from relevant ethics committees in Scotland and followed the tenets of
the Declaration of Helsinki. Genotypes were generated using HumanHap
300v2 or 370CNV-Quad Illumina SNP arrays. Genotypes were determined
using the Illumina BeadStudio software following the manufactureraˆs
standard recommendations. Imputation of allele dosage for over 2 million
SNPs on the 22 autosomal chromosomes with reference to HapMap CEU
build 36 release 22 was performed using the software MACH v1.0.15.
RAINE (Western Australian Pregnancy Cohort 20 year follow up Eye Study)
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The Western Australian Pregnancy Cohort (Raine) Study is an ongoing
prospective cohort study of pregnancy, childhood, adolescence and young
adulthood in Perth, Western Australia. At the initiation of the study, 2,900
pregnant women were recruited at 16-18 weeks’ gestation from the state’s
largest public women’s hospital and surrounding private practises for
a randomised clinical trial investigating effects of intensive ultrasound
and Doppler studies in pregnancy outcomes. Following this study, the
offspring of the recruited individuals have been evaluated in detail during
childhood and adolescence. At the 20-year review of the cohort, Raine
participants underwent a comprehensive ocular examination for the
first time. DNA samples and consents for GWAS studies were available
from the previous assessments. Genotype data was generated using
the genome-wide Illumina 660 Quad Array at the Centre for Applied
Genomics (Toronto, Ontario, Canada). Imputation was performed with
MACH v1.0.16 (http://www.sph.umich.edu/csg/yli/mach/index.html)
software using the CEU samples from HapMap phase2 build 36 release 22
(http://hapmap.ncbi.nlm.nih.gov/index.html.en).
Rotterdam Study (RS-I, RS-II, RS-III)
The Rotterdam Study is a prospective population-based cohort study in
the elderly living in Ommoord, a suburb of Rotterdam, the Netherlands
(Hofman et al. 2011). In brief, the Rotterdam Study consists of 3
independent cohorts: RSI, RS-II, and RS-III. Participants underwent
multiple physical examinations with regular intervals from 1991 to present.
All measurements in RS-I, RS-II and RS-III were conducted after the
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Medical Ethics Committee of the Erasmus University had approved the
study protocols and all participants had given a written informed consent in
accordance with the Declaration of Helsinki. DNA was extracted from blood
leucocytes according to standard procedures. Genotyping of SNPs was
performed using the Illumina Infinium II HumanHap550 chip v3.0 array
(RS-I); the HumanHap550 Duo Arrays and the Illumina Human610-Quad
Arrays (RS-II), and the Human 610 Quad Arrays Illumina (RS-III). Data
were imputed up to NCBI build 36, HapMap release.
Singapore cohorts (SIMES, SINDI, SCES)
Singapore Malay Eye Study (SIMES)
SIMES is a population-based prevalence survey of Malay adults aged 40 to
79 years living in Singapore that was conducted between August of 2004
and June of 2006 (Foong et al. 2007). From a Ministry of Home Affairs
random sample of 16,069 Malay adults in the Southwestern area, an
age-stratified random sampling strategy was used in selecting 1400 from
each decade from age 40 years onward (40-49, 50-59, 60-69, and 70-79
years). The 4,168 eligible participants from the sampling frame, while
3,280 (78.7%) participated. Genome-wide genotyping was performed in
3,072 individuals. Total of 3,072 DNA samples were genotyped using the
Illumina Human 610 Quad Beadchips.
Singapore Indian Eye Study (SINDI)
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SINDI is a population-based survey of major eye diseases in ethnic Indians
aged 40 to 80 years living in the South-Western part of Singapore and was
conducted from August 2007 to December 2009. In brief, 4,497 Indian
adults were eligible and 3,400 participated. Genome-wide genotyping was
performed in 2,953 individuals. The Illumina Human610 Quad Beadchips
was used for genotyping all DNA samples from SINDI (n=2,593).
Singapore Chinese Eye Study (SCES)
Similar to SINDI, the Singapore Chinese Eye Study (SCES) is a
population-based cross-sectional study of eye diseases in Chinese adults 40
years of age or older residing in the southwestern part of Singapore. The
methodology of the SCES study has been described in details previously.
Between 2009 and 2011, 3,353 (72.8%) of 4,605 eligible individuals
underwent a comprehensive ophthalmologic examination, using the same
protocol as SINDI. Genome-wide genotyping using was done in a subset of
1,952 SCES participants using Illumina Human610-Quad BeadChip. After
phenotype and genotype QC, 1,723 individuals were left for the analysis.
POAG case-control cohorts
ANZRAG
The Australian and New Zealand Registry of Advanced Glaucoma
(ANZRAG) recruits cases of advanced glaucoma Australia-wide through
ophthalmologist referral. The cohort also included participants enrolled in
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the Glaucoma Inheritance Study in Tasmania (GIST) that met the criteria
for ANZRAG. Advanced Primary Open Angle Glaucoma was defined as
best-corrected visual acuity worse than 6/60 due to primary open angle
glaucoma, or a reliable 24-2 Visual Field with a mean deviation of worse
than -22db or at least 2 out of 4 central fixation squares affected with
a Pattern Standard Deviation of < 0.5%. The less severely affected eye
was also required to have signs of glaucomatous disc damage. Worst ever
recorded intraocular pressure was obtained from the patientaˆs medical
record. Due to the advanced nature of the glaucoma, all participants were
on medical treatment to lower intraocular pressure and/or had undergone
surgery for the same. DNA extracted from peripheral whole blood was
genotyped on Illumina Human1M-Omni or OmniExpress arrays. SNPs with
a mean BeadStudio GenCall score < 0.7 were excluded. Controls used for
this analysis were historic, primarily unexamined controls, from several
sources. The Blue Mountains Eye Study (described above) were included.
Known cases of glaucoma were excluded from this dataset. Additional
controls from the Wellcome Trust Case Control Consortium 1958 British
Birth Cohort genotyped on Illumina arrays and Caucasian samples from
the Illumina iControl datasets were used. Imputation was calculated with
reference to HapMap release 22 CEU using MACH.
deCode
The Icelandic primary open angle glaucoma (POAG) cases were identified
from a list of participants in the Reykjavik Eye Study and from a list
compiled by Icelandic ophthalmologists in 2008 that included patients
55-86 years old at the time of diagnosis, all meeting either structural
(glaucomatous optic neuropathy) or functional (glaucomatous visual field
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defects) criteria of glaucoma or both. For visual fields measurements,
Octopus 123 perimeter (Haag-Streit AG, Koniz Switzerland) was used.
Intra ocular pressure (IOP) was not a part of the definition. On gonioscopy
the angles were found to be open and normal in appearance. The combined
list includes 598 individuals, 290 men and 308 women with POAG. The
diagnosis of exfoliation syndrome (XFS) was specifically evaluated and if
detected the participant was excluded from the study. The control group
included 98,670 Icelandic individuals without know history of glaucoma.
533 of the POAG samples and 85,689 of the controls samples were assayed
with the Illumina HumanHap300, HumanCNV370, HumanHap610,
HumanHap1M, HumanHap660, Omni-1, Omni 2.5 or Omni Express bead
chips at deCODE genetics and genotypes for about 34 million sequence
variants were imputed into the chip typed individuals based on a training
set of 2,230 whole genome sequenced Icelanders.
MEEI
491 cases and 351 controls collected from the Massachusetts Eye and
Ear Infirmary glaucoma clinic and comprehensive ophthalmology clinics
were recruited for this study. All cases and controls were residents of
the continental United States and were of mainly European ancestry,
which was confirmed by both self-identification and genetic markers.
Primary open angle glaucoma (POAG) cases were defined as individuals
for whom reliable visual field (VF) tests show characteristic VF defects
consistent with glaucomatous optic neuropathy. Individuals were classified
as affected if the VF defects were reproduced on a subsequent test or
if a single qualifying VF was accompanied by a cup-disc ratio (CDR) of
0.7 or more in at least one eye. The examination of the ocular anterior
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segment did not show signs of secondary causes for elevated IOP such as
exfoliation syndrome or pigment dispersion syndrome and the filtration
structures were deemed to be open based on clinical measures. Elevation
of IOP was not a criterion for inclusion; however, 67% of cases did have
a history of elevated IOP (≥ 22 mm Hg) measured in a clinical setting
(typically between the hours of 8AM and 5PM) and were classified as
high-pressure glaucoma (HPG). Genotyping was performed using the
Illumina Human660WQuadv1 array and 495,132 SNPs passed quality
control filters. Illumina’s BeadStudio and GenomeStudio and Autocall
software along with genotype cluster definitions based on study samples
were used to generate genotyping calls. Imputation was performed with
IMPUTE2 using the March 2012 1000 genomes as a reference panel.
NEIGHBOR
2,170 cases and 2,347 controls collected from 12 sites throughout the
United States were genotyped for the NEIGHBOR study. Primary open
angle glaucoma (POAG) cases were defined as individuals for whom
reliable visual field (VF) tests show characteristic VF defects consistent
with glaucomatous optic neuropathy. Individuals were classified as affected
if the VF defects were reproduced on a subsequent test or if a single
qualifying VF was accompanied by a cup-disc ratio (CDR) of 0.7 or more
in at least one eye. The examination of the ocular anterior segment did
not show signs of secondary causes for elevated IOP such as exfoliation
syndrome or pigment dispersion syndrome and the filtration structures
were deemed to be open based on clinical measures. Elevation of IOP
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was not a criterion for inclusion; however, 67% of cases did have a
history of elevated IOP (≥ 22 mm Hg) measured in a clinical setting
(typically between the hours of 8AM and 5PM) and were classified as
high-pressure glaucoma (HPG). Genotyping was performed using the
Illumina Human660WQuadv1 array and 523,528 SNPs passed quality
control filters. Allele cluster definitions for each SNP were determined
using Illumina GenomeStudio Genotyping Module version 1.7.4, GenTrain
version 1.0 and the combined intensity data from 99.9% of the samples.
The resulting cluster definitions were used on all samples. Imputation
was performed with IMPUTE2 using the March 2012 1000 genomes as a
reference panel.
Chapter 2. Materials and methods 56
Study n Mean age(sd) Age Range % men Mean VCDR(sd) VCDR range
BATS 966 20.2(3.8) 13-34 46.1 0.46(0.13) 0.09-0.75
BMES 1656 66.2(9.8) 49-97 57 0.43(0.13) 0.09-0.94
ERF 2131 47.3(14) 18-85 44.4 0.31(0.2) 0.00-0.87
GHS-I 783 55.9(10.9) 35-74 52.7 0.42(0.09) 0.22-0.86
GHS-II 485 55.1(10.9) 35-74 49.1 0.42(0.11) 0.17-0.90
Glaugen 341 64.4(11.1) 40-89 46.3 0.3(0.1) 0.10-0.70
Neighbor 2050 69.3(11.3) 35-97 43.9 0.32(0.13) 0.00-0.90
RAINE 1046 20(0.4) 18-22 51.3 0.28(0.2) 0.00-0.78
RS-I 5322 68(8.4) 55-99 41.6 0.5(0.13) 0.05-0.87
RS-II 2054 64.9(7.8) 55-98 45.8 0.5(0.13) 0.10-0.86
RS-III 1962 56.1(5.5) 45-89 43.9 0.29(0.21) 0.00-1.00
TEST 376 20.9(17.4) 5-79 41.5 0.44(0.12) 0.09-0.88
TwinsUK 1922 56.9(11.6) 16-83 2.1 0.34(0.11) 0.04-0.70
BES 727 58.6(9.3) 45-86 35 0.43(0.13) 0.00-0.77
SCES 1726 58.8(9.6) 44-86 51.2 0.34(0.17) 0.00-0.95
SINDI 2026 58(10) 43-84 51.2 0.46(0.23) 0.00-1.00
SIMES 2305 59.1(11) 40-80 49.4 0.39(0.23) 0.00-1.00
Table 2.2: Summary of demographic and phenotypes characteristics for each cohort for
VCDR
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Table 2.3: This table has been published elsewhere (Hysi et al. 2014). Summary of the
demographic and phenotypes characteristics for each cohort for intraocular
pressure
2.2 Statistical analyses
To date several methods have been used to investigate the genetic of
complex disease such as POAG. I present here the statistical analyses used
and developed for the purpose of this thesis.
2.2.1 Imputation and quality control for the BMES cohort
Genotyping data from the BMES cohort were imputed up to 1000Genomes
Pilot data (2010) (http://www.1000genomes.org/) using IMPUTE2
(Howie et al. 2009). Imputation methods estimate unobserved genotypes
Chapter 2. Materials and methods 58
by combining a reference panel of individuals genotyped at a dense set
of polymorphic sites (i.e. SNPs) with a study sample collected from a
genetically similar population and genotyped at a subset of these sites.
A population genetic model is used to extrapolate allelic correlations
measured in the reference panel that can predict unobserved genotypes in
the study sample. The aim is to expand the set of SNPs that can be tested
for association and can enhance true association signals and facilitate
meta-analysis.
All other cohorts included in this thesis were imputed to HapMap2 when
I have started my Phd course, for this reason only the SNPs also available
in the HapMap 2 data-set were selected from the 1000G imputation. This
step lead to a total of 2,617,903 SNPs.
Quality control was then performed at SNP and individual level using
Plink v1.07 (http://pngu.mgh.harvard.edu/ purcell/plink/). At the SNP
level quality control included excessive missing genotype, identification
of SNPs showing a significant deviation from Hardy-Weinberg equilibrium
(Hardy Weinberg p-value less than 0.001) and removal of markers with
very low allele frequency (less than 4%). Removing these low quality SNPs
was a key process in further analyses in order to reduce false positives
and identify the true association. Quality control was also performed
in the samples. Classically it involves identification of individuals with
discordant sex information, outlying missing genotype and heterozygosity
rate and duplicated and related individuals. In addition, homogeneity
of the population was checked in order to avoid issue due to ancestry
structure using principal components. The principal components are
calculated so that the first principal component accounts for as much
variation as possible in the data. In the PCA model of ancestry detection,
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the observations are the individuals and the potentially correlated variables
are the markers. I calculated the principal component in the BMES data
using pruned genome-wide genotype, that is when only independent (non
in LD) markers are included. This is was done in Plink v1.07. Figure 2.1
shows the plot of the first two principal components against each other.
The data were then merged with four reference panels from HapMap Phase
2 data from Europe (CEU), Asia (CHB+ JPT) and Africa (YRI). Figure 2.2
shows that the BMES cohort clusters together with the CEU population
from HapMap2.
Figure 2.1: First and second principal components for the BMES cohort
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Figure 2.2: First and second principal components for the BMES cohort plotted with
HapMap2 reference panels
2.2.2 Genome-wide association studies
Following quality control, genome-wide association analyses were
performed in the BMES and TwinsUK cohorts.
The analysis of genome-wide association data is a series of single-locus
tests, examining each SNP independently for association to the phenotype.
Quantitative traits are generally analysed using linear regression model
approaches where the phenotype of interest is the outcome (y) and the
genotype for a locus is the predictor(x) as in:
y = Xβ +  (2.1)
The measure of association between x and y is given by β1 , defined as the
amount of change that occurs with one unit change in x. If x is an indicator
for the presence of a variant allele at a given SNP locus and y is the
IOP level, then β1 is the difference in the mean IOP between individuals
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with or without this variant allele. Importantly, β1 is a measure of linear
association, capturing information on the extent to which the relationship
between x and y is a straight line. A linear regression can also include
multiple independent variables becoming a multivariable linear regression
model. For this additive model, the null hypothesis is the no association
between the genotype and the trait, given by h0 : β1 = 0. The calculation of
the parameter can be done with application of the Wald test or likelihood
ratio test.
All GWAS for the BMES in this thesis are performed using Plink v1.07
(http://pngu.mgh.harvard.edu/ purcell/plink/). An example command is:
1 for i in {1..22}
do
plink --bfile mydata_chromosome$i --linear --ci 0.95
--pheno mydata_pheno --pheno -name IOP --covar mydata_cov
5 --covar -name AGE ,SEX --out results
done
The outcome of the model were POAG endophenotypes (IOP, optic
disc measurements and RNFL thickness) and the predictor was the
genotype. All analysis were adjusted for age and sex. GWAS for the
TwinsUK were conducted in a similar way, however the analyses needed
to take into account the family structure. This is was done using MERLIN
(http://csg.sph.umich.edu/abecasis/Merlin/).
Manhattan and quantile-quantile plots were produced with R
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(https://www.r-project.org/). The QQ plot shows the expected distribution
of association test statistics (X-axis) across the million SNPs compared to
the observed values (Y-axis).
Genomic control was calculated for each GWAS using a R package
called GenABEL (http://www.genabel.org/). Genomic control is a standard
quality-control measure for GWAS and meta-analysis and the concept
behind is that apart from a small number of SNPs that show true
association with the trait, the test statistics for other SNPs should follow
the distribution under the null hypothesis of no association between a
SNP and a trait. Test statistics will be inflated across the whole genome
in case of an artificial difference in allele frequencies for example due to
population stratification, cryptic relatedness and errors.
Regional association plots of GWAS results were
produced using a web programme called LocusZoom
(http://locuszoom.sph.umich.edu/locuszoom/)
2.2.3 Meta-analysis of genome-wide association studies
Inverse variance weighted fixed-effect meta-analyses
were performed using either METAL software
(http://www.sph.umich.edu/csg/abecasis/metal/index.html) or GWAMA
(http://www.well.ox.ac.uk/gwama/). For IGGC meta-analyses, summary
association statistics for each variant and phenotype of interest (IOP and
VCDR) were generated from individual level information locally at each
participating team. All study effect estimates were corrected using genomic
control and were oriented to the positive strand of the NCBI Build 36
reference sequence of the human genome. After meta-analysis SNPs that
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were available in less than 16 populations and/or were showing large
heterogeneity, defined as I2>75% were removed. Heterogeneity is an
important concept in meta-analysis and it exists when the true effects differ
between studies and may be detectable if the variation between the results
of the studies is greater than expected by chance. It is therefore important
to quantify the extent of heterogeneity among a collection of studies. I2
describes the percentage of variability in point estimates that is due to
heterogeneity rather than sampling error (Higgins & Thompson 2002).
2.2.3.1 Gene expression
As the majority of the common genetic variants that are associated
with complex traits map to non-coding regions and may thus alter gene
regulation (Pennisi 2011), gene expression data were used to investigate
whether regions identified through GWAS and meta-analyses were related
to cis-regulation (in the vicinity of the gene) of mRNA. This analysis
was performed following IGGC meta-analysis on IOP. mRNA expression
of selected variants was investigated across multiple tissues: adipose,
lymphoblastoid cell lines (LCL) and skin. The analysis was performed in
856 mono and dyzigotic twins from the TwinsUK cohort from the MuTHER
(Multiple Tissue Human Expression Resource) project (Grundberg et al.
2012).
2.2.4 Gene annotation and gene-set enrichment analysis
Results for each GWAS obtained were annotated using the ENSEMBL
database (www.ensembl.org). Each gene was initially assigned the
significance of the best associated Single Nucleotide Polymorphism (SNP)
within its transcription-coding protein and the ±100 kb flanking its
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transcription coding site. The choice of the extent of the flanking region
is often subjective. This choice was made on the basis of evidence that
most cis- regulation occurs within this distance for most genes (Dixon et al.
2007). In case of conflict (a SNP eligible for more than one gene) the
gene closest to the SNP was used for annotation purposes and in the rare
instances where a SNP was inside two genes’ transcript start sequences,
both genes were assigned the significance of the SNP in question as long as
this was the strongest associated SNP within their sequences. Only genes
whose best-associated SNP passed a pre-set significance threshold of p≤
0.001 were included in further enrichment analysis.
Gene set enrichment analyses (GSEA) were carried out using the
Database for Annotation, Visualisation and Integrated Discovery (DAVID)
Bioinformatics tool (Huang et al. 2008) to determine if genes selected
on the basis of their GWAS significance participate in specific annotation
categories. The rationale of GSEA is that if a biological process is abnormal
in a given study, the co-functioning genes should have a higher potential
(enriched) to be selected as a relevant group by GWAS. I focused on
functional categories for the enrichment of the three classes of the Gene
Ontology (GO) database (biological processes, cellular components and
molecular functions) (http://www.geneontology.org/) and also the Kyoto
Encyclopedia of Genes and Genomes (KEGG) categories. I then investigated
the evidence that any of these categories were over-represented in the
GWAS results. Fisher’s exact tests were conducted to assess the actual
representation of these annotation categories compared to expectations
under the null hypothesis of non enrichment and randomness of each gene
set in the GWAS results.
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2.2.4.1 Meta-analysis of gene-set enrichment results
Fisher’s exact p-values were meta-analysed using a method to combine
p-value developed by Fisher. I included in the meta-analyses only those
results for which fold-change enrichment’s values were in the same
direction for all cohorts, all greater than 1 or all smaller than 1, and
removed from the analyses functional categories that showed trends with
less clear directionality.
2.2.5 Multivariate analysis
Several methodologies have been used to combine POAG quantitative
traits in a GWAS setting including epidemiological and genetic correlation,
dimension reduction methods and regression models.
2.2.5.1 Correlation
A total of 2,302 from the BMES was included in the analysis. A list
of several factors putatively linked with POAG was compiled. This list
included: IOP, vertical disc diameter (VDD), vertical cup diameter (VCD),
VCDR, CCT, refractive error and age. All variables were standardised in
order to have all mean equal to zero and standard deviation equal to
1. A correlation analysis was carried out in the BMES sample using R
(http://www.r-project.org/) and Pearson’s coefficient was obtained.
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2.2.5.2 Genetic correlation
I used a linear mixed model to obtain estimates of the genetic covariance
and hence genetic correlation between POAG traits as implemented in
GCTA software (Yang et al. 2011) (Genome Complex trait analysis). This
technique allows to estimate the genetic variance of each trait and that
genetic covariance between two traits that can be captured by all SNPs
(Lee et al. 2012). A set of 2,301 individuals with information on a panel of
2,617,903 SNPs from the BMES was analysed.
2.2.5.3 Principal factor analysis
A total of 5,796 individuals of Caucasian origin were taken from two
different cohorts: 2,302 from the BMES and 3,493 from the TwinsUK.
An iterated factor analysis was carried out aiming to capture the main
variation from POAG phenotypes. IOP, VDD, VCD, CDR, CCT measurements
and age were included. The analysis was run including all the cohorts in
order to have a phenotype that I could compare across populations. The
analysis was run in STATA version 12 (Stata Corp. College Station, TX)
using ”ipf” command. The most relevant factors were identified, using
a threshold of an eigenvalue of 1 (Kaiser’s criterion) as the criterion to
include principal factors in subsequent stages of the analysis.
2.2.5.4 Regression models
There are several approaches to perform a multivariate test of association
with multiple phenotypes. For instance, one could simply test the global null
hypothesis of no association with either phenotype using MANOVA treating
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the two phenotypes as a bivariate normal response and the single genetic
variant as an explanatory variable (Stephens 2013).
A set of 2,302 of individuals from the BMES and a set of 1,508 from the
TwinsUK were analysed. In the TwinsUK one twin of each pair needed to be
excluded to avoid issue created by family structure. A bivariate regression
model was implemented including IOP and VCDR. The multivariate linear
model is:
Y(nxm) = X(nxk+1)B(k+1xm) + E(nxm)
where Y is a matrix of n observation on m response variable; X is a
model matrix with columns for k+1 regressors, B is a matrix of regression
coefficients, one column for each response variable; and E is a matrix of
errors. There are several commonly employed multivariate test statistics
that can be used: Pillai-Bartlett Trace, Hotelling-Lawley Trace, Wilk’s
Lambda and Roy’s Maximum Root. This multivariate linear model was fit
in R with the lm function, where the left-hand side of the model is a matrix
of responses with a column for IOP and a column for CDR and each row
and observation; the right-hand side of the model are the same as for an
univariate linear model. The response matrix is composed from individual
response variables via the cbind function. First I fitted a multivariate linear
model to the data, treating IOP and CDR as responses:
1 mod <- lm(cbind(IOP , CDR) ∼ SNP + age + gender
We then use the manova function in R to test the null hypothesis of no
association with either IOP and CDR:
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1 test <- manova(mod)
I then use the function summary to extract the Pillai-Bartlett Trace
p-values. Results from the BMES and TwinsUK were then combined using
Fisher’s combine probability method as described elsewhere (Fisher 1992).
Another multivariate regression model known as generalised estimating
equation (GEE) was implemented. This approach includes generalised
linear models that take into account a possible unknown correlation
between outcomes. A set of 2,302 individuals from the BMES and
1,508 from the TwinsUK cohort were selected. The GEE implemented
in SMAT R package was applied. Specifically in Schifano et al. paper
(Schifano et al. 2013) when multiple phenotypes are positively correlated
and measure the same underlying trait in the same direction (after
transformation), the authors have implemented an inverse probability
weighted (IPW) regression in order to test and estimate the shared
common effect of SNPs on multiple continuous secondary phenotypes.
As an estimating-equation-based approach, it accounts for arbitrary
correlation among multiple phenotypes and is robust to departure from
normality.
2.2.6 Snp by snp interaction model
An interaction model was implemented to take into account of snp by snp
interaction in a regression framework.
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Two lists of 17 SNPs associated with VDCR and 10 SNPs associated with
IOP in the IGGC meta-analysis described in Chapter 3 were compiled.
The model was:
V CDR = β1SNP1 + β2SNP2 + β3SNP1xSNP2 (2.2)
and:
IOP = β1SNP1 + β2SNP2 + β3SNP1xSNP2 (2.3)
where SNP1 is one of the variant included in the lists and SNP2 in
a SNP included in all genome (imputed to HapMap2 for a total of >
2,500,000 variants). This produced a total of >17∗2,500,000 interaction
models for VCDR and >12∗2,500,000 for IOP. All analyses were adjusted
for age and sex. The analysis was performed in Plink v1.07 (command
–epistasis). Family structure was not taken into account, thus only unrelated
individuals could be used. For example, for the TwinsUK, I selected one
individual from each pair at random to be included in further analyses.
2.2.7 Investigating the shared genetics between two diseases
Several methods can be used to investigate the genetic link between two
diseases or quantitative traits. A possible genetic overlap between the
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RNFL and Alzheimer’s disease (AD) was investigated. AD information
was not available either in the BMES or TwinsUK cohorts, thus a list of
candidate genetic variants for AD was create through literature search.
In particular, results from the Alzheimer’s Disease Genetics Consortium
(ADGC) on late-onset Alzheimer’s disease (Naj et al. 2011) were used. The
meta-analysis included a total of 18,832 cases and 35,597 controls and
genotypes were imputed up to HapMap 2. Summary statistics for all SNPs
with a p-value<0.0001 were publicly available. 435 genetic variants were
included in the list. A more recent meta-analysis for AD was conducted
in 2013, however results from the meta-analysis in 2011 were preferred
because all results with a p-value <0.0001 were included in the paper and
data were imputed in HapMap 2 rather than 1000G. This AD-associated
SNPs list was used to check whether there was an overlap with RNFL
meta-analysis and if the effect sizes from the two meta-analyses were
correlated. All these analyses and related graphs were performed in R
(http://www.r-project.org/).
2.2.7.1 Polygenic risk score
To evaluate whether AD-associated SNPs have an aggregated role on
RNFL thickness, polygenic risk score analysis was performed. Variation
across associated loci for AD was summarised into quantitative scores and
then these scores were related to RNFL thickness variation in the BMES
population. Two sets of SNPs were used to generate aggregate risk scores.
The first risk score included 37 SNPs, selecting from the 435 AD-associated
SNPs according to linkage disequilibrium (LD). The second score was
created including 16 AD-associated SNPs that are also significant in the
RNFL meta-analysis conducted and are independent between each other.
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For each individual in the BMES cohort I calculated the number of score
alleles they possessed, each weighted by the log of the odds ratio from the
AD meta-analysis. The score is simply a sum across SNPs of the number
of reference alleles (0,1,2) and that SNPs multiplied by the score for that
SNP. The process of selecting SNPs according to linkage disequilibrium and
the calculation of the risk scores was done using PRSice software (Euesden
et al. 2015). PRSice is a software package written in R, including wrappers
for PLINK2 (Chang et al. 2015) to minimise computational time.
2.2.7.2 Multi-SNP risk score
Large sample sizes are required to identify genetic association and
likely the BMES cohort alone does not have enough power to pinpoint
genetic overlap between RNFL thickness variation and AD through the
polygenic risk score. Given the small sample size in the BMES cohort
(960 individuals), a multi-SNP score analysis, which allows summary
results from both RNFL thickness meta-analysis and AD meta-analysis, is
appealing. The method has been proposed to investigate the link between
adiponectin levels and Type 2 Diabetes (Dastani et al. 2012). Using this
methodology, the average effect of AD risk alleles on RNFL thickness could
be approximated, allowing the use of meta-analysis summary statistics
rather than individual level data as used normally in polygenic risk
score calculation. The weighted sum of the individual SNP coefficients
leads also to an estimate of the explained variance. The genetic risk
score was calculated using results from AD consortium and the RNFL
thickness meta-analysis described in this chapter. The risk score was
weighted using the AD effects for the 16 independent SNPs, previously
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selected to be significant in both AD and RNFL thickness meta-analysis
and not in LD. This analysis was performed with the R package ”gtx”
(https://cran.r-project.org/web/packages/gtx/index.html)
Plots were produced using basic graph, ggplot2 and routines in R language
(http://www.r-project.org/). Ggplot2 is a plotting system for R, which
provides a powerful model of graphics (http://ggplot2.org/).
CHAPTER 3
Genome-wide association studies and glaucoma endophenotypes
In this chapter I will present my work aimed to unravel the genetic
architecture of POAG endophenotypes using GWAS, meta-analysis of
GWAS and gene-set enrichment analysis.
STATEMENT OF CONTRIBUTION TO THIS RESEARCH:
I performed quality control and GWAS for the BMES study for POAG
endophenotypes. I was involved in the conceptualisation and experimental
design of the project on ATOH7 gene and I performed all the analysis for
the BMES. I am first author of the manuscript that has been published in
the British Journal of Ophthalmology (Venturini et al. 2014b).
For the IGGC meta-analysis, I partecipated in the meta-analysis and
performed all analyses required for the BMES. I took part in revising the
manuscript and producing some of the graphs of the original publications
in Nature Genetics (see reference (Hysi et al. 2014) and (Springelkamp
et al. 2014)).
I was involved in the experimental design and performed gene-set
enrichment analysis for each cohort and meta-analysed the results. Results
were previously presented at ARVO meeting 2014.
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3.1 Background
Studying an age-related complex disease like POAG presents several
challenges. An important strategy for gene discovery in POAG is to dissect
the disease into its associated endophenotypes, that are quantitative traits
associated with the disease (Cannon & Keller 2006). Optic disc parameters
and IOP are considered endophenotypes for POAG, they can be measured
on a quantitative scale in large data set of healthy individuals and may be
more sensitive measures of salient aspects of POAG pathogenesis.
Optic nerve parameters are important aspects of POAG assessment
and treatment. Evaluation of the structural integrity of the optic nerve
head is part of the assessment of POAG. Specifically, the optic disc is the
location where the axons of the retinal ganglion cells leave the eye and
form the optic nerve (O’Neill et al. 2009). Glaucomatous optic neuropathy
can be recognised by changes in the morphology of the optic disc, caused by
loss of retinal ganglion cells. Clinically, the optic nerve can be quantitatively
assessed measuring different parameters such as the optic disc size and the
cup/disc ratio (CDR). The CDR is a parameter commonly used in clinical
glaucoma management (Kwon et al. 2009). An unusually large CDR is a
significant determinant of glaucoma (Keltner et al. 2006) and an increasing
CDR may be a sign of glaucoma progression (Hsu et al. 2010). On the
other hand, the disc size, measured as the area or the diameter of the disc,
has a controversial role in POAG assessment. It has been suggested that a
larger optic disc may suffer more from IOP-related stress (Bellezza et al.
2000). However, it has been argued that a larger optic disc may have more
anatomical reserve due to a higher number of nerve fibres (Hoffmann et al.
2007), and thus larger optic disc may be protective against POAG.
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Elevated IOP is the main risk factor for POAG and the only one that
can be modifiable by treatments (Czudowska et al. 2010; Kass et al. 2002).
Currently, IOP-lowering is the only treatment for POAG and has been
shown to reduce visual field loss and thus decrease POAG progression
(Maier et al. 2005).
Several genes have been associated with optic disc measurements
and IOP and some of them were also implicated in POAG (as described
in Chapter 1). For example, the ATOH7 gene has been associated with
both VCDR and POAG (Burdon et al. 2011; Macgregor et al. 2010; Ramdas
et al. 2010, 2011). This gene is expressed in the retina where it controls
photoreceptor development and, in addition, it has a key role in ocular
embryogenesis (Khor et al. 2011). Another example is represented by
the TMCO1 gene which has been associated with both IOP and POAG
susceptibility (Burdon et al. 2011; van Koolwijk et al. 2012).
Despite the encouraging successes with GWAS, we still lack a clear
understanding of the biological mechanisms and molecular events
controlling POAG endophenotypes and consequently the risk of POAG. The
genetic associations reported to date explain only a small percentage of the
trait heritability, as GWAS need even larger samples to achieve sufficient
power to identify further variants. Using current sample sizes, true positive
association signals may be hidden among the random noise of false positive
results (Yang et al. 2010).
In this chapter, I will present my work, in which I aimed to investigate
the genetic architecture of POAG endophenotypes using genome-wide
Chapter 3. Genome-wide association studies and glaucoma endophenotypes 76
association studies. GWAS for optic disc measurements and IOP have
already led to discoveries about genes and pathways about POAG
providing new biological insight. The aim of this chapter was to confirm
and identify novel genetic factors for POAG endophenotypes through
extensive meta-analyses and interpretation of GWAS results. Specifically
the objectives were:
• to identify novel genetic variants affecting POAG endophenotypes
through GWAS in the BMES and also to clarify the role of ATOH7
gene in optic nerve measurements
• to meta-analyse the results from the BMES with several other
European and Asian cohorts from IGGC
• to identify functional categories of genes associated with IOP using
gene-set enrichment analysis from GWAS results from IGGC
3.2 Methods
Quality control and genome-wide association studies were performed on
IOP and VDCR in the BMES cohort as described in Chapter 2.2.2. In brief,
average between the two eyes was used as phenotype for both VCDR and
IOP and a linear regression was performed adjusted for age and sex.
I performed further analysis in a candidate region including ATOH7 gene
in the BMES and TwinsUK cohorts. ATOH7 was defined as the open reading
frame ±100 kbp. This candidate region covers from 560k bp to 761k bp on
chromosome 10 based on NCBI36/hg18 assembly. I performed association
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analysis for the ATOH7 gene region and three different linear regressions
were performed:
• the first linear regression had disc size (diameter for the BMES and
area for TwinsUK) as output and genotypes as predictor adjusted on
age, sex and IOP
• the second linear regression had CDR as output and genotypes as
predictor adjusted on age, sex and IOP
• finally the third model had CDR as output, genotypes as predictor and
adjustments were done for age, sex, IOP and disc size.
Meta-analysis of GWAS results with European and Asian cohorts were
performed as part of the IGGC and more details are described in Chapter
2.2.3. Analysis for VCDR were also adjusted for disc size and those for IOP
were adjusted for CCT.
Following IOP meta-analysis, a gene-set enrichment analysis for GWAS
for each cohort was carried out. Results were then meta-analysed using
Fisher’s combined probability method. More details are described in the
Chapter 2.2.4).
3.3 Results
3.3.1 Genome-wide association analyses in the BMES for POAG
endophenotypes
The first aim of this chapter was to investigate common genetic variants
underlying POAG endophenotypes in the BMES cohort.
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2,617,903 SNPs were analysed for a total of 1,677 individuals from the
BMES data set. The average age in the BMES cohort was 66.2 (SD=9.8,
range=49-97) and 57% of them were males.
3.3.1.1 Association analyses for VCDR
The mean VCDR was 0.43 (SD=0.13) and the phenotype was normally
distributed (Figure 3.1).
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Figure 3.1: Distribution of VCDR in the BMES cohort: the figure shows the histogram and
the density curve of the VCDR phenotype.
A GWAS on VCDR in the BMES sample was carried out and the inflation
factor αwas 1.006, showing the absence of population substructure. Results
were plotted in a quantile-quantile plot (Q-Q plot) as shown in Figure 3.2.
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Figure 3.2: Q-Q plot for the GWAS for VCDR in the BMES cohort
No loci passed Bonferroni correction as shown in Figure 3.3. However,
a number of loci of suggestive significance were identified in the VCDR
GWAS for the BMES data set (Figure 3.3). Several genetic signals were
pinpointed on chromosome 6, for example at rs287832 and rs1757824
(respectively β=0.026, SE=0.005, P=3.786E-07 and β=0.026, SE=0.005,
P=3.856E-07) which are close to the TPBG transcript. This gene encodes
a leucine-rich transmembrane glycoprotein that may be involved in cell
adhesion. The effect size for these loci was 0.026, which means that each
copy of the risk alleles (in this case the minor alleles: A for rs287832 and
G for rs1757824) increased VCDR of 0.026 mm. The minor allele was 0.27
for both variants.
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Figure 3.3: Manhattan plot of the results from the GWAS for VCDR in the BMES cohort:
the 22 autosomes are plotted along the x-axis, whereas the values in the y-axis
denote the log 10 transformed p-values from the GWAS in the BMES cohort
with VCDR observed for any of the SNPs
3.3.1.2 Clarifying the role of ATOH7 gene in optic disc measurements
Following the GWAS on VCDR in the BMES cohort, I focused on a candidate
region, including ATOH7 gene (Venturini et al. 2014b). A set of 1,677
individuals from the BMES data set was analysed. After adjustments for
confounds, a strong signal was found at rs7916697 (Allele=G, β=3.78,
SE=0.66, P=1.68E-08) for VDD. In addition, rs7916697 was significant
to a lesser degree for VCDR (Allele=G, β=0.02, SE=0.005, P=2.43E-04)
adjusted on age, sex and IOP. However, no association signal at this SNP
was found when the analysis for VCDR was adjusted on age, sex, IOP
and VDD (Allele=G, β=0.007, SE=0.04, P=0.15) as shown in Figure 3.4.
Results are shown in Table 3.1.
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A1 Effect BMES SE BMES P BMES Effect TwinsUK SE TwinsUK P TwinsUK
Disc size G 3.779 0.66 1.676E-08 0.15 0.02 1.84E-08
CDR G 0.019 0.005 2.43E-04 0.01 0.004 0.01
CDR adjusted on disc size G 0.007 0.004 0.148 0.005 0.004 0.24
Table 3.1: The results of the three association analyses for rs7916697 for the BMES
and TwinsUK cohorts: the table shows the results for the association analysis
for rs7916697 lying on ATOH7 gene. Effect, effect size; SE, standard error;
P, p-value for the association. This table has been published elsewhere (see
reference (Venturini et al. 2014b))
Figure 3.4: Regional association plots for VCDR (A) and VCDR adjusted for disc diameter
(B) for the results in the BMES cohort: this figure shows the regional
association plots for analysis on VCDR and VCDR adjusted for disc diameter
in the BMES cohort for ATOH7 gene region (Venturini et al. 2014b).
The results showed that adjusting for disc size decreased the magnitude of
the effect. In the BMES cohort, each additional copy of the susceptibility
allele for rs7916697 increased the VCDR by an average of 0.019 units
when the analysis was not adjusted on disc size. When VDD was added
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as covariate, the increase was only of 0.007 units. Replication analyses
were carried out in 1,922 individuals from the TwinsUK cohort. The signal
at rs7916697 for disc size was replicated (Allele=G, β=0.15, SE=0.02,
P=1.84E-08). The association for this SNP was significant to a lesser
degree for CDR (Allele=G, β=0.01, SE=0.004, P=0.01), but was not
significant for CDR additionally adjusted on disc size (Allele=G, β=0.005,
SE=0.004, P=0.24).
3.3.1.3 Association analyses on IOP
Similar to the VCDR analysis, another GWAS was performed for IOP level.
1,667 individuals from the BMES cohort were analysed with 16.04 mmHg
(SD=2.63) average IOP and 66.19 (SD=9.77) mean age (Figure 3.5).
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Figure 3.5: Distribution of IOP in the BMES cohort: the figure shows the histogram and
the density curve of the VCDR phenotype in mmHg scale.
The genomic inflation factor (α) was calculated and was estimated to be
0.99 for the BMES cohort, suggesting within-study control (Figure 3.6).
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Figure 3.6: Quantile-quantile plot for the GWAS for IOP in the BMES cohort
GWAS results on IOP suggested that several loci were associated with IOP
in the BMES cohort (Figure 3.7). One signal crossed the genome-wide
significance at rs1571173 on chromosome 20 (β=1.135, SE=0.2,
P=3.415E-08). For each copy of the risk allele (A) IOP increased of
1.135 mmHg. This SNP was imputed in the BMES with an high imputation
score (0.914) and minor allele frequency of 0.06. The variant lies on an
intergenic region and the closest gene is DOK5. The protein encoded by
this gene is a member of the DOK family of membrane proteins, which
are adapter proteins involved in signal transduction. It interacts with
phosphorylated receptor tyrosine kinases to mediate neurite outgrowth
and activation of the MAP kinase pathway. Near the same gene, another
variant was identified with suggestive significance (rs1571172: β=1.052,
SE=0.2, P=5.626E-07). Another suggestive genetic locus was found at
rs4792947 on chromosome 17 (β=0.571, SE=0.116, P=1.031E-06). This
is a genotyped variant (minor allele frequency = 0.25) which lies on an
intergenic region. However, this region shows high regulatory activity and
it is close to several genes such as SLC25A39,RNDC3A, SCC4A1, GPATCH8,
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HDAC5, G6PC3.
A further GWAS on IOP level adjusted on CCT measurements was
conducted. The results for the BMES cohort did not change after adjusting
for CCT. The two loci near to DOK5 gene did not lose in strength
and significance (rs1571173: β=1.127, SE=0.204, P=4.312E-08 and
rs1571172: β=1.044, SE=0.209, P=6.856E-07).
Figure 3.7: Manhattan plot of the results from the GWAS for IOP in the BMES cohort: the
22 autosomes are plotted along the x-axis, whereas the values in the y-axis
denote the log 10 transformed p-values from the GWAS in the BMES cohort
with IOP observed for any of the SNPs. The blue line represents a suggestive
significance (P=1E-05).
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3.3.2 Meta-analysis of genome-wide association studies for POAG
endophenotypes
A large meta-analysis for POAG endophenotypes with data from several
studies from Europe, USA, Australia and Asia, as part of the IGGC (more
details on the IGGC, see Chapter 2) was performed to investigate genetic
factors underlying POAG.
For VCDR meta-analysis, 21,094 individuals from 10 European-derived
populations were used in the meta-analysis. Replication was performed in
6,784 individuals from four Asian cohorts. 2.5 million SNPs imputed to
HapMap2 were analysed. More details were described in Chapter 2.2.3.
For VCDR meta-analysis, the overall inflation factors (λ) was calculated
and was 1.05.
In the meta-analysis of European cohorts, 440 genome-wide significant
SNPs across 15 different regions were identified (Table 3.2). Genome-wide
significance was assessed using Bonferroni correction.
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SNP CHR Gene A1 MAF Euro Effect Euro SE Euro P Euro MAF Asians Effect Asians SE Asians P Asians Effect Com SE Com P Com P Het
rs4658101 1 CDC7/TGFBR3 a 0.18 0.015 0.002 8.80E-14 0.14 0.016 0.005 3.13E-03 0.015 0.002 1.06E-15 0.17
rs2623325 3 COL8A1 a 0.09 0.018 0.003 7.05E-09 0.17 0.011 0.005 1.46E-02 0.016 0.003 6.61E-10 0.70
rs17658229 5 DUSP1 c 0.05 -0.02 0.004 8.06E-09 0 -0.086 0.133 5.17E-01 -0.02 0.004 8.06E-09 0.59
rs17756712 6 EXOC2 g 0.17 0.01 0.002 1.98E-08 0.12 0.011 0.005 1.76E-02 0.01 0.002 1.13E-09 0.72
rs7865618 9 CDKN2BAS g 0.43 -0.013 0.001 2.80E-20 0.15 -0.021 0.005 8.11E-06 -0.013 0.001 4.97E-24 0.70
rs1900005 10 ATOH7 a 0.23 -0.019 0.002 7.21E-31 0.26 -0.01 0.004 2.08E-02 -0.018 0.002 5.51E-31 8.5E-05
rs7072574 10 PLCE1 a 0.33 0.009 0.002 6.17E-09 0.37 0.007 0.003 4.80E-02 0.009 0.001 1.02E-09 0.26
rs1346 11 SSSCA1 t 0.19 -0.014 0.002 2.54E-15 0.16 0.003 0.005 5.23E-01 -0.012 0.002 4.89E-13 0.15
rs4936099 11 ADAMTS8 c 0.42 -0.009 0.002 6.38E-09 0.06 -0.007 0.009 4.15E-01 -0.009 0.002 4.61E-09 0.68
rs11168187 12 RPAP3 g 0.16 -0.009 0.002 2.96E-08 0.18 -0.005 0.004 2.80E-01 -0.009 0.002 2.96E-08 0.99
rs10862688 12 TMTC2 g 0.45 0.008 0.001 1.24E-11 0.55 0.004 0.003 2.48E-01 0.008 0.001 1.49E-11 0.02
rs4901977 14 SIX1/6 t 0.31 0.01 0.002 1.98E-11 0.51 0.017 0.003 2.64E-07 0.011 0.001 2.13E-16 0.20
rs1345467 16 SALL1 g 0.27 0.01 0.002 2.70E-12 0.11 0.011 0.006 5.53E-02 0.01 0.001 4.19E-13 0.25
rs6054374 20 BMP2 t 0.42 -0.009 0.002 1.79E-08 0.73 0.001 0.004 8.66E-01 -0.007 0.001 1.69E-07 0.08
rs1547014 22 CHEK2 t 0.31 -0.013 0.001 2.98E-18 0.15 -0.013 0.004 4.26E-03 -0.013 0.001 4.77E-20 0.39
rs301801 1 RERE c 0.33 0.008 0.001 1.61E-07 0.13 0.012 0.005 2.59E-02 0.008 0.001 1.66E-08 0.52
rs868153 6 HSF2 g 0.36 -0.007 0.001 5.08E-06 0.38 -0.013 0.003 1.44E-04 -0.007 0.001 1.39E-08 0.79
rs5756813 22 CARD10 g 0.39 0.006 0.001 1.60E-05 0.33 0.017 0.004 1.71E-06 0.008 0.001 7.73E-09 0.20
Table 3.2: Summary of the results of the meta-analysis of genome-wide association studies
for VCDR: this table shows the summary of the results of the meta-analysis
of genome-wide association studies for VCDR that showed genome-wide
significance in 21,094 European and 6,784 Asian individuals. Gene is based
on reference NCBI build 37; A1, reference allele; MAF, minor allele frequency;
effect, effect size on VCDR based on A1; SE, standard error of the effect size; P
het, test for heterogeneous effects between European and Asian samples. This
table has been published elsewhere (Springelkamp et al. 2014).
Genetic factors identified in the Caucasian meta-analysis were checked for
replication in the Asian cohorts. Eight of these genetic loci were nominally
significant at p < 0.05 and the direction and magnitude of the effects was
consistent with the Caucasian sample (Table 3.2). In addition, five of the
seven loci that did not reach nominal significance in those of Asian descent
had a similar effect in the same direction.
A combined meta-analysis of the European and Asian populations was
also performed and resulted in three additional genome-wide-significant
loci on chromosomes 1, 6 and 22 (Table 3.2, Figure 3.8). The level of
heterogeneity across the samples is shown in Table 3.2, suggesting that for
most variants the difference between studies was not significant.
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Figure 3.8: This figure has been published elsewhere (see reference (Springelkamp et al.
2014)). Manhattan plot of the GWAS meta-analysis for vertical cup-disc
ratio in the combined analysis (n=27,878). The plot shows the − log 10
transformed P values for all SNPs. The red-dotted horizontal line represents
the genome-wide significance threshold of P<5E-08; the blue-dotted line
indicates P value of 1E-05. Red circles indicate novel loci identified for VCDR.
Ten novel loci were identified for VCDR and lies next to/within COL8A1,
DUSP1, EXOC2, PLCE1, ADAMTS8, RPAP3,SALL1, BMP2, HSF2 CARD10
genes. The allele frequency was not different across different cohorts. A
number of loci identified for VCDR in the combined meta-analysis have
been previously associated with optic disc area: CDC7/TGFBR3, ATOH7,
SALL1 and CARD10 (Ramdas et al. 2010; Khor et al. 2011). In particular,
in the combined meta-analysis rs1900005 was the most significant signal
(β=-0.018, SE=0.002, P=5.51E-31) that lies within ATOH7 gene. The
effect size (β) was -0.018, meaning that each copy of A allele decreased
VCDR of 0.018 mm in average. The second signal was identified at
rs7865618 within CDKN2BAS gene. The effect size was -0.013 (SE=0.001)
and the p-value was 4.97E-24.
Further analyses included GWAS results adjusted for optic nerve disc
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size (Table 3.3). For CDC7-TGFBR3 locus (rs4658101), adjusting for disc
area reduced the significance in the IGGC meta-analysis (p=3.48E-11 to
p=9.00E-03). As observed for BMES and TwinsUK cohorts, effect sizes
reduced also for the variants lying in ATOH7 gene. However, in the
meta-analysis, there was still some significant disc-area independent effect
(P=1.60E-06). For the ten novel loci, there was no change in association
significance suggesting that these genetic factors affect primarily CDR and
not the disc area.
SNP CHR Gene A1/A2 Effect Unadj SE Unadj P Unadj Effect adj disc size SE adj disc size P adj disc size
rs4658101 1 CDC7/TGFBR3 a/g 0.014 0.002 4.26E-13 0.005 0.002 9.04E-03
rs2623325 3 COL8A1 a/c 0.018 0.003 1.50E-10 0.015 0.003 2.70E-08
rs17658229 5 DUSP1 c/t -0.020 0.004 3.56E-08 -0.017 0.004 8.35E-07
rs17756712 6 EXOC2 g/a 0.010 0.002 6.08E-09 0.008 0.002 3.19E-06
rs7865618 9 CDKN2BAS g/a -0.014 0.002 7.04E-21 -0.014 0.001 9.56E-27
rs1900005 10 ATOH7 a/c -0.018 0.002 4.44E-29 -0.007 0.002 1.60E-06
rs7072574 10 PLCE1 a/g 0.009 0.002 2.98E-10 0.007 0.001 1.38E-06
rs1346 11 SSSCA1 t/a -0.012 0.002 7.21E-12 -0.010 0.002 2.25E-08
rs4936099 11 ADAMTS8 c/a -0.009 0.002 4.66E-08 -0.008 0.001 5.93E-09
rs11168187 12 RPAP3 g/a -0.009 0.002 6.17E-07 -0.008 0.002 2.04E-06
rs10862688 12 TMTC2 g/a 0.007 0.001 4.32E-09 0.005 0.001 6.66E-06
rs4901977 14 SIX1/6 t/c 0.012 0.002 7.56E-17 0.014 0.001 8.89E-23
rs1345467 16 SALL1 g/a 0.010 0.002 1.44E-10 0.007 0.002 2.35E-05
rs6054374 20 BMP2 t/c -0.007 0.002 2.20E-06 -0.007 0.001 5.65E-09
rs1547014 22 CHEK2 t/c -0.013 0.002 1.15E-17 -0.011 0.002 3.23E-13
rs301801 1 RERE c/t 0.008 0.002 6.42E-07 0.008 0.002 1.49E-07
rs868153 6 HSF2 g/t -0.008 0.002 2.24E-07 -0.007 0.001 2.76E-06
rs5756813 22 CARD10 g/t 0.009 0.002 3.32E-09 0.007 0.001 2.62E-09
Table 3.3: SNPs that showed genome-wide significant (P<5E-08) association with VCDR
in subjects of European and Asian ancestry combined, adjusted for disc size: the
table shows results for the meta-analysis on VCDR asjusted for disc size. Only
individuals with both information on VCDR and disc size were included in this
comparison. A1 = reference allele; A2 = other allele; Effect = effect size on
VCDR based on allele A1; Chr= chromosome; SE = standard error
Likewise, a meta-analysis for IOP as part of the IGGC was conducted.
The IOP meta-analysis included 35,296 individuals whose 27,558 were of
European ancestry and 7,738 of Asian ancestry. 2.5 million SNPs imputed
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to HapMap2 were analysed.
The results for each cohort showed that the inflation factors α ranged
between 0.992 and 1.043. There were 145 SNPs that crossed conventional
genome-wide significance threshold (p<5E-08) (Dudbridge & Gusnanto
2008)(Table 3.4). All of these SNPs clustered around seven separate
regions of the genome (Figure 3.9). The most significant signal was
found at rs9913911 (β=-0.179, SE=0.026, P=1.03E-11), lying within
GAS7 gene. G allele was protective, leading to a decrease of 0.179
mmHg of IOP level. GAS7 gene has been previously identified for IOP
(van Koolwijk et al. 2012). Two variants were identified at rs4656461 and
rs7555523 (respectively β=0.228, SE=0.039, P=6.51E-09 and β=0.235,
SE=0.039, P=2.19E-09), lying within TMCO1 gene. This gene has also
been previously associated with IOP (Burdon et al. 2011; van Koolwijk et al.
2012). There was also an association for IOP level with variants within
CAV1 and CAV2 genes (P=1.87E-11 for rs10258482) which had previously
been associated with POAG (Thorleifsson et al. 2010). The region on
chromosome 11 was novel for IOP and included several genes such as
AGBL2, SPI1 and PTPRJ (best p=1.04E-11 for rs747782). Other novel
loci on chromosome 9 included ABCA1 gene (P=2.80E-11 for rs2472493)
and ABO (P=3.08E-11 for rs8176743). Another novel signal was found at
rs6445055 on chromosome 3 within FNDC3B gene (P=4.19E-08).
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CHR BP SNP A1/A2 Gene Effect SE P P Heterogeneity I2
1 165687205 rs4656461 G/A TMCO1 0.228 0.039 6.51E-09 0.46 0
1 165718979 rs7555523 C/A TMCO1 0.235 0.039 2.19E-09 0.55 0
3 171992387 rs6445055 A/G FNDC3B -0.177 0.03 4.19E-08 0.17 0.24
7 116150095 rs10258482 A/C CAV1 0.196 0.029 1.87E-11 0.81 0
7 116150952 rs10262524 A/C CAV1 0.186 0.029 9.69E-11 0.67 0
9 107695848 rs2472493 G/A ABCA1 0.159 0.024 2.80E-11 4E-05 0.66
9 136131415 rs8176743 T/C ABO 0.261 0.039 3.08E-11 0.53 0
11 47468545 rs12419342 C/T RAPSN 0.153 0.026 4.77E-09 0.75 0
11 47940925 rs747782 C/T NUP160 PTPRJ 0.203 0.03 1.04E-11 0.95
11 47969152 rs1681630 T/C PTPRJ 0.144 0.026 1.69E-08 0.6 0
11 48004369 rs7946766 T/C PTPRJ 0.23 0.035 2.71E-11 0.35 0.09
17 10031183 rs9913911 G/A GAS7 -0.179 0.026 1.03E-11 4E-04 0.61
Table 3.4: Results for the IGGC meta-analysis for IOP from the general population cohorts:
this table shows the results for the association with IOP from the general
population cohorts for SNPs significant at a multiple testing correction level
(p<5E-08). This table has been published elsewhere (Hysi et al. 2014).
Figure 3.9: This figure has been published elsewhere (see reference (Hysi et al. 2014)).
Manhattan plot of the results from the meta-analyses of results from 18
multi-ethnic cohorts from the IGGC. The 22 autosomes are plotted along the
x-axis, whereas the values in the y-axis denote the log 10 transformed p-values
from the meta-analysis of association with IOP observed for any of the SNPs.
Loci previously associated with IOP are shown in grey.
I also investigated whether the genetic signal near to DOK5 gene identified
in IOP GWAS in the BMES cohort was confirmed in the IGGC meta-analysis.
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Even though rs1571173 did not reach genome-wide significance in
this larger sample, it showed nominal significance (β=0.09, SE=0.04,
P=0.042).
Following the meta-analysis, the effect on the clinical outcome of the
SNPs identified of POAG was investigated in four independent cohorts.
These included 4,284 POAG cases and 95,560 controls. Novel associations
to IOP were also confirmed in POAG for variants lying on ABCA1 gene
(P=4.15E-09 for rs2472493), FNDC3B gene (P=0.03 for rs6445055) and
on the chromosome 11 cluster (p=0.008 for rs12419342). Association
for known loci for POAG was also confirmed: TMCO1 (P=1.34E-16
for rs7555523), CAV1/CAV2 (P=6.27E-09 for rs10258482) and GAS7
(P=5.22E-13 for rs12150284). All alleles associated with an increase of
IOP were also associated with an increased risk of POAG (see Table 3.5
). The only gene that was not associated with POAG susceptibility was ABO.
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CHR BP SNP A1/A2 Gene OR 95% CIs 95% CIs P
1 165687205 rs4656461 G/A TMCO1 1.38 1.28 1.5 2.55E-15
1 165718979 rs7555523 C/A TMCO1 1.4 1.3 1.52 1.34E-16
3 171992387 rs6445055 A/G FNDC3B 0.92 0.85 0.99 0.03
7 116150095 rs10258482 A/C CAV1 1.2 1.13 1.28 6.27E-09
7 116150952 rs10262524 A/C CAV1 1.2 1.13 1.28 1.39E-08
9 107695848 rs2472493 G/A ABCA1 1.24 1.16 1.34 4.15E-09
9 136131415 rs8176743 T/C ABO 1.07 0.96 1.19 0.2
11 47468545 rs12419342 C/T RAPSN 1.09 1.02 1.16 0.008
11 47940925 rs747782 C/T NUP160/PTPRJ 1.03 0.96 1.11 0.36
11 47969152 rs1681630 T/C PTPRJ 1.06 0.99 1.12 0.08
11 48004369 rs7946766 T/C PTPRJ 1.03 0.95 1.12 0.43
17 10031183 rs9913911 G/A GAS7 0.8 0.75 0.85 2.98E-13
Table 3.5: Results for the association of IOP identified SNPs with POAG in a case-control
validation meta-analyses: this table shows the results for POAG case-control
meta-analysis for the SNPs identified in the IOP meta-analysis. CHR:
chromosome; BP: base-pair position; A1: effect allele; A2: other allele; Gene:
closest gene/transcript; OR: odds ratio; 95% CIs: 95% confidence intervals; P=
p-value of the meta-analysis. This table has been published somwehere else
(Hysi et al. 2014).
Following this analysis, a linear regression was performed to investigate
whether effect sizes for IOP meta-analysis were linearly related to effect
sizes on POAG case-control analysis (Do et al. 2013). The findings
suggested that the strength on SNP effect on IOP levels was related with
their effects on the risk of POAG (β=0.788, SE=0.264, P=0.031).
Gene expression for IOP identified loci was investigated (as described
in Chapter 2.2.3.1) in 856 mono and dyzigotic twins from the TwinsUK
cohort (Table 3.6).
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CHR BP SNP A1/A2 Gene Adipose LCL Skin Probe Gene
1 165687205 rs4656461 G/A TMCO1 0.004 0.12 0.003 1793829 TMCO1
1 165718979 rs7555523 C/A TMCO1 0.39 0.0001 0.05 1761804 ALDH9A1
3 171992387 rs6445055 A/G FNDC3B - - - -
7 116150095 rs10258482 A/C CAV1 - - - - -
7 116150952 rs10262524 A/C CAV1 5.79E-16 8.54E-05 3.91E-13 1687583 CAV1
9 107695848 rs2472493 G/A ABCA1 0.19 3.67E-05 0.36 1766054 ABCA1
9 136131415 rs8176743 T/C ABO - - - - -
11 47468545 rs12419342 C/T RAPSN 0.002 4.32E-08 0.0003 1696463 SPI1
11 47940925 rs747782 C/T NUP160 0.36 - - - -
11 47969152 rs1681630 T/C PTPRJ 0.006 2.72E-10 0.002 1696463 SPI1
11 48004369 rs7946766 T/C PTPRJ 0.66 2.02E-05 0.0066 1688627 AGBL2
17 10031183 rs9913911 G/A GAS7 - - - - -
Table 3.6: eQTL effects observed for the IOP associated SNPs in three different tissues:
eQTL effects observed for the IOP associated SNPs in three different tissues
(adipose, LCL and skin) from 849 individuals from the TwinsUK cohort. This
table has been published elsewhere (Hysi et al. 2014).
Significant eQTL association was observed for rs4656461 and rs7555523
(P=0.003 and P=0.0001 with TMCO1 and ALDH9A1 transcript expressions
in skin and LCLs respectively), rs2024211 (P=5.43E-16 and 3.84E-13
with CAV1 in adipose and skin tissues respectively), rs2472493 with
ABCA1 (P=3.67E-05 in LCLs) and rs1681630 with the SPI1 expression on
chromosome 11 (P=2.72E-10 in LCLs) (Table 3.6).
CCT is known to be related with IOP, therefore, additional analyses were
performed for IOP adjusted on age, sex and also CCT measurements (Tonnu
et al. 2005). The results were similar in the meta-analysis with 19,563
individuals with CCT measurements. Rs6445055 within FNDC3B gene was
previously associated with CCT (Lu et al. 2013), however it maintained
nominal significance for IOP after adjustment (P= 9.87E-04, β= -0.121
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compared to -0.177 prior to adjustment for CCT), suggesting that this locus
has some independent effect on CCT.
3.3.3 Common mechanisms underlying IOP identified in functional analysis
of gene lists from GWAS results
Following IOP GWAS and meta-analysis, the results for each GWAS from
the IGGC were annotated using Ensembl as described in Chapter 2.2.4.
After annotation the number of genes from each annotation did not exceed
2,000 unique genes or transcripts. Gene set enrichment analysis was
carried out for each cohort and meta-analysed the results. I focused on
Gene Ontology (GO) database, which describes gene products in three
structured ontologies in terms of their associated biological processes,
cellular components and molecular functions. For this analysis, a total of
14,721 entries from the GO database were investigated: 9,818 biological
processes, 1,208 cellular component entries, and 3,695 molecular functions.
In the discovery cohorts of European descent, several GO entries that were
highly significantly enriched across all cohorts were identified. There was a
remarkable overlap of results between all data sets, both in term of strong
probabilities for significant enrichment and highly correlated values of fold
enrichment for the respective terms. Meta-analysed results for each GO
category are shown in Table 3.7, Table 3.8 and Table 3.9.
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GO Term GO ID European meta-analysis p-value Asian meta-analysis p-value
biological adhesion GO:0022610 1.91E-20 1.39E-04
cell adhesion GO:0007155 1.43E-19 1.47E-04
cell-cell adhesion GO:0016337 1.03E-11 N.S
neuron development GO:0048666 4.37E-11 0.01
neuron differentiation GO:0030182 7.09E-10 0.001
cell projection organization GO:0030030 3.42E-09 N.S.
cell motion GO:0006928 9.34E-09 3.26E-04
homophilic cell adhesion GO:0007156 1.5x10-08 1.47x10-04
Table 3.7: Gene-set enrichment meta-analysis results: Gene ontology (GO) biological
process: this table shows the results of the gene-set enrichment meta-analysis
for biological processes for both European and Asian cohorts. Go Term: gene
ontology term; GO ID: gene ontology identification number
GO Term GO ID European meta-analysis p-value Asian meta-analysis p-value
plasma membrane part GO:0044459 9.76E-18 2.33E-08
plasma membrane GO:0005886 2.32E-16 7.65E-05
cell junction GO:0030054 2.68E-15 1.9E-05
synapse GO:0045202 9.14E-10 3.34E-05
cell projection GO:0042995 1.42E-08 0.02
Table 3.8: Gene-set enrichment meta-analysis results: Gene ontology (GO) cellular
component: this table shows the results of the gene-set enrichment
meta-analysis for cellular components for both European and Asian cohorts.
Go Term: gene ontology term; GO ID: gene ontology identification number
Term GO ID European meta-analysis p-value Asian meta-analysis p-value
calcium ion binding GO:0005509 6.56x10-20 1.23x10-04
Table 3.9: Gene-set enrichment meta-analysis results: Gene ontology (GO) molecular
function: this table shows the results of the gene-set enrichment meta-analysis
for molecular functions for both European and Asian cohorts. Go Term: gene
ontology term; GO ID: gene ontology identification number
Across the different GO categories, strong suggestions for association
between adhesion pathways and IOP were found in the discovery cohorts of
European descent. Among the most associated GO entries were biological
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adhesion (P= 1.91E-20), cell adhesion (P= 1.44E-19) and plasma
membrane (P= 9.76E-18), cell junction (P= 2.68E-15), and calcium ion
binding (P= 6.57E-20). Most of these results suggest the importance of
cellular adhesion and calcium channels in IOP regulation. GO entries
are not independent between each other and a simplified scheme of the
associated GO entries taking into account their dependencies is shown in
Figure 3.10
Figure 3.10: Scheme of the main Gene Ontology entries and dependencies significantly
enriched in the meta-analysis: the figure shows the GO entries identified in
the meta-analysis (marked with a star) and how they are related between
each other.
The importance of cellular adhesion was confirmed in the Asian replication
populations. Biological and cell adhesion showed significant enrichment in
the four Asians cohorts (P= 1.39E-04 and P= 1.47E-04 respectively). In
addition, plasma membrane (P= 2.34E-08), cell junction (P= 2.68E-15)
and calcium ion binding (P=1.23E-04) were also replicated in the Asian
cohorts, suggesting a role of cellular adhesion in plasma membrane and
calcium channels in IOP regulation.
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3.4 Discussion
In this chapter I investigated the genetic architecture of POAG
endophenotypes, in particular VCDR and IOP, in order to better understand
the mechanisms underlying POAG.
Firstly, I investigated common genetic variants underlying POAG
endophenotypes in the BMES cohort. For VCDR, no loci crossed
genome-wide significance, however a few suggestive regions were
identified. A region on chromosome 6 near to TPBG gene was identified,
encoding a leucine-rich transmembrane glycoprotein that may be involved
in cell adhesion (Murakami et al. 2010). Another signal significant for
VCDR was a locus within ATOH7, a known gene for disc size (Ramdas et al.
2010; Macgregor et al. 2010; Khor et al. 2011). The role ATOH7 in optic
disc phenotypes variation was investigated further. The association for a
locus within ATOH7 gene was strong for disc size, however it was totally
lost for VDCR adjusted on disc size. Therefore, these results suggest that
ATOH7 gene has a key role in disc size variation, however its association
with CDR depends on the correlation between the two measurements.
ATOH7 gene encodes a member of the basic helix-loop-helix family of
the transcription factors with similarity to Drosophila atonal gene that
controls photoreceptor development. Studies in mice suggest that this
gene plays a central role in retinal ganglion cell and optic nerve formation
(Mao et al. 2011). CDR is a well known POAG endophenotype, whereas
the relationship between the disease and disc size is weak and not well
understood. Larger optic discs may suffer more from IOP-related stress,
however the size of the disc affects the likelihood of clinical diagnosis of
glaucoma, thus providing a source of bias (Crowston et al. 2004).
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For IOP in the BMES cohort, I identified a significant region nearby
DOK5 gene. The protein encoded by this gene is a member of the DOK
family of membrane proteins, which are adapter proteins involved in signal
transduction. The encoded protein interacts with phosphorylated receptor
tyrosine kinases to mediate neurite outgrowth and activation of the MAP
kinase pathway. In addition, it may have a role in apoptosis (Pan et al.
2013) and cardiomyocyte differentiation (Wen et al. 2009). The gene has
been also associated with obesity and type-2 diabetes (Tabassum et al.
2010).
Larger sample sizes are needed to increase the power to detect genetic
variants underlying POAG endophenotypes. For this purpose, the BMES
GWAS results were meta-analysed with several European and Asian
populations from the IGGC. For VCDR meta-analysis, 18 loci were
associated with VCDR and ten of them were novel. Most of them were
associated independently of the disc size. The results suggest a role of
cellular stress response. For instance, DUSP1 expression is induced by
oxidative/heat stress and growth factor and it is involved in oxidative
stress and environmental stress response (Keyse & Emslie 1992). It may
also play a role in negative regulation of cellular proliferation and in
the immune response (Ca´ceres et al. 2013). In addition, also HSF2 is
part of the cellular stress response pathway. This gene is part of the HSF
family of transcription factors that bind specifically to the heat-shock
promoter element and activate transcription. Heat shock transcription
factors activate heat-shock response genes under conditions of heat or
other stresses and its role is crucial in the maintenance of neural survival,
also in retinal ganglion cells (Kwong et al. 2006). It is also involved in
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neuronal migration (El Fatimy et al. 2014). Another process involved in
CDR variation is exocytosis. EXOC2 gene encodes a protein part of the
exocyst complex, which is involved in directing exocytic vesicles to the
plasma membrane (Lipschutz & Mostov 2002). This mechanism is also
important for neuronal degeneration (Coleman & Yao 2003). PLCE1 is an
interesting gene for VCDR as it encodes for a phospholipase enzyme that
may affect cell growth and differentiation and cancer (Wang et al. 2010;
Wang et al. 2014; Abnet et al. 2010).
Seven regions were identified through IGGC meta-analysis for IOP. A
signal within ABCA1 gene were identified. This gene encodes for a
membrane-associated protein, member of the super family of ATP-binding
cassette (ABC) trasnporters and it functions as a cholesteral efflux pump in
the cellular lipid removal pathway. The gene has been previously associated
with Alzheimer’s disease (Furney et al. 2011). In addition, ABCA1 gene
is expressed in many tissues (Denis et al. 2003) and its expression in
leukocytes is significantly up-regulated in glaucoma patients (Yeghiazaryan
et al. 2005).The meta-analysis pinpointed a number of SNPs within ABO
blood group gene and IOP. However, this association was not confirmed
in the POAG case-control meta-analysis and this might be due to type I
error in the first meta-analysis or insufficient power to detect IOP SNPs
in the case-control meta-analysis which also includes NTG patients. The
findings showed an association between IOP and variants within a large
region on chromosome 11 and eQTL analysis underlined SPI1 and AGBL2
as possible interesting candidates. SPI1 gene encodes an ETS-domain
transcription factor that activates gene expression during myeloid and
B-lymphoid cell development. The protein encoded by SPI1 gene binds to
a purine-rich sequence known as the PU-box found near the promoters
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of target genes, and regulates their expression in coordination with other
transcription factors and co-factors. The regulation of the transcription
factor is disrupted in leukemia (Prange et al. 2014) and it may also be
involved in viability and function of human brain microglia (Smith et al.
2013). AGBL2 gene is a latexin-interacting protein that regulates tubulin
tyrosination cycle and it may be involved in cell proliferation in gastric
(Zhu et al. 2014) and breast cancer (Zhang et al. 2014).
Interestingly, the signal for DOK5 identified in the BMES cohort for IOP
was replicated, albeit at nominal significance, in the IGGC meta-analysis,
showing that apoptosis might be involved in IOP regulation.
eQTL analyses pinpointed ALDH9A1 gene as a possible candidate for
IOP, given its location downstream of the TMCO1-associated variant.
ALDH9A1 encodes a protein that belongs to the aldehyde dehydrogenase
family of proteins is expressed in the ciliary body (Janssen et al. 2012).
After the meta-analysis on IOP level, I investigated potential biological
categories affecting the IOP control among general populations through
gene-set enrichment analysis. Aqueous humour outflow pathway is a key
determinant of IOP. Fluid flow in the anterior chamber maintains IOP and
supplies nutrients to the non-vascularised cornea, lens, and trabecular
meshwork (TM) (Tian et al. 2000). I identified calcium ion binding as a
significantly enriched GO term in the molecular process category in both
European and Asian samples. The effect of calcium on IOP has been studied
previously and, in particular, several investigators have focused on how
calcium channel blockers (CCBs) affect IOP in humans and animals. CCBs
have a wide spectrum of action and are primarily used for the treatment
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of hypertension and angina. High levels of systolic blood pressure are
known to be associated with higher IOP in several studies (Klein & Klein
1981). One of the first studies investigating the association of CCBs with
IOP conducted by Abelson and colleagues (Abelson & Smith 1988) found
that local application of verapamil, an L-type calcium blocker, significantly
decreased the IOP in both eyes in human participants. In addition, many
studies have reported the effect of CCBs on IOP after topical administration,
but not with systemic administration (Mayama 2014). However, the extent
of the IOP drop after topical CCBs seems to be very small, and has been
reported to be approximately 2 mmHg after topical verapamil in humans
(Abreu et al. 1998). CCBs may affect IOP through several mechanisms.
For instance, they may alter the aqueous humour inflow by interfering
with the gap junctions between the pigmented and pigmented ciliary
epithelium (Abelson & Smith 1988) and cation transport in the non
pigmented ciliary epithelial cells (Mito et al. 1993). In addition, it has been
shown that human and bovine trabecular meshwork cells express voltage
activated L-type calcium channels (Steinhausen et al. 2000). Finally, CCBs
may increase the conventional outflow facility via trabecular meshwork
(Erickson et al. 1995).
I found several GO terms related to biological and cellular adhesion,
gap junction and plasma membrane enriched for IOP. Adhesion molecules,
such as integrins, selectins and the immunoglobin super family, play a
key role in blood pressure and in particular in the vascular tone, i.e.
the contractile activity of vascular smooth muscle cells (SMCs) in the
walls of small arteries and arterioles. For their role in the vascular tone,
adhesion molecules are relevant not only for hypertension, but also for
a number of artery disease processes (i.e. atherosclerosis) (Jang et al.
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1994). Cell adhesion molecules exert their activity mostly in cell-cell
interaction and cell-extracellular matrix interaction. High BP increases
stress on the endothelium, and may result in endothelial cell activation or
even damage. Several studies have reported increased level of adhesion
molecules, including sVCAM-1, sICAM-1 and sE-selectin in the presence of
hypertension. Increased expression of endothelial cell adhesion molecules
may contribute to the development of hypertension due to failure of the
endothelium in regulating vascular tone (Schram & Stehouwer 2005). The
physiology of the correlation between BP and IOP is still speculative and
several mechanisms have been proposed (Klein & Klein 1981). Bill et al.
demonstrated that variation in systolic BP resulted in small changes in
aqueous humour flow formation, possibly related to increased capillary
pressure in the ciliary body (Bill 1973). Blood pressure may also affect the
episcleral venous pressure, which is important in regulating the aqueous
humour outflow across the TM and the Schlemm’s canal (Bill 1975; Klein
et al. 2005). Given this correlation, the processes that affect vascular tone,
such as cellular adhesion, are likely to play a role in aqueous humour
outflow facility and thus in regulating IOP. In fact, a number of factors such
as cell shape, volume, contractility and adhesion to neighbouring cells and
to the extracellular matrix (ECM) could affect resistance by altering the
dimensions or direction of flow pathways (Tian et al. 2000). Alteration of
the actin cytoskeleton, which is responsible for cell adhesion, might play a
role in modifying these factors and influence outflow facility within the TM.
GO terms are not independent and they can overlap and show different
aspect of the same process. It is well known that Ca2+ is involved nearly
in every aspect of cellular life, including muscle contraction, cell shape,
and adhesion (Clapham 2007). In particular, Ca2+ affects cadherins and
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integrins, families of molecules critical for cell adhesion (Bamji 2005).
Genetic studies provide evidence of the involvement of cellular adhesion
and calcium channel activity in IOP regulation. Genes encoding proteins
involved in adhesion are of key importance for the maintenance of
the TM architecture and regulation of outflow. RNA expression studies
in TM showed that proteins involved in adherents and gap junctions,
which permit the mechanical attachments between adjacent cells and are
important in biological adhesion, are present in TM tissue (Borra´s 2003).
In addition, genes previously associated with IOP seem to be involved in
adhesion processes and calcium channel activity. GAS7, for example, is
involved in cell remodelling and in the reorganization of microfilaments,
which are a part of the cytoskeleton (Wentz-Hunter et al. 2004). MYOC,
encoding for myocilin, a protein found in the TM extracellular matrix
tissue, has been previously associated with POAG. Calcium ions are
important biological factors that have several roles in extracellular matrix
proteins and recently a novel, high affinity Ca2+ binding site within the
OLF domain of myocilin has been identified (Donegan et al. 2012). TMC01,
another gene associated with IOP and POAG, is highly expressed in the
TM (Liton et al. 2006). CAV1/CAV2 have been previously associated with
POAG and also with IOP in the IGGC meta-analysis. Caveolae are highly
abundant in mammalian cells and they form stable membrane domains
in the plasma membrane and respond to plasma membrane changes.
Caveolae can be found in smooth-muscle cells, fibroblasts, endothelial
cells and adipocytes and are implicated in a number of signal transduction
events, including calcium signalling. Caveolae also seem to have a role
in the regulation of cell adhesion, focal contacts and extracellular matrix
interactions (Parton & Simons 2007). Caveolins from genetically modified
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mice also suggest that they may have a role in cardiovascular functions,
including endothelial barrier function, regulation of nitric oxide synthesis,
cholesterol metabolism, and cardiac function (Gratton et al. 2004).
3.5 Conclusion
In summary, I investigated the genetic architecture of VCDR and IOP
through association studies. I clarified the role of ATOH7 gene in
VCDR, showing that its main effect is on disc size. Through IGGC
meta-analysis, ten novel loci were identified for VCDR that underlie
the role of neuronal cell growth and cellular response to stress as key
mechanisms in determining VCDR variation and possibly POAG. IGGC
meta-analysis also identified a number of novel loci involved in IOP
regulation and POAG susceptibility. These genes are involved in biological
and cellular adhesion in the plasma membrane and cell junctions and also
to calcium ion binding. Identifying genes and mechanisms underlying IOP
and VCDR variation will have an impact on the future investigation of
potential therapy for POAG.
CHAPTER 4
Quantitative traits underlying POAG and combination of
phenotypic information in genetic analysis
In this chapter I will describe and discusses the relationship amongst
POAG quantitative traits and whether and how we could combine
them to better understand the genetic architecture of POAG.
STATEMENT OF CONTRIBUTION TO THIS RESEARCH:
I designed this study and I performed all the analysis described in this
chapter.
4.1 Background
Genome-wide association studies are a common tool in searching for
genetic factors underlying human traits and conditions (Hindorff et al.
2009). Often a complex disease is studied through analyses of its underlying
quantitative traits, especially in cases where the disease represents only
the extremes of a smoothly distributed trait, qualitatively present in the
general population, or when studying quantitative traits correlated with
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the presence of the disease. In addition, quantitative traits studies are
useful where recruitment of a large number of affected cases is impractical
or extremely difficult (such as late onset diseases).
To date, most genetic studies have focused on single traits.
Single-phenotype association studies had an enormous success and they
identified thousands of genetic variants associated with a large number
of traits and conditions. However, large-scale clinical and epidemiological
studies often include data collection for multiple traits. For example
studies on POAG include measurements on the same individuals for IOP,
optic nerve head measurements and other ocular and non ocular traits.
POAG-related traits taken alone are only imperfect predictors of the
disease status. For instance, IOP is considered the main risk factor and
often chosen as proxy in genetic analysis, however IOP is not even part of
the criteria used for clinical diagnosis. Moreover, the signs of glaucomatous
optic nerve damage may occur at any pressure level and only 5-10% of
individuals with high pressure have such damage (Leske 1983). In addition,
from a statistical point of view, POAG traits are correlated between each
other and this correlation is not taken into consideration in single traits
analysis and this might lead to loss of information and thus power in GWAS.
Many methods have been proposed to test the association between a
genetic variant and multiple phenotypes. Firstly, it is possible to implement
a polygenic score approach to assess whether pleiotropy exists between
two phenotypes without pointing to any particular variants. A polygenic
approaches uses all or a large proportion of SNPs genome wide to establish
genetic overlap between two phenotypes. Secondly, multivariate analyses
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jointly analyse more than one trait in a unified framework and test for
the association of multiple phenotypes with a genetic variant. The aim of
these analyses is to identify loci associate with multiple traits and these
associations are termed cross-phenotype (CP) associations (Solovieff et al.
2013). These analyses are well suited for studies in which subjects are
phenotyped across various traits since multivariate methods require that
all phenotypes are available on the same individual. This also allows the
investigation of the correlations between the traits themselves. Numerous
approaches have been proposed for testing the association between
a genetic variant and multiple phenotypes, especially for correlated
traits.Some approaches include a dimension reduction techniques on the
phenotypes before testing the association with the genetic variant. For
example principal component analysis and principal factor analysis extracts
linear combinations of the phenotypes (i.e. principal components or
factors) that explain the most variance in the data that can be used as new
phenotypes in a GWAS. Other approaches, for continuous phenotypes, are
based on a multivariate regression framework, for example a multivariate
analysis of variance (MANOVA). This model is used when there are two or
more dependent variables and it helps to understand whether a change
in the independent variable (i.e. genotypes) have a significant effect on
the dependent variables (Solovieff et al. 2013). Other methods extend
the regression framework, using variations of the generalised estimating
equations (GEE), which are generalised linear models that account for a
possible unknown correlation between outcomes.
Advantages of performing combined analysis of correlated traits include
increased power to detect loci and increased precision of parameter
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estimation (Jiang & Zeng 1995; Zhu & Zhang 2009). Moreover, combined
analyses will allow to explore pleiotropy (one locus influencing multiple
correlated traits) as well as to investigate endophenotypes intermediate
between a gene and a trait. Furthermore, multivariate analysis avoids
multiple testing penalty incurred in analysing each phenotype separately
(Yang & Wang 2012).
So far there has been little discussion about whether and how these
methods could be implemented in glaucoma’s genetics research. Following
the above considerations, the aim of this project was to explore whether
pleiotropy exists between POAG endophenotypes and to identify genetic
cross-phenotypes loci within POAG. To achieve this, the specific objectives
were:
• to explore epidemiological correlation amongst POAG
endophenotypes
• to investigate genetic correlation amongst POAG endophenotypes
• to use dimension reduction approaches in a GWAS setting
• to explore multivariate regression models to accommodate multiple
phenotypes in GWAS settings.
4.2 Methods
More details are described in Chapter 2.2.5. To establish the amount of
correlation between POAG endophenotypes in the BMES cohort, a list of
several factors linked to POAG was compiled including IOP, vertical disc
diameter (VDD), vertical cup diameter(VCD), VCDR, CCT and spherical
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equivalent (SE). All variables were standardised and a correlation analysis
was carried out to obtain Pearson’s coefficients as described in Chapter
2.2.5.1.
A linear mixed model was used to calculate the genetic correlation
for POAG traits in the BMES cohort as implemented in GCTA (more details
Chapter 2.2.5.2).
An iterated factor analysis was carried out including IOP, VDD, VCD,
CDR, CCT and age in the BMES and TwinsUK cohorts (Chapter 2.2.5.3).
The most relevant factors were selected based on the eigenvalue’s value.
The selected factors were then used as outcome in GWAS analyses in the
BMES and TwinsUK populations. A meta-analysis was then run with the
results from the two data sets.
A multivariate linear model (MANOVA) was implemented including
IOP and VCDR as outcomes as described in Chapter 2.2.5.4. Results from
the BMES and TwinsUK cohorts were then meta-analysed with Fisher’s
combining probability method.
A multivariate model based on generalised estimating equation
(GEE), which takes into account of correlation between outcomes,
was implemented in the BMES and TwinsUK cohorts and results were then
meta-analysed (Chapter 2.2.5.4).
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4.3 Results
4.3.1 Correlation between POAG quantitative traits
2,302 Caucasian individuals from the BMES cohort with measurements
for IOP, VDD, VCD, VCDR, SE, CCT and age were used in the correlation
analysis. Measurements of the optic disc nerve head are correlated between
each other: the VCDR is correlated with the VCD (Pearson’s correlation
coefficient = 0.64) and with the CDR (Pearson’s correlation coefficient
= 0.42). The VCD and the VCDR were highly correlated (Pearson’s
correlation coefficient = 0.96). In addition, the VDD is also correlated
with SE (Pearson’s correlation coefficient = 0.21). IOP was correlated with
CCT (Pearson’s correlation coefficient = 0.09) and with CDR (Pearson’s
correlation coefficient = 0.10) (Table 4.1).
AGE IOP SE VDD VCD VCDR CCT
AGE 1.00 0.07 0.32 0.03 0.04 0.05 -0.11
IOP 0.07 1.00 -0.04 -0.07 0.12 0.17 0.09
SE 0.32 -0.04 1.00 0.21 0.04 -0.02 -0.01
VDD 0.03 -0.07 0.21 1.00 0.64 0.42 -0.02
VCD 0.04 0.12 0.04 0.64 1.00 0.96 -0.03
VCDR 0.05 0.17 -0.02 0.42 0.96 1.00 -0.03
CCT -0.11 0.09 -0.01 -0.02 -0.03 -0.03 1.00
Table 4.1: Correlation for POAG endophenotypes. The table shows Pearson’s correlation
coefficients between several POAG phenotypes: IOP, VDD, VCD, VCDR and CCT.
Other variables, usually included in POAG analysis, were incorporated in the
analysis.
4.3.2 Genetic correlation between POAG quantitative traits
Given the epidemiological relationship between POAG traits, genetic
correlation was investigated. 2,302 individuals with information on a panel
of 2,617,903 SNPs from the BMES were analysed. Firstly, I calculated a
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SNP based heritability for each trait as shown in Table 4.2. All SNPs used
explained a total of 19% of the variance of IOP, 16% of the variance
of VCDR and 11% for VCD. The SNPs seem to account for a very low
proportion of VDD’s variance. 88% of the variance of CCT might be
explained by all SNPs. Figure 4.1 shows a summary of the SNP-based
heritability for POAG traits.
Phenotype Proportion of variance explained by SNPs SE
IOP 0.19 0.17
VCDR 0.16 0.17
VCD 0.11 0.17
VDD 0.0005 0.17
CCT 0.88 0.32
Table 4.2: SNP-based heritability: the table shows the heritability calculated with several
SNPs for all POAG traits (proportion of variance explained by SNPs) and
stardard errors (SE).
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IOP - 19%
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VDD - 0.05%
POAG
Figure 4.1: SNP based heritability for POAG traits. The figure shows the heritability
calculated with the SNPs for POAG quantitative traits
The mixed model analysis yielded a SNP-based correlation of -0.64
(SE=0.97) for IOP and VCDR (Table 4.3 and Figure 4.2). This means that
61% of the epidemiological correlation between the two traits could be
explained by the SNPs. The negative sign of the correlation is more difficult
to explain. It might indicate that genetic factors for IOP and CDR are
negatively correlated with some genes that increase one trait and decrease
the another one. In addition, IOP and CCT are negatively correlated with
an estimate of -0.56 (SE=0.57). As expected, the genetic factors for VCDR
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and VCD are highly correlated (estimate close to 1, with a SE of 0.11).
Phenotypes Genetic correlation SE
IOP-VCDR -0.64 0.97
IOP-CCT -0.37 0.38
Table 4.3: Genetic correlation between POAG phenotypes: the table shows the genetic
correlation between IOP and VCDR and IOP and CCT with standard errors (SE).
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Figure 4.2: Barplot for the genetic correlation between POAG traits: the figure shows the
barplot of the genetic correlation and standard errors for POAG quantitative
traits
4.3.3 Principal factor analysis in POAG quantitative traits
4.3.3.1 Calculating principal factors
A set of 2,302 individuals from the BMES cohort and 3,493 individuals
from the TwinsUK cohort were analysed. The principal factors analysis
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produced five different factors. Only the first principal factor had an
eigenvalue greater than 1 (2.17) and alone explained 68% of the variance.
The second factor was also kept for further analyses. The eigenvalue was
0.48 and the variance explained was of 0.15. Factor loadings represent
how much a factor explains a variable. In Figure 4.3 the factor loadings for
each variable for the first factor are plotted against those for the second
factor, showing that the first factor summarises well the data for the optic
disc variables, whereas the second factor describes IOP and CCT and VCDR.
Figure 4.3: Loading factors of the principal factor analysis: the figure shows the loading
factors for each variable for the first factor (factor1) plotted against those for
the second factor (factor2). Factor1 has a loading factor of >0.8 for VCD and
VCDR, meaning that it explains a large amount of these variables. On the other
hand, factor2 has a high loading factor for IOP and CCT.
In addition, correlation analysis between POAG traits and the first principal
factor showed that the principal factor correlated well with VCD (0.9999)
and VCDR (0.86). The second factor was correlated with IOP (0.53) and
CCT (0.43) as shown in Figure 4.4.
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Figure 4.4: Correlation between POAG endophenotypes and principal factors: the figure
is a graphical display of the correlation matrix, using blue for positive and red
for negative correlations. The ellipses represent the level of correlation.
4.3.3.2 Genome wide association studies with the principal factors
GWAS analyses were performed for the two first principal factors in
the BMES (n=2,303) and in the TwinsUK (n=3,494) data sets on a
panel of more than 2 million SNPs imputed to HapMap2. An inverse-based
meta-analysis was then performed with GWAS results from the two cohorts.
The top results for both principal factors are shown in Table 4.4. Figure
4.5 displays -log10 p values for the first principal factor across all SNPs
traditional passing quality control. Quantile-quantile plot for the first
principal factor p-values is shown in Figure 4.6.
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Phenotype SNP A1 MAF Meta P Meta Effect Meta SE BMES P BMES Effect BMES SE TwinsUK P TwinsUK Effect TwinsUK SE Gene
Pf1 Rs11017216 A 0.08 1.079E-07 0.34 0.06 0.010 0.25 0.10 1.468E-06 0.40 0.08 GLRX3
Pf1 Rs11017215 A 0.08 1.364E-07 0.33 0.06 0.012 0.24 0.10 1.460E-06 0.40 0.08 GLRX3
Pf1 Rs12097296 T 0.27 1.346E-06 0.17 0.03 6.839E-04 0.18 0.05 5.093E-04 0.15 0.04 RGS7
Pf1 Rs12593257 A 0.42 1.520E-06 0.15 0.03 0.001 0.15 0.04 3.245E-04 0.15 0.04 LOC102724973
Pf1 Rs10762198 A 0.38 1.652E-06 -0.17 0.04 4.923E-05 -0.21 0.05 0.005 -0.13 0.05 PBLD
Pf1 Rs7916697 A 0.42 1.937E-06 -0.17 0.04 1.516E-04 -0.20 0.05 0.003 -0.14 0.05 ATOH7
Pf1 Rs7972528 T 0.37 2.529E-06 -0.15 0.03 0.004 -0.13 0.05 1.390E-04 -0.16 0.04 TMTC2
Pf1 Rs729679 T 0.44 2.669E-06 -0.15 0.03 0.002 -0.14 0.04 3.066E-04 -0.15 0.04 LOC102724973
Pf1 Rs1115988 A 0.15 2.727E-06 -0.15 0.03 0.002 -0.14 0.05 4.204E-04 -0.15 0.04 LINC00290
Pf1 Rs11777845 T 0.08 2.884E-06 -0.24 0.05 2.182E-04 -0.30 0.08 0.002 -0.20 0.07 ASPH
Pf2 Rs12031354 A 0.40 4.915E-07 0.11 0.02 5.642E-06 0.14 0.03 0.011 0.08 0.03 UHMK1
Pf2 Rs920581 A 0.11 2.099E-06 -0.16 0.03 0.002 -0.15 0.05 3.447E-04 -0.17 0.05 SCAMP1
Pf2 Rs7555190 A 0.42 2.672E-06 0.10 0.02 1.005E-04 0.12 0.03 0.006 0.09 0.03 C1orf111
Pf2 Rs12912995 T 0.19 2.854E-06 -0.14 0.03 0.003 -0.11 0.04 1.242E-04 -0.17 0.04 IQGAP1
Pf2 Rs4910524 A 0.13 2.926E-06 -0.16 0.03 0.009 -0.12 0.05 4.937E-05 -0.19 0.05 OR51E1
Pf2 Rs292654 T 0.47 3.353E-06 -0.10 0.02 0.001 -0.10 0.03 7.978E-04 -0.11 0.03 STRA8
Pf2 Rs2057671 T 0.11 4.751E-06 0.16 0.04 2.553E-04 0.17 0.05 0.005 -0.15 0.06 JAZF1
Pf2 Rs17063793 T 0.43 4.980E-06 0.10 0.02 3.765E-04 -0.11 0.03 0.004 -0.10 0.04 LINC00347
Pf2 Rs4722750 T 0.11 5.185E-06 0.16 0.04 2.939E-04 0.17 0.05 0.005 0.15 0.06 JAZF1
Pf2 Rs292641 C 0.49 5.219E-06 0.10 0.02 0.001 0.10 0.03 8.004E-04 0.11 0.03 STRA8
Table 4.4: Results GWAS for the first two principal factors: the table shows the top hits
for the meta-analysis of GWAS performed on the first two principal factors in
the BMES and TwinsUK cohorts. Pf1: first principal factor, pf2: second principal
factor, A1: effect allele, MAF= minor allele frequency, Meta P = p-value from
the meta-analysis, Meta Effect= β from the meta-analysis, Meta SE= standard
error from the meta-analysis, BMES P= BMES GWAS p-value, BMES Effect =
BMES GWAS effect size, BMES SE= BMES GWAS standard error, TwinsUK P=
TwinsUK GWAS p-value, TwinsUK Effect = TwinsUK GWAS effect size, TwinsUK
SE = TwinsUK GWAS standard error, Gene: closest transcript/gene
Figure 4.5: Manhattan plot for the meta-analysis of GWAS for the first principal factor: the
figure shows the -log10 of the p-values for the meta-analysis of GWAS results
for the first principal factor
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Figure 4.6: Q-Q plot for the meta-analysis of GWAS for the first principal factor: the figure
shows the quantile-quantile plot of the p-values from the first principal factor
results
For the first principal factor, the strongest signal was found on chromosome
10 at rs11017216 (P= 1.079E-07, effect=0.335, SE= 0.063). Figure
4.7 shows the forest plot for this SNP where the effects in both cohorts
follow the same direction and the confidence intervals largely overlapped.
This SNP lies on an intergenic region (chr10:132,004,985) and there are
no genes within 100k bp. However, the closest gene is GLRX3 (chr10:
131,824,652-131,872,774).
Figure 4.7: Forest plot for rs11017216 in the meta-analysis for the first principal
component: the figure shows a graphical representation (forest plot) of the
top hit rs11017216 meta-analysis results. The vertical line represent no effect.
Effect sizes and confidence intervals for each cohort are plotted.
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Another signal was found at rs12097296 (P=1.346E-06, effect=0.165,
SE=0.034). The effects for both cohorts are positive and the confidence
intervals overlapped. This SNP lies within the sequence region of RGS7
(regulator of G-protein signaling 7), which is a protein-coding gene.
Another genetic signal was identified at rs12593257 on chromosome 15
which lies in an intergenic region (chr15: 98,320,782-chr15:98,321,282)
with an effect of 0.15 and standard error of 0.031 (P=1.520E-06). This
region shows a regulatory activity and the closest gene are LOC102724973
and ADAMTS17. Another signal for the first principal component has been
found at rs7916697 on chromosome 10 with an effect size of -0.17. This
SNP lies within the region of ATOH7 gene.
Figure 4.8 shows the -log 10 p-values for the second principal factor
across all genome. Figure 4.9 shows the quantile-quantile plot for the
results. The strongest signal was found at rs12031354 on chromosome 1
with an effect size of 0.111 (SE=0.022 and P=4.915E-06). This SNP lies
on an intergenic region (chr1:161,128,721-161,129,221) and the closest
gene is C1orf110. In addition, we identified another signal at rs920581 on
chromosome 5 with an effect of -0.158 (SE=0.033, P=2.099E-06). This
SNPs lies on an intergenic region (chr5:78,009,982-78,060,081) which
is highly conserved across species and has a high regulatory activity. The
closest gene is LHFPL2. Other signals for the second principal factor were
identified within IQGAP1, OR51E1 and JAZF1 genes.
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Figure 4.8: Manhattan plot for the meta-analysis of GWAS for the second principal factor:
the figure shows the -log10 of the p-values for the meta-analysis of GWAS
results for the second principal factor.
Figure 4.9: Q-Q plot for the meta-analysis of GWAS for the second principal factor:
the figure shows the quantile-quantile plot of the p-values from the second
principal factor meta-analysis results
4.3.4 Multivariate regression models in POAG quantitative traits
Rather than reduce the dimensions of the outcome, multivariate analyses
jointly analyse more than one phenotype in an unified framework and
test for association of multiple phenotypes with a genetic variant. Two
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methods were selected: multivariate analysis of variance (MANOVA) and
a generalised estimating equations (GEE) method.
4.3.4.1 Multivariate analysis of variance (MANOVA)
A set of 2,302 of individuals from the BMES cohort and a set of 1,508
from the TwinsUK cohort were analysed. In the TwinsUK dataset only
one twin of each pair was included to avoid family structure. A bivariate
regression model, also called multivariate analysis of variance (MANOVA),
was implemented including IOP and VCDR. The results from the two
cohorts were combined using Fisher’s combining probability method.
No SNPs crossed the line of genome-wide significance (Figure 4.10).
However, there are some suggestive signals (Table 4.5). The strongest
signal was identified at rs2902210 on chromosome 1 (P=1.366E-06).
This SNP lies within SEC16B/RGPR/KIAA1926 genes. Another signal was
found at rs7792197 (P=3.001E-06) on chromosome 7 and it lies in an
intergenic region. The closest genes are LOC100128464, LOC100419447,
EIF4A1P13. Other signals were found near other genes such as DOCK11P1,
RRAGAP1, LOC101927351, LOC101927395, LOC101927418, C14orf28,
LOC401770 and KLHL28. The -log10 of the Fisher’s combined p-values
across all genome are shown in Figure 4.10 and Figure 4.11 shows the
quantile-quantile plot for the Fisher’s pvalues.
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Marker Name Chr Position P-value Gene
rs2902210 1 177936039 1.366E-06 SEC16B
rs7792197 7 88432198 3.001E-06 LOC100128464,LOC100419447,EIF4A1P13
rs17353068 7 88433028 4.081E-06 LOC100128464,LOC100419447,EIF4A1P13
rs1593278 14 44841227 4.467E-06 DOCK11P1,RRAGAP1,LOC101927351,LOC101927395,LOC101927418,C14orf28,LOC401770,KLHL28
rs17092468 14 44842318 4.467E-06 DOCK11P1,RRAGAP1,LOC101927351,LOC101927395,LOC101927418,C14orf28,LOC401770,KLHL28
rs17115642 14 44844397 4.467E-06 DOCK11P1,RRAGAP1,LOC101927351,LOC101927395,LOC101927418,C14orf28,LOC401770,KLHL28
rs11965318 6 82778474 4.485E-06 TPBG
rs2494174 1 210197611 5.366E-06 ST13P19,SYT14,SERTAD4,SERTAD4-AS1
rs2485901 1 210197416 6.075E-06 ST13P19,SYT14,SERTAD4,SERTAD4-AS1
rs1865273 18 40427300 6.236E-06 LINC01477
Table 4.5: Fisher’s combined results for the bivariate analysis for IOP and CDR: the table
shows the results from the meta-analysis for the bivariate analysis using IOP
and VCDR in the BMES and TwinsUK cohorts. Chr: chromosome, Position:
base-pair position of the SNP, P-value: p-value of the bivariate test, Gene: closest
transcript/gene
Figure 4.10: Manhattan plot for Fisher’s combined results for the bivariate model
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Figure 4.11: Q-Q plot Fisher’s combined p-values for the bivariate model
4.3.5 GEE regression model
Another multivariate regression model was applied on the same 2,302
of individuals from the BMES and a set of 1,508 from TwinsUK cohort.
This method is an extension of GEE models as described by Schifano et
al. (Schifano et al. 2013). The main difference between this model and
the previous MANOVA analysis is that GEE model can take into account
correlation between traits. After running the regression model, results for
BMES and TwinsUK cohorts were meta-analysed using Fisher’s combined
probability method.
Figure 4.12 displays -log10 Fisher’s combined p values for GEE approach
across all SNPs passing quality control. Quantile-quantile plot for the SMAT
combined p-values is shown in Figure 4.13.
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Figure 4.12: Manhattan plot of the meta-analysed results for GEE regression model: the
figure shows the -log10 of the p-values obtained from Fisher’s meta-analysis
for GEE model across all genome.
Figure 4.13: Q-Q plot of the meta-analysed results for GEE regression model: the figure
shows the Q-Q plot of the p-values from Fisher’s meta-analysis for SMAT
model.
No SNPs passed genome-wide significance, however there were 8 SNPs that
reached p<E-07 (see Table 4.6). Most of these SNPs lie within CACNA2D3
gene. In addition, another signal reached p<E-07 which lies within SNED1
gene.
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Marker Name Chr Position Gene Chisq P-value TwinsUK pvalue BMES pvalue
rs11130451 3 55078388 CACNA2D3 36.866 1.919E-06 4.102E-08 0.240
rs17257847 3 55085117 CACNA2D3 36.756 2.022E-06 4.683E-08 0.222
rs17257660 3 55081044 CACNA2D3 35.506 3.657E-06 8.132E-08 0.239
rs4955928 3 55081482 CACNA2D3 35.506 3.657E-06 8.132E-08 0.239
rs4955929 3 55081645 CACNA2D3 35.506 3.657E-06 8.132E-08 0.239
rs4955925 3 55079930 CACNA2D3 35.492 3.681E-06 8.132E-08 0.241
rs4955926 3 55079974 CACNA2D3 35.492 3.681E-06 8.132E-08 0.241
rs7571117 2 241040133 SNED1 34.136 6.987E-06 4.135E-06 0.093
rs2859365 6 28423688 ZSCAN23 33.295 1.039E-06 0.020 2.876E-06
rs11241800 5 125312879 LOC101927421 33.185 1.094E-06 0.341 1.820E-06
Table 4.6: Results of the meta-analysed results for GEE regression model: the table shows
the meta-analysed results for the GEE regression model: chr:chromosome,
Position: the base-pair position, Gene: the closest gene, Chisq: the chi-square of
the Fisher’s combined method, P-value: the p-value of the Fisher’s meta-analysis,
TwinsUK pvalue: the p-value from the regression model for the TwinsUK cohort,
BMES pvalue: the p-value form the regression model for the BMES cohort
4.4 Discussion
Although association analyses have been successful in identifying thousands
of variants associated with many traits, including POAG, most GWAS have
been conducted using the simple statistical models focused on single
phenotype, leaving out interactions and inter-relationships with putative
biologic significance. Methods for analysing multivariate phenotypes can
accommodate different degrees of dependence between several POAG
phenotypes in integrated models. The aim of this project was to explore
whether pleiotropy exists between POAG endophenotypes and thus to
identify genetic cross-phenotypes loci within POAG. To achieve this, firstly
I established and confirmed the correlation amongst POAG traits and I
then explored several ways to combine these phenotypes in a multivariate
framework.
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Firstly, epidemiological correlation between POAG traits was analysed.
Results were in line with previous studies. The relationship between IOP
and CCT (Doughty & Zaman 2000) and between optic disc measurements,
including disc size and VCDR (Quigley HA et al. 1990) was confirmed.
More interesting is the link between IOP and CDR. The relationship
between IOP and the glaucomatous damage is not clear, however critical
to understand and treat the disease.
Mere phenotypic correlation between quantitative traits does not guarantee
the presence of pleiotropy and shared genes for several POAG traits as
the correlation may due to environmental factors. Interestingly, a genetic
correlation of 64% was identified for IOP and VCDR, showing a shared
genetic determination between the two traits and thus suggesting the
existence of pleitropic factors underlying both phenotypes.
Principal factor analysis was used to reduce the dimensions of the traits
and calculate factors that can be used in a GWAS setting. Meta-analysis
of GWAS in two Caucasian Populations using principal factors identified
suggestive signals lying close or within GLRX3, RGS7, LOC102724973,
ADAMTS17 and ATOH7 genes. GLRX3 gene encodes a member of the
glutaredoxin family. The encoded protein binds to and modulates the
function of protein kinase C theta and may also inhibit apoptosis, playing
a role in cellular growth (Cheng et al. 2011). Regulator of G protein
signalling (RGS) protein are appreciated modulators of neurotransmitter
actions. Many neurotransmitters and hormones rely on G proteins to
activate intracellular signalling pathways that regulate nearly all aspects
of cell and organ physiology (Rose et al. 2000). RGS7 gene is expressed
predominantly in the brain and it attenuates signal transduction in
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mammalian cells. In addition, it may play a role in synaptic vesicle
exocytosis (Hunt et al. 2003) and may play an important role in the rapid
regulation of neuronal excitability (Saitoh et al. 1999). RGS7 gene may
also has a role in the eye and especially in the retina (Cabrera et al. 1998).
In addition, a genetic signal (rs12593257) for the first principal factor was
identified on chromosome 15. This SNP lies in an intergenic region (chr15:
98,320,782-chr15:98,321,282) that shows a regulatory activity and the
closest genes are LOC102724973 and ADAMTS17. The latter encodes a
member of the ADAMT protein family. The function of this protein has not
been determined, however truncating mutations within this gene family
produce typical eye anomalies described in Weill-Marchesani syndrome,
which is characterised by high myopia and secondary glaucoma due to
shallowing of anterior chamber angles (Morales et al. 2009). Another
signal for the first principal factor has been found at rs7916697 on
chromosome 10. This SNP lies within the region of ATOH7 gene which is
a well known gene for optic disc parameters and glaucoma (Ramdas et al.
2011; Springelkamp et al. 2014).
For the second principal factor, the strongest signal has been found
at rs12031354 on chromosome 1. This SNP lies on an intergenic region
(chr1:161,128,721-161,129,221). The closest gene is C1orf110 which
is a protein binding gene. It is worth noticing that another gene in the
proximity is RGS4, which is a member of the RGS (regulator G protein
signaling) and it may inhibit signal transduction and includes pathways
similar to RGS7 previously identified for the first principal factor. RGSA4
has been previously associated with schizophrenia (Morris et al. 2004)
and seems to be specific to the neural system, modulation the function of
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dopamine and glutamate receptors (De Vries et al. 2000).
Multivariate regression models can directly take into account two or
more outcomes without the need of calculate factors first. Results for
bivariate regression using MANOVA with IOP and CDR showed that no
SNPs crossed the line of genome-wide significance. However, there are
some suggestive interesting signals which lie within/close to SEC16B
and SYT14 genes. SEC16B is involved in the organisation of transitional
endoplasmatic reticulum (ER) sites and protein export (Watson et al. 2006)
and also it has been associated with obesity (Hotta et al. 2009). SYT14
gene is a member of the synaptotagmin gene family and encodes a protein
similar to other family members that mediate membrane trafficking in
synaptic transmission. The encoded protein is a calcium-independent
synaptotagmin. Mutations in this gene are a cause of autosomal recessive
spinocerebellar ataxia-11 (SCAR11), and a t(1;3) translocation of this gene
has been associated with neurodevelopmental abnormalities (Sailer &
Houlden 2012). Alternatively spliced transcript variants encoding multiple
isoforms have been observed for this gene, and a pseudogene of this gene
is located on the long arm of chromosome 4.
Since POAG traits are correlated between each other, it may be more
appropriate to use a regression model that can take into account the
correlation between the traits such as GEE.Using a GEE regression model,
other suggestive signals were identified in the meta-analysis between
BMES and TwinsUK cohorts. CACNAD3 is a member of the alpha-2/delta
subunit family that modulates the expression and the function of the
voltage-gated calcium channel complex. The protein encoded is expressed
in spiral ganglion neurons and auditory brain stem nuclei and it might be
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required for normal acoustic response (Pirone et al. 2014). In addition,
this gene seems to be involved in pain sensitivity. Mice mutant exhibit
impaired behavioural heat pain sensitivity and SNPs variants in humans
were associate with reduced sensitivity to acute noxious heat and chronic
back pain (Neely et al. 2010). SNED1 is a protein-coding gene and GO
annotations include calcium ion binding. An important paralog of this gene
is DLK2, which is an epidermal growth factors-like protein and has been
identified as a modulator of adipogenesis in vitro (Rivero et al. 2012).
Despite identifying a few suggestive signals, the results of applying
multivariate models on glaucoma endophenotypes are far from being
definitive. Mechanisms underlying POAG, in particular the role of the high
IOP and the changes in the optic disc nerve head in the pathophysiology,
have not been determined yet. The cupping of the optic disc arises
in response to IOP. It has been hypothesised that an increase of IOP
raises the pressure gradient across the lamina cibrosa and leads to
a deformation of retinal ganglion cell axons due to the mechanical
stress (Bellezza et al. 2003; Pena et al. 2001). Animal models provide
evidence for this hypothesis. For example, monkeys have been shown
to develop glaucomatous changes in the optic nerve when their IOP is
raised experimentally (Crawford et al. 2001). However, there is a certain
grade of in-dependency amongst mechanisms that regulate IOP and the
cupping in the optic nerve head. The retina is dependent on its blood
supply for metabolic needs, and local ischaemia-hypoxia, probably due to
dysfunction of blood flow regulation, it has been implicated. In particular
vascular factors has been proven important for normal tension glaucoma,
where vascular dysregulation increases the impact of ischemia affecting
also the optic nerve without high IOP (Mi et al. 2014). Other factors
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that contribute independently to IOP to death of retinal ganglion cells
and optic nerve fibres may be excessive stimulation of the glutamatergic
system (i.e. N-methyl-D-aspartate subtypes) (Dreyer et al. 1996), poorly
functioning cellular pumps and glutamate transporters, oxidative stress
and formation of free radicals, inflammatory cytokines in and aberrant
immunity (Schwartz 2003).
Of course there are a number of limitations that might have diminished
the chance of identifying shared signals between POAG endophenotypes.
First of all, it is often very difficult to give a meaningful interpretation of
multivariate analyses. For instance, effect sizes are difficult to interpret
since they were represented as a matrix (for regression models) or not
informative such as in principal factor analysis. Moreover, multivariate
approaches need complete observations for each individuals leading to
to the exclusions of subjects that miss even only one phenotype and thus
decreasing the total sample size. GWAS need thousands of individuals to
identify significant loci, considering genetic variants affecting multiple
phenotypes are likely to have a small effect. In addition, the use of
HapMap2 data might make difficult to pick up rare genetic signals because
focused on common variants which are known to have very small effect on
phenotypes.
4.5 Conclusion
This study has investigated the correlation between POAG endophenotypes
and the existence of genetic loci affecting both IOP and VCDR. The
link between POAG endophenotypes have been confirmed through
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epidemiological and genetic correlation. However, this study has identified
a very small number of suggestive signals shared between IOP and VCDR in
a GWAS setting and the role of these variants is not clear. Therefore, these
findings suggest that IOP and VCDR might underlying different processes of
the disease. The contribution of this study has to be confirmed with future
association studies, however it has gone some way towards enhancing our
understanding of POAG mechanisms.
CHAPTER 5
Detecting gene-gene interactions in POAG endophenotypes in a
meta-analysis of multi-ancestry cohorts
In this chapter I will describe and discuss my research on epistatic
interaction on POAG, in particular I investigated whether CDR and
IOP known loci interacted with other loci in the genome to affect CDR
and IOP.
STATEMENT OF CONTRIBUTION TO THIS RESEARCH:
I helped to design the study and I performed all the analyses described in
this chapter for the BMES and TwinsUK cohort. I participated in leading the
meta-analysis in the IGGC (i.e. writing the protocol for the analysis) and in
performing the meta-analysis.
5.1 Background
GWAS have been a successful tool to identify common genetic factors
associated with POAG phenotypes, though the variants identified only
explain a small portion of the heritability (Manolio et al. 2009). Usually
GWAS use an additive framework where each allele that affects a trait
acts in an independent, non linear, cumulative manner. However, a line of
thought in the literature supports the idea that the mechanisms of gene
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action, thus genetic architecture of complex traits, are much more complex
than the additive model (Carlborg & Haley 2004; Phillips 2008; Moore
et al. 2006; Wright 1931). Epistasis has been suggested to answer part of
the missing heritability problem (Manolio et al. 2009; Frazer et al. 2009;
Eichler et al. 2010; Zuk et al. 2012). As heritability in a narrow sense (h2)
accounts for additive variance, epistasis should be part of the unknown
(non additive) heritability (Visscher et al. 2008). However, it has been
shown that epistasis might also contribute to h2, not only by statistical
illusion of additive variance (where confounding non additive and common
environmental affects twin study calculation of h2, but also creating real
additive variation as marginal effects from higher order genetic interaction
(Hemani et al. 2013).
Epistasis is very common in nature and is a key in characterising the
genetic basis of complex disease. For example it has been described in
model organisms such as budding yeast (Costanzo et al. 2010) and in
Drosophila (Huang et al. 2012). Epistasis seems to have an evolutionary
role for example maintaining deleterious variants under selection (Hemani
et al. 2013). At the macroevolutionary scale, it has been shown that
advantageous substitution in one specie is often found deleterious in
others, supporting the idea that effect on fitness depends upon not only
another gene but all the genetic background (Breen et al. 2012).
Gene-gene interactions are also described in human studies, yet there
is little empirical exploration of the role of epistasis in complex traits in
humans. Interaction between HLA-C and ERAP1 loci has been reported for
psoriasis (Strange et al. 2010) and polymorphisms of ERAP1 only affect
ankylosing spondylitis risk in HLA-B27-positive individuals (Evans et al.
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2011). Hemani et al. (Hemani et al. 2014) identified 501 interactions
between common SNPs and expression of 238 genes in a cohort of 846
individuals with 7,339 gene expression levels measured in peripheral
blood. They also demonstrated physical organisation of interacting loci
within a cell, suggesting a mechanism by which biological function can
lead to epistatic genetic variance, since different chromosomal regions
spatially co-localise in the cell through chromatin interaction (Hemani
et al. 2014). Brown et al. reported 26 replicated variance eQTL and 57
replicated cis-epistatic interactions, which explain 16% of the variance of
BMI using RNA-sequence data from lymphoblastoid cell lines (LCLs) from
the TwinsUK cohort (Brown et al. 2014). At the time of writing, only one
study investigated epistasis interaction in glaucoma (Hu et al. 2015). The
authors build a human phenotype network (HPN) and used GLAUGEN
glaucoma GWAS dataset and apply HPN as a biological knowledge-based
filter to prioritise genetic variants. After that, they used a statistical
epistasis network (SEN) to identify significant connected network of
pairwise epistatic interactions among the prioritised SNPs. After functional
annotation, Hu at al. were able to link glaucoma to several complex
diseases (such as T2D, obesity, Alzheimer’s disease, cataracts and myopia).
Epistasis is defined as interaction between different genes (Cordell
2002). Two different definitions of epistasis exist: biological and statistical
interaction. In 1909, Bateson (Bateson 2007) described the ”masking
effect” where a variant or allele prevents another one from manifesting its
effect in a similar manner to a dominance effect. This concept is similar
to biological protein-protein interaction and it has been described as
”biological interaction”. Studying the biological interactions between genes
might exploit the qualitative nature of the mechanism of action of a factor
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affected by the presence/absence of another. Another definition of epistasis
was proposed by Fisher (Cordell 2002) and it has been called ”statistical
interaction”. Fisher describes epistasis as deviation from additivity in the
effect of alleles at different loci with respect to their contribution to a
quantitative trait. The statistical interaction is basically a deviation from a
linear model. It is worthy to underlie that statistical interaction does not
necessarily imply interaction at a biological level (Greenland 2009; Gibson
1996; VanderWeele 2009; Cordell 2009).
Several approaches have been used to study epistatic interactions,
including regression framework, information theory and entropy, two locus
versus high order interactions approaches, machine learning, data-mining,
recursive partioning, multifactorial dimension reduction and Bayesian
model of selection (Cordell 2009).
Following the previous point, the aim of this chapter was to investigate
epistatic interactions in POAG phenotypes. The objectives of this chapter
were:
• perform snp by snp interaction analyses to identify novel variants that
interact with known ones to alter VCDR in the general population and
to elucidate whether known VCDR-associated SNPs interact together
to affect the phenotype
• perform snp by snp interaction analyses to identify novel variants that
interact with known ones to alter IOP in the general population and
to elucidate whether known IOP-associated SNPs interact together to
affect the phenotype
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5.2 Methods
An interaction model was implemented as described in Chapter 2.2.6.
A list of 17 SNPs associated with VDCR in the IGGC meta-analysis described
in Chapter 3 was compiled. The interaction model was performed for each
pair of SNPs where the first SNP was on of the 17 SNPs in the list and
the second SNP was one included in HapMap2. This produced a total
of >17∗2,500,000 interaction models. Likewise, for IOP, 12 SNPs were
selected for their association in the IGGC meta-analysis (Chapter 3) for
a total of >12∗2,500,000 interactions. All analyses were adjusted for age
and sex. Fifteen cohorts from IGGC participated in the analysis and the
snp-snp genome-wide interaction analysis was performed for each cohort.
Quality control and meta-analysis was then carried out (Chapter 2.2.6 and
Chapter 2.2.3).
5.3 Results
The aim is to investigate epistatic interactions amongst the known
glaucoma quantitative traits hits (in association with IOP and CDR) and all
other HapMap2 SNPs.
5.3.1 Cup to disc ratio
Fourteen cohorts from the IGGC for a total of 24,629 individuals were
included in the analysis.Quality control and analysis for each cohort
were performed independently by each group and I was responsible for
the BMES and the TwinsUK cohorts. However, before the meta-analysis,
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another quality control was necessary to assess the quality of the results
received.
Results were grouped in 17 different GWAS that included interactions from
one of the 17 SNPs included in the VCDR list against all the genome in
HapMap2. Genomic inflation factors were then checked for each of the 17
meta-analysis (Figure 5.1), showing a high variability of λ that varies from
0.01 to 7.43. To understand whether this variability was due to specific
cohorts, genomic inflation was double-checked for each cohort for the 17
analysis. As Figure 5.2 shows, one particular cohort, Gutenberg Health
Study 1 (GHS1) had a wide range of λ values including the extreme values
of 0.01 and 7.43 and therefore was excluded for further analysis.
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Figure 5.1: VCDR genomic inflation factor λ for each SNPs for all cohorts: this figure
shows the 17 VCDR-related SNPs included in the analysis (x-axis) the log of
the inflation factors λ in all cohorts (y-axis).
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Figure 5.2: CDR genomic inflation factor λ for each cohort for all SNPs: the figure shows
the 14 cohorts included in the analysis (x-axis) and the log of the inflation
factors λ for all SNPs (y-axis).
Multiple testing correction was necessary due to the multiple tests
performed. Conventionally for GWAS with imputed HapMap 2 data,
Bonferroni genome-wide significance threshold is represented by 5E-08.
However, in gene-gene interaction analysis the number of tests increase
and in this case Bonferroni threshold is 1.17E-09 (considering an
average of 2,500,000 SNPs times 17 SNPs). No interaction passed
Bonferroni correction (Figure 5.3. However, several loci reached suggestive
significance (Table 5.1). I identified rs13244205, rs3801350, rs7793287
on chromosome 7 that interacted with rs7072574 on chromosome 10
(respectively β=0.0155, SE=0.002, P=4.19E-08, β=0.0127, SE=0.002,
P=1.36E-07, β=0.0127, SE=0.002, P=1.40E-07). The three SNPs lies
within/next to PDE1C transcript and rs7072574 on PLCE1 gene. Another
interesting suggestive interaction was between rs579343 (located in
PITX2 gene) on chromosome 4 and rs17658229 within DUSP1 gene on
chromosome 5 (β=-0.040, SE=0.007, P=1.55E-07). Interactions were also
found for rs13071457 and rs4658101 (EFHB and CDC7/TGFBR3 genes),
rs2029203 and rs1345467 (PCDH7 and SALL1 genes), rs11610668 and
rs4901977 (C2CD5 and SIX1/6 genes).
Chapter 5. Detecting gene-gene interactions in POAG endophenotypes in a
meta-analysis of multi-ancestry cohorts 138
Chr1 SNP1 Gene1 Chr2 SNP2 Gene2 β SE P I2
10 rs7072574 PLCE1 7 rs13244205 PDE1C 0.015 0.002 4.19E-08 0.00
10 rs7072574 PLCE1 7 rs3801350 PDE1C 0.012 0.002 1.36E-07 0.00
10 rs7072574 PLCE1 7 rs7793287 PDE1C 0.012 0.002 1.40E-07 0.00
5 rs17658229 DUSP1 4 rs579343 PITX2 -0.040 0.007 1.55E-07 0.00
1 rs4658101 CDC7/TGFBR3 3 rs13071457 EFHB 0.022 0.004 1.78E-07 0.00
16 rs1345467 SALL1 4 rs2029203 PCDH7 0.018 0.003 2.77E-07 0.35
14 rs4901977 SIX1/6 12 rs11610668 C2CD5 0.028 0.005 3.43E-07 0.00
1 rs7072574 PLCE1 2 rs13432997 OSR1/WDR35 0.017 0.003 4.15E-07 0.00
6 rs868153 HSF2 12 rs17801352 PPFIBP1 -0.017 0.003 4.66E-07 0.12
12 rs11168187 RPAP3 4 rs9992273 PCDH7 0.018 0.003 4.77E-07 0.36
Table 5.1: Most significant meta-analysis results for VCDR snp-snp interaction GWAS: the
table shows the most significant results for all the 17 meta-analysis for VCDR.
CHR1: chromosome for the SNP in the list, SNP1: SNP in the VCDR-associated
variants’ list, Gene1: closest gene in the list, CHR2: chromosome for the SNP in
the genome that showed interaction, SNP2: SNP in the genome that showed
interaction, Gene2: closest gene for the SNP in the genome that showed
interaction
The interactions between the 17 SNPs was also investigated to check
whether the most significant variants for VCDR worked independently or
had a joint effect on the phenotype. Table 5.2 showed that rs301801 and
rs17658229 are interacting with several other VCDR SNPs.
In particular, rs17658229 located in DUSP1 gene interacted with the
variants in SSCA1, RPAP3, PLCE1 and TMTC2 genes. TMTC2 gene also
interacted with CHEK2 gene. In addition, the genetic variants within RERE
gene had significant interactions with SNPs located in SALL1, CDKN2BAS
and CDC7/TGFBR3 genes (Figure 5.4). Also the variant in SIX1/6 gene
seems to interact with the one in CARD10. Figure 5.4 and Figure 5.4 are
graphical representations of the interactions.
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(a) rs10862688 (b) rs4658101 (c) rs1900005
(d) rs1345467 (e) rs17658229 (f) rs2623325
(g) rs4901977 (h) rs5756813 (i) rs301801
(j) rs1346 (k) rs11168187 (l) rs1547014
(m) rs868153 (n) rs7865618 (o) rs6054374
(p) rs7072574 (q) rs4936099
Figure 5.3: Manhattan plots for epistatic meta-analyses with VCDR SNPs: the figure shows
the 17 different meta-analysis performed for each of the 17 VCDR-associated
SNP interacting with all the genome. The rs number for each plot represents
the different 17 VDCR-related SNPs.
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Snp1 Snp2 Effect SE P
rs301801 rs4658101 0.01 0.00 0.04
rs301801 rs1345467 0.01 0.00 0.01
rs301801 rs7865618 0.01 0.01 0.00
rs2623325 NA NA NA
rs17658229 rs10862688 -0.01 0.01 0.01
rs17658229 rs1346 0.02 0.01 0.02
rs17658229 rs7072574 -0.01 0.01 0.01
rs17658229 rs11168187 -0.01 0.01 0.05
rs868153 NA NA NA
rs4936099 NA NA NA
rs10862688 rs1547014 0.01 0.00 0.02
rs4901977 rs5756813 -0.00 0.00 0.05
rs6054374 NA NA NA
Table 5.2: SNP-SNP interactions between VCDR-related SNPs: this table shows the
interactions between VCDR-associated variants. Effect, SE and P refer to effect
sizes, standard errors and p-values of the interaction model.
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Figure 5.4: SNP-SNP interactions between VCDR genes: this figure shows three separate
clusters of interaction between the 17 variants associated with VCDR. The
figure only shows the name of the gene in which the variant is located.
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RERE
CDC7/TGFBR3
SALL1
CDKN2BAS
DUSP1
TMTC2
SSSCA1
PLCE1
RPAP3
CHEK2
SIX1/6
CARD10
Figure 5.5: SNP-SNP interactions between VCDR genes network: this figure shows genes’
clusters for VCDR as networks. Variants are represented with the names of the
closest genes.
5.3.2 Intraocular pressure
Similar analyses were performed for IOP. Fifteen cohorts from the IGGC
for a total of 26,816 individuals were included in the analysis. Each group
was responsible for quality control and analysis for their own cohort, I
performed the analyses for the BMES and TwinsUK cohorts.
As for VCDR, another quality control was necessary to assess the quality of
the results received. 12 separate analyses were performed for each of the
12 IOP-associated SNPs. Genomic inflation factors were checked for each
of the 12 SNPs interaction analysis (Figure 5.6), showing a high variability
of λ that varies from 0.2 to 6.645. High variability was due mainly to the
Asian-ancestry populations 5.7. For this reason, Beijing Eye Study (BES),
Singapore Chinese Eye Study (SCES) and Singapore Malay Eye Study
(SIMES) were excluded for further analysis.
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Figure 5.6: IOP genomic inflation factor λ for each SNPs for all cohorts: x-axis shows the
12 SNPs included in the analysis and y-axis the log of the inflation factors λ in
all cohorts.
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Figure 5.7: IOP genomic inflation factor λ for each cohort for all SNPs: x-axis shows the
15 cohorts included in the analysis and y-axis the log of the inflation factors λ
for all SNPs.
Multiple testing correction was necessary due to the high number of test
performed and Bonferroni threshold was equal to 1.17E-09. No interaction
passed Bonferroni correction (Figure 5.8). However, several loci reached
suggestive significance (Table 5.3). The most significant interaction was
between rs2211675 (located within SCAF4/SOD1 gene) and rs7946766
(within PTPRJ gene) (β=-0.335, SE=0.058, P=1.27E-08). Another
interesting interaction was between rs17607561 (SLC3A1 gene) and
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rs8176743 (ABO gene) (β=0.626, SE=0.111, P=1.75E-08). Interestingly,
the variant located in CAV1 gene (rs10258482) had significant interactions
with varianys lying within TBC1D1 gene on chromosome 4 and TOX2 gene
on chromosome 20 (respectively β= -0.330, SE=0.059, P=2.63E-08 and
β=-0.303, SE=0.054, P=2.77E-08). The variant within PTPRJ gene also
interacted with the one within SORBS2 gene (rs1401571, β=0.251, SE=
0.045, P=3.96E-08). Rs4656461 and rs7555523 both near TMCO1 gene
had a significant interaction with rs17124680 (GNG2 gene) (respectively
β=0.455, SE=0.083, P=4.71E-08 and β=0.454, SE=0.083, P=5.26E-08).
Finally, the variant in ABO gene (rs8176743) had a suggestive interaction
with the variant within DOCK7 gene (β=-0.432, SE=0.080, P=8.09E-08).
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(a) rs747782 (b) rs1681630 (c) rs2472493
(d) rs4656461 (e) rs6445055 (f) rs7555523
(g) rs7946766 (h) rs8176743 (i) rs9913911
(j) rs10258482 (k) rs10262524 (l) rs12419342
Figure 5.8: Manhattan plots for epistatic meta-analyses with IOP SNPs: the figure shows
the 12 different meta-analysis performed for each of the 12 IOP-associated
SNP interacting with all the genome. The rs number for each plot represents
the different 12 IOP-related SNPs.
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Chr1 Gene1 SNP1 Chr2 SNP2 Gene2 Effect SE P I2
11 PTPRJ rs7946766 21 rs2211675 SCAF4/SOD1 -0.335 0.059 1.27E-08 0.00
9 ABO rs8176743 2 rs17607561 SLC3A1 0.627 0.111 1.75E-08 0.00
7 CAV1 rs10258482 4 rs1364953 TBC1D1 -0.330 0.059 2.63E-08 0.00
7 CAV1 rs10258482 20 rs17753711 TOX2 -0.304 0.055 2.77E-08 0.31
11 PTPRJ rs1681630 4 rs1401571 SORBS2 0.252 0.046 3.96E-08 0.18
1 TMCO1 rs4656461 14 rs17124680 GNG2 0.456 0.083 4.71E-08 0.35
1 TMCO1 rs7555523 14 rs17124680 GNG2 0.454 0.083 5.26E-08 0.33
9 ABO rs8176743 1 rs10493333 DOCK7 -0.433 0.081 8.09E-08 0.03
11 PTPRJ rs7946766 17 rs8075325 SDK2 0.398 0.075 1.04E-07 0.38
11 PTPRJ rs1681630 4 rs4862626 SORBS2 0.253 0.048 1.11E-07 0.14
11 PTPRJ rs1681630 4 rs6814242 SORBS2 0.239 0.045 1.48E-07 0.20
11 PTPRJ rs7946766 21 rs2833737 SCAF4/SOD1 -0.308 0.059 1.81E-07 0.27
11 PTPRJ rs7946766 11 rs10897770 LOC101928944 -0.394 0.075 1.82E-07 0.00
11 RAPSN rs12419342 5 rs283763 P4HA2 -0.300 0.057 1.82E-07 0.00
11 PTPRJ rs7946766 18 rs2006776 RAB27B -0.389 0.075 1.87E-07 0.39
Table 5.3: Top results for IOP interaction meta-analysis: CHR1, SNP1 and Gene1 refers to
the chromosomes, snnps and genes for the 12 IOP-related SNPs whereas CHR2,
SNP2 and Gene2 to the SNPs in all genome that interacted with known gene
for IOP
As for VCDR, I checked whether IOP SNPs interacted amongst each other.
Variants located within PTPRJ gene (rs747782 and rs1681630) significantly
interacted with rs9913911 within GAS7 gene and rs6445055 within
FNDC3B gene (respectively β=0.115, SE=0.056, P=0.042,β= -0.062,
SE=0.028, P=0.030). Variants located in ABCA1 and TMCO1 genes also
had a significant interaction (rs2472493-rs4656461: β=-0.138, SE=0.066,
P=0.037). Graphical representations are shown in Figure 5.9 and Figure
5.10.
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Figure 5.9: SNP-SNP interactions between IOP genes: this figure shows two separate
clusters of interaction between the 12 variants associated with IOP. The figure
only shows the name of the gene in which the variant is located.
PTPRJ
GAS7
FNDC3B
ABCA1
TMCO1
Figure 5.10: SNP-SNP interactions between IOP genes network: this figure shows genes’
clusters for IOP as networks. Variants are represented with the names of the
closest genes.
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5.4 Discussion
The aim of this chapter was to investigate the epistatic interactions between
genetic variation associated with POAG endophenotypes in order to identify
novel variants that interact with known ones to alter VCDR and IOP.
Several suggestive genetic variants were identified for VCDR. PLCE1 is a
known gene for VCDR and it encodes for a phospholipase enzyme that
might affects cell growth and cell differentiation, oesophageal (Wang
et al. 2010; Wang et al. 2014) and gastric cancer (Abnet et al. 2010). I
found a suggestive significant interaction between a variant within this
gene and a variant within PDE1C trascript on chromosome 7. This gene is
involved in calcium-calmodulin complex (Repaske et al. 1992), it regulates
soluble adenylyl cyclase/ cAMP signalling and lysosome-mediated collagen
1 protein degradation, in particular regulating collagen homeostasis during
pathological vascular remodelling (Cai et al. 2011). Interestingly, pde1c
has male-specific expression pattern in the central nervous system and
affect fertility in Drosophila melanogaster (Morton et al. 2010). Another
interesting interaction affecting VCDR variation was between variants
located in DUSP1 and PITX2 genes. DUSP1 gene is known to affect VCDR
and it is a MAPK negative regulator influencing the regulation of the host
immune response (i.e. for poxvirus infection) (Ca´ceres et al. 2013). The
protein of this gene is inducible by oxidative stress and heat shock and
may play a role in environmental stress response and participates in the
negative regulation of cell proliferation (Keyse & Emslie 1992). PITX2
gene is a member of the homeobox protein family, whose transcription
factor plays a critical role in early development, especially of the anterior
segment of the eye (Gage et al. 2005). Mutations in PITX2 gene are
involved in Axenfeld Rieger syndrome which affects mostly the eye but also
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has systemic manifestations. Knock-out mice die from cardiac pathology
and have several eye defects, including loss of extraocular muscles (Gage
et al. 2005). In zebrafish models, alteration of pitx2 produces disruption
of neural crest migration into the craniofacial region, malformation of
the jaw and corneal endothelium iris stroma. It also acts with CYP1B1
gene and retinoic acid to specify a population of neural crest-derived cells
for migration and differentiation (Bohnsack et al. 2012). Interestingly it
also seems to be involved in atrial fibrillation with CAV1, a POAG gene
(Martin et al. 2015). Another interesting interaction was found between
variants located in CDC7/TGFBR3, which are involved in cellular growth
and cancer, and EFHB genes. The latter is involved in calcium-ion binding
and it is associated with type 1 diabetes (Howson et al. 2009). Another
gene for VCDR SALL1 had a significant interaction with PCDH7 gene.
SALL1 encodes for a zinc finger transcriptional repressor involved in
ocular development, neural tube closure in mice (Bo¨hm et al. 2008) and
a congenital anomaly-mental retardation syndrome that causes central
nervous system defects and cortical blindness (Vodopiutz et al. 2013).
PCDH7 encodes an integral membrane protein, involved in cell-cell
recognition and adhesion, calcium-ion binding and axon guidance (Leung
et al. 2013). This gene has also been identified through GWASs associated
with sleep (Ollila et al. 2014), epilepsies (on Complex Epilepsies 2014)
and musical aptitude and ear development (Oikkonen et al. 2015). It has
been also involved in cell division in post-natal and adult mice’ amygdala
(Hertel et al. 2012). Finally, I identified another novel gene, C2CD5 whose
variant had a significant interaction with a variant within SIX1/6 gene.
C2CD5 encodes an insulin-stimulated glucose transporter.
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To investigate whether known VCDR genes interact with each other, I
focused on interactions between the 17 SNPs associated with VCDR
variation. The interaction is not affected by the strength or significance of
these variants with VCDR, but it is only based on the statistical interaction
between the two variants. The SNP in DUSP1 gene interacted with
variants located in PLCE1, SSSCA1, RPAP3 and TMTC2 genes, which also is
connected with CHEK2 gene. These interactions underline the role of cell
growth and cell differentiation in VCDR variation, supporting the findings
in our previous GWAS meta-analysis paper (Springelkamp et al. 2014). The
SNP within RERE gene had significant interactions with variants located
in SALL1, CDKN2BAS and CDC7/TGFBR3 genes, suggesting an influence
during embrionic development on VCDR variation. Indeed, RERE gene is
involved in eye and cerebellum development (Kim et al. 2013; Kim & Scott
2014), SALL1 gene in neural tube development (Bo¨hm et al. 2008) and
CDC7/TGFBR3 gene in cell growth.
Suggestive interactions between IOP genetic variations and others in
all genome were identified, allowing the discovery of new potential
genes that may affect IOP variation in the general population. The
SNP in PTPRJ gene had suggestive interactions with variants located in
SCAF4/SOD1 and SORBS2 genes. PTPRJ gene is involved in a variety
of cell processes including cell growth, differentiation, mitotic cycle and
oncogenic transformations. In particular, it might play a role in cancer
cell proliferation (Ortuso et al. 2013) and, interestingly, in endothelial cell
permeability induced by vascular endothelial growth factor (Spring et al.
2014). The role of SCAF gene is mostly unknown and its possible role in
IOP variation not clear. It has been associated with diabetic nephropathy
(Alwohhaib et al. 2014). SOD1 is a known gene for ocular colobomas ,
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brain malformation and Alzheimer’s disease (Spisak et al. 2014) and it
is well studied for amyotrophic lateral sclerosis (Rotunno et al. 2014).
This gene, which is ubiquitously expressed and which genomic sequence
is highly conserved across species, binds copper and zinc ions and forms
a homodimer. Its role is of defence of oxygen toxicity (Saccon et al.
2013). Lack of sod1 increased the vulnerability to stress of motor neurons
leading to cell death and axon injury (Saccon et al. 2013). Interestingly,
knock-out mice exhibit a contractile vascular phenotype with impairment
of endothelial function during ageing (Didion et al. 2006). SORBS2 gene
encodes an adapter protein that assemble signalling complexes in stress
fibres and it is localised in epithelial and cardiac muscle cells: it is released
from damaged cardiac tissue into the bloodstream upon lethal acute
myocardial infarction (Kakimoto et al. 2013). It has been also associated
with diabetic nephropathy (Nakatani et al. 2011). A variant within ABO,
blood group gene, had showed suggestive interactions with variants within
SLC3A1 gene, which encodes a renal amino acid transporter and it is
involved in cystinuria (Miyamoto et al. 1996), and DOCK7 gene. The latter
is crucial for axon formation (Pinheiro & Gertler 2006), neural polarisation
(Watabe-Uchida et al. 2006) and encepholopathy and cortical blindness
(Perrault et al. 2014). Another suggestive interaction was between variants
located in TMCO1 and GNG2 genes. The latter is important for signalling
mechanisms across membranes. It is involved in proliferation of malignant
melanoma cells in humans (Yajima et al. 2012). The knockdown of
the G protein gng2 blocks the normal angiogenic process in developing
zebrafish embryos. In particular, loss of function of this protein inhibits
the ability of VEGF (vascular endothelium growth factor) to promote
the angiogenic sprouting of blood vessels (Leung et al. 2006). Finally,
suggestive interactions between variants located in CAV1 and TOX2 and
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TBC1D1 genes were identified. TOX2 gene regulates human natural killer
cell development by controlling T-BET expression (Vong et al. 2014) and it
has been associated with dyastolic blood pressure in a gene-environment
association study (Basson et al. 2014). TBC1D1 gene is crucial for cell
growth regulation and differentiation and it is important in human skeletal
muscle (Cartee 2010).
I also checked whether IOP associated genes interacted with each other.
A variant within PTPRJ gene had nominal significant interaction with
variants GAS7 and FNDC3B genes, suggesting a role of cell growth and
neuronal differentiation in IOP.
There are potential limitations of the study. Firstly, statistical interaction
does not necessarily imply interaction at the biological level. Functional
epistasis (i.e. protein-protein interaction) is a ubiquitous component
of the pathogenesis of any disease, however this does not mean this
epistasis will be detected as statistical interaction, especially if genetic
variations examined are surrogates for true causal variants because of
linkage disequilibrium (Cordell 2009). Despite this limitation, allowing
for interaction can lead to improved power to detect genetic factors
underlying the trait or disease (Cordell 2002). Another limitation is that
gene-gene interaction does not strictly help to explain the remain missing
heritability we cannot explain with GWAS. GWAS try to describe narrow
sense heritability, which is made up of additive variance. By definition,
since gene-gene interaction is a deviation of the additive model, it would
not help to explain narrow sense heritability but should be part of the
unknown heritability (Visscher et al. 2008). However, Herani et al. has
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suggested the epistasis could also contribute to additive variance by
statistical illusion (confounding non additive and environmental effects in
twin study calculation) and creating real additive variation as marginal
effects (Hemani et al. 2013). In this study, Bonferroni correction was used
to filter significant results, even though tests are not independent of each
other and thus it may be too conservative. Other corrections methods,
such as permutation, are computationally prohibitive and the choice of
specificity over sensitivity was made. This study also focused on two-locus
interaction rather than high-order interactions. However an exhaustive
search of all three-way or four-way or any higher level interactions seems
impractical in a genome-wide and meta-analysis settings.
5.5 Conclusion
To summarise, findings suggest that mechanisms such as cell growth,
neuronal differentiation, calcium channels and axon guidance might
alter VCDR, thus playing a role in the pathogenesis of POAG. The role
of neural development was confirmed also in IOP variation, providing
evidence for a link between increased IOP and optic nerve alterations in
POAG. IOP is also affected by vascular and systemic processes, including
vascular endothelium mechanism, blood pressure and diabetes. To my
knowledge this is the first study investigating epistatic interactions in POAG
endophenotypes at the meta-analysis level. The present findings extends
our knowledge of mechanisms underlying VCDR and IOP, thus POAG, and
will serve for future studies to better understand POAG mechanisms.
CHAPTER 6
Novel genetic loci and Alzheimer’s disease genes influence retinal
nerve fibre layer thinning: an European ancestry meta-analysis of
10,502 individuals
In this chapter I will describe and discuss my research on RNFL
thickness genetics in the BMES cohort and other European-ancestry
populations. I will also investigate the overlap between RNFL
thickness and Alzheimer’s disease.
STATEMENT OF CONTRIBUTION TO THIS RESEARCH:
I designed the study and performed all the analysis described in this chapter.
This work will be presented at ASHG 2015 as a poster.
6.1 Background
The retina is the neurosensory component of the eye and it is constituted
by different cell elements and layers to meet all functional needs. The
ganglion cell axons travel towards the optic nerve head within the retinal
nerve fibre layer (RNFL). Ganglion cell axons, as all the other axons in
the brain, are supported by glia, in particular astrocytes and Muller cells
(Hildebrand & Fielder 2011).
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Several technologies allow the measurements of the retinal ganglion
layers and in particular of RNFL layer. For instance, HRT (Heildenberg
Retina Tomograph) is a confocal scanning laser that takes images of serial
sections of the optic nerve to create a map of topographical sections of
the optic nerve head and the surrounding retina. HRT can measure the
changes and loss of RNFL (Belyea et al. 2014).
Optical coherence tomography (OCT) has revolutionised ophthalmology
and it has become a very important tool in clinical practice. Time-domain
OCT has been recently replaced by the newer Spectral-Domain OCT
technology that has faster acquisition time and higher resolution. OCT
provides high-resolution images of the peripapillary RNFL, macular volume,
macular ganglion cell layer and optic nerve (Rebolleda et al. 2015). Both
technologies are quick and efficient, allowing a sensitive and non-invasive
measurement of the axonal integrity in the retina.
RNFL evaluation is a useful tool in early glaucoma diagnosis (Jonas &
Dichtl 1996). Glaucoma involves the loss of axons of the ganglion cells and
RNFL loss can be detected even before functional loss (Kass et al. 2002).
Airaksinen et al. studied 51 individuals with glaucoma, 52 with ocular
hypertension and 29 controls. Reduction of nerve fibres was seen in 48 of
51 individuals with glaucoma, 27 of the 52 with high intraocular pressure,
but only 7 in the controls (Airaksinen et al. 1984). Similarly, Sammer et
al. checked 1,400 eyes divided into those with glaucomatous with visual
field loss and controls and showed that assessing RNFL thickness has a
80% sensitivity (proportion of glaucomatous eyes with nerve fibre loss)
and 94% specificity (proportion of normal control eyes without defects)
(Sommer et al. 1984).
Family history of glaucoma is a risk factor for thinner RNFL, together
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with age, male gender and axial length (Rougier et al. 2015). Genetics
is likely to play a role in RNFL thickness variation. Heritability ranges
between 40% and 49% in different sectors of RNFL in 1552 Dutch
individuals (Koolwijk et al. 2007). However, only a very few genetic studies
have been published to this date. Axenovich et al. conducted a linkage and
association studies on a family-based Dutch population (ERF) with a total
of 1,434 (for linkage study) and 1,488 (for association study) individuals
(Axenovich et al. 2011). Linkage study on RNFL thickness identified a peak
region on chromosome 14 which include SIX1, a gene associated with
cup/disc ratio (Ramdas et al. 2010). DCLK3 gene on chromosome 3 was
identified by the same authors through GWAS. This gene is a member of the
doublecortin family, which is involved in neuronal migration, neurogenesis
and eye-receptor development (Axenovich et al. 2011).Further genetic
studies have focused on the role of SIX1/SIX6 in RNFL thickness. A
recent quantitative trait locus (QTL) analysis in 231 participants from
the Diagnostic Innovations in Glaucoma Study and African Descent and
Glaucoma Evaluation Study investigated rs10483727 (SIX1/SIX6) and
found that each copy of the T allele decreased the thickness of RNFL by
-0.16 µm. Likewise Cheng et al. have investigated the variant rs33912345
(SIX6) in 2,129 eyes from 1,243 individuals of the SCES study and showed
that the C allele of the SIX6 His141 decreases the RNFL thickness by
1.44 µm (Cheng et al. 2015). SIX6 gene is expressed in neural retina and
optic nerve during embryonic development (Conte et al. 2010). Missense
variants in SIX6 gene have been shown to reduce eye size and optic nerve
volume in a zebrafish model (Iglesias et al. 2014).
Besides the application in ophthalmology, RNFL thickness has also been
investigated as a possible bio-marker in various neurological conditions.
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Alzheimer’s disease (AD) is the most common degenerative dementia and
causes a progressive decline in several cognitive functions (Blennow et al.
2006). AD affects 13% of people over 65 years old and 30%-50% over
80 years old (Hebert et al. 2003). The disease manifests with progressive
decline in memory and other cognitive functions, leading to loss of
autonomy.
Interestingly, visual impairment is one of the earliest complaints in
AD patients (Valenti 2010). Visual functions such as contrast sensitivity in
lower spatial frequency (Cronin-Golomb et al. 1991), motion perception
(Thiyagesh et al. 2009; Mapstone et al. 2008; Gilmore et al. 1994), visual
field (Armstrong 1996; Trick et al. 1995) and colour discrimination
(Cronin-Golomb et al. 1993) decreased in AD, showing a similarity
with the visual deficits in glaucoma (Quigley et al. 1982; Shabana et al.
2003). Patients with AD and glaucoma show a more rapid and aggressive
glaucomatous visual field loss (Bayer & Ferrari 2002). Both AD and
glaucoma affect the visual pathway, but start in different region along
the neural pathway. AD might start in the visual association area (McKee
et al. 2006) whereas glaucoma has its initial damage in the optic nerve. In
addition, AD treatments have been shown to have an impact on glaucoma.
ChEI (cholinesterase inhibitors) treatment, commonly prescribed for AD,
lowers IOP and seems to be protective for retinal ganglion cells (Estermann
et al. 2006; Miki et al. 2006). Memantine is a neuroprotective drug for
AD and also have implications for the visual system. Memantine has
been investigated also for the treatment of glaucoma and in monkeys with
glaucoma and it slows down the progression of cell loss in lateral geniculate
nucleus (LGN) compared with those animals not treated (Yu¨cel et al. 2006).
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Epidemiological studies have shown the link between the two diseases.
Two groups whose 112 with AD and 774 without have been compared and
25.9% of the people with AD developed also glaucoma, but only 5.2% of the
group without AD. The authors suggested that the optic nerve might be less
resistant to IOP levels in AD patients (Bayer et al. 2002). Likewise, Tamura
et al. investigated 172 AD patients in Japan compared with 156 controls
and found that those with AD has a greater rate of glaucoma (23.8%)
compared with the controls (9.9%) (Tamura et al. 2006).Even though AD
and glaucoma might be two different degenerative processes affecting
the visual pathway, surely some structures and functions are similar, for
example there is evidence that AD affects the RNFL layer. Parisi et al.
compared RNFL thickness in 17 AD and 14 control individuals, showing
that RNFL is thinner in participants with AD (Parisi et al. 2001). Another
study showed a likewise result with decrease of RNFL thickness in AD and
also correlated the thickness of RNFL with severity of cognitive function
loss (Iseri et al. 2006). Interestingly, also mild-cognitive impairment (MCI),
a condition characterised by slight, but noticeable decline in cognitive skills
and associated with AD risk, showed a decrease of RNFL thickness. Paquet
et al. analysed 14 mild AD, 23 MCI and 15 controls and found a thinner
RNFL in AD and MCI in comparison with controls (Paquet et al. 2007).
Loss of nerve fibre layer tissue in the retina and optic nerve may be
an early bio marker for AD and may appear even before any hippocampus
damage, which is the brain structure that impacts memory (Valenti 2011).
Given that AD diagnosis is complicated and can be only confirmed in
post-mortem examination, RNFL assessment may become an useful and
precise tool (and also non invasive) and it is been showed to be at least as
sensitive and specific as current methods for AD diagnosis (Larrosa et al.
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2014).
Considering the previous points, the objectives of this chapter are:
• to clarify the relationship of RNFL thickness with POAG
endophenotypes in order to understand whether RNFL thickness can
be used as a POAG quantitative trait itself
• to investigate common genetic factors and related biological pathways
underlying RNFL thickness variation in the general population given
the lack of genetic studies on RNFL thickness so far
• to explore the genetic link between RNFL thickness and AD in order
to identify possible shared biological mechanisms that can firstly
elucidate the relationship with POAG and also can help to clarify the
role of RNFL thickness as a marker of AD
6.2 Methods
To assess the link between RNFL thickness and other POAG traits
correlation and linear regression models were used in the BMES cohort.
RNFL thickness was available in 960 individuals for the right eye and
details about the measurement are described in Chapter 2.1.1.
A GWAS using RNFL thickness as outcome was then performed in
the BMES cohort adjusting for age and sex as described in Chapter
2.2.2. Inverse-based fixed effect meta-analysis was performed in 10,502
individuals from seven European-derived cohorts: BMES cohort, Gutenberg
Health Study 1 and 2, Erasmus Rucphen Family Study and Rotterdam 1,2,3.
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To investigate a possible genetic link between RNFL thickness and AD
several analyses were performed. A list of 435 AD-associated variants was
compiled from the Alzheimer Disease Genetics Consortium as described
in Chapter 2.2.7. A second list of 50 SNPs that were associated both
with AD and RNFL thickness was compiled. Effect sizes from AD and
RNFL meta-analyses were compared (Chapter 2.2.7). To evaluate whether
AD-associated variants SNPs have an aggregate role on RNFL thickness in
the BMES cohort, two polygenic risk score analyses were performed. The
first risk score included 37 SNPs, selected from the list of 435 variants
associated with AD , whereas the second one included 16 independent SNPs
selected from the 50 SNPs associated with both AD and RNFL thickness
(Chapter 2.2.7.1). Regression analysis were performed with the scores as
predictors in separated models and RNFL thickness as outcome, adjusting
for age and sex. These models were compared using r-squares and ANOVA
with the null model of a regression including only age and sex as predictors.
Given the small sample size in the BMES cohort (960 individuals), a
multi-SNP score analysis, which allows summary results from both RNFL
thickness meta-analysis and AD meta-analysis, was performed. The risk
score was weighted using the AD effects for the 16 independent SNPs,
previously selected to be significant in both AD and RNFL thickness
meta-analysis and not in LD (Chapter 2.2.7.2).
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6.3 Results
6.3.1 RNFL thickness and POAG endophenotypes in the BMES cohort
A total of 960 individuals from the BMES cohort had genotypic and
phenotypic information and were used for further analysis. RNFL thickness
measurements were available in mm only in the right eye. The distribution
was approximately normally distributed (Figure 6.1) with a mean of 0.23
mm (SD=0.07) and median 0.22 mm and the values range from 0.02 mm
to 0.83 mm. Given this, raw data were used for further analyses and no
transformation was applied.
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Figure 6.1: RNFL thickness distribution in the BMES cohort: the figure displays the
histrograms and the density curve for the RNFL thickness phenotypes
measured in mm. The vertical red line represent the mean of the distribution.
To better understand the role of RNFL in POAG pathogenesis, the
epidemiological link between RNFL thickness and POAG quantitative traits
was explored. Thus, correlation between RNFL thickness and the other
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POAG phenotypes was investigated in the BMES cohort. The highest
correlation was found with optic disc measurements: VCDR (-0.144) and
VCD (-0.134) (Table 6.1), showing that an increase of the diameter of the
cup disc is associated with thinner RNFL. The correlation between RNFL
and IOP was -0.075 and 0.035 with refractive error.
Phenotypes Pearson coefficient
IOP -0.075
VCDR -0.144
SE 0.035
VDD -0.020
VCD -0.134
CCT 0.001
Table 6.1: Correlation between RNFL thickness and POAG endophenotypes in the BMES
cohort: the table shows the Pearson’s coefficients for the correlation analysis in
960 individuals analysed.
To further investigate the link between RNFL and POAG endophenotypes,
a univariate linear model was fitted with RNFL thickness as outcome and
POAG quantitative traits as predictors. All analyses were adjusted for age
and sex. VCDR and VCD were associated (respectively P= 0.00002 and
P=0.00007) even though with a small effect on RNFL thickness (β=-0.07
for VCDR and β=-0.0004 for VCD). An increase of IOP was also significantly
associated with thinner RNFL (P=0.02) with a small effect size (β=-0.002).
In addition, refraction was shown to be associated with RNFL thickness
(β=0.002 and P=0.03).
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Phenotype Estimate SE P
IOP -0.002 0.0008 0.020
VCDR -0.076 0.0180 2.19E-05
VDD -8.77E-05 1.42E-04 0.53
SE 0.002 0.0012 0.03
VCD -3.94E-04 9.88E-05 7.10E-05
CCT -4.23E-06 8.21E-05 0.95
Table 6.2: Results for linear models fitted with RNFL thickness as outcome and POAG
endophenotypes as predictors in the BMES cohort: this tables shows the results
for a linear regression on RNFL thickness. Estimate: effect size, SE: standard
error, P: p-value
6.3.2 The genetics of RNFL thickness
In order to explore potential genetic influences of RNFL thickness in the
general population, a genetic association study was conducted. Firstly, a
GWAS for RNFL thickness in the BMES was performed, then a meta-analysis
with other European ancestry populations was carried out.
6.3.2.1 GWAS for RNFL thickness in the BMES population
A set of 960 individuals with information for a panel of 2,297,195 SNPs
was analysed. All of these SNPs passed stringent quality control criteria as
described in the Chapter 2.
No SNPs reached genome-wide significance for RNFL thickness (Figure
6.2). However, suggestive association signals have been found in several
new loci. The SNP that reached the highest significance is rs1154119
(P=2.41E-07). This SNP lies within the genomic sequence of SLC25A21
gene (chromosome 14, Figure 6.3). The second SNP that reached the
highest significance is rs2493383 (P=9.82E-06), located in an intergenic
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region on chromosome 6 (Figure 6.4). Another suggestive locus is on
chromosome 14 (rs6571668, P=1.67E-06, MAF= 0.44) close to SNX6
gene (Figure 6.5). This gene is involved in several stage of intracellular
trafficking and it promotes lysosomal degradation of CDKN1B.
Figure 6.2: Manhattan plot for RNFL thickness in the BMES population: the 22 autosomes
are plotted along the x-axis, whereas the values in the y-axis denote the -log 10
transformed p-values from the GWAS in the BMES cohort on RNFL thickness
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Figure 6.3: Regional association plot for rs2493383: the figure shows the regional
information of rs2493383 such as the strength of the association (y-axis)
relative to genomic position, local linkage disequilibrium, represented by the
red colour and recombination patterns (blue lines).
Figure 6.4: Regional association plot for rs1154119: the figure shows the regional
information of rs1154119 such as the strength of the association (y-axis)
relative to genomic position, local linkage disequilibrium, represented by the
red colour and recombination patterns (blue lines).
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Figure 6.5: Regional association plot for rs6571668: the figure shows the regional
information of rs6571668 such as the strength of the association (y-axis)
relative to genomic position, local linkage disequilibrium, represented by the
red colour and recombination patterns (blue lines).
6.3.2.2 Meta-analysis for RNFL thickness
As larger sample sizes are needed to unravel common variants underlying
complex diseases, GWAS results on RNFL thickness for 10,502 individuals
from 7 populations of European ancestry were meta-analysed. The
meta-analysis included BMES, Gutenberg Health Study 1 and 2, and four
Dutch studies, Rotterdam 1,2 and 3 and Erasmus Rucphen Family study.
The results showed that the genomic inflation factors λ in individuals
studies ranged between 0.9-1.01, indicating within-study control of
population structure (Figure 6.6).
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Figure 6.6: Q-Q plot for all the 7 cohorts included in the meta-analysis: the figure shows
the -log10 of the p-values for each study (in black) plotted with the expected
value of no association (red line). In grey are the confidence intervals.
Four SNPs crossed the conventional genome-wide significance threshold of
P=5E-08, as shown in the Manhattan plot Figure 6.7.
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Figure 6.7: Manhattan plot for RNFL thickness meta-analysis results: the 22 autosomes
are plotted along the x-axis, whereas the values in the y-axis denote the log 10
transformed p-values from the meta-analysis on RNFL thickness. The red line
represents the genome-wide significance line (P=5E-08), whereas the blue
line shows the suggestive significance line (1E-05).
Rs Chr Position A1 Eaf Effect SE P Dir Gene
rs7554059 1 244460825 G 0.890 0.014 0.002 1.17E-08 ++++-+? C1orf100
rs6429459 1 244460570 C 0.944 0.015 0.003 1.35E-08 ++++-+? C1orf100
rs12087686 1 190481726 C 0.054 0.013 0.002 1.92E-08 ++++-+? BRINP3
rs11625568 14 101230885 A 0.959 -0.014 0.003 4.72E-08 - - - - - +? DLK1
rs1277751 10 18522260 T 0.832 0.007 0.001 5.04E-08 +++++++ CACNB2
rs1277752 10 18522474 A 0.833 0.007 0.001 5.54E-08 +++++++ CACNB2
rs1966778 17 6434680 C 0.943 0.012 0.002 6.63E-08 +++++++ PITPNM3
rs12322558 12 70080152 G 0.108 -0.008 0.002 1.06E-07 - - - - - + - BEST3
rs11879136 19 54760690 T 0.250 0.008 0.001 1.18E-07 ++++++? LILRB5
rs2913316 5 5597977 G 0.727 -0.006 0.001 1.29E-07 - - - - - + - NA
Table 6.3: Most significant variants for RNFL thickness meta-analysis: the table shows
the results of the RNFL thickness meta-analysis. Rs: marker name, Chr:
chromosome, A1: effect allele, Eaf: effect allele frequency, Effect: effect size,
SE: standard error, P= p-value, Dir: direction of the effect for all cohorts, Gene:
closest gene
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As shown in Table 6.3, the strongest signal was found at rs7554059 and
rs6429459 (respectively P=1.17E-08 and P=1.35E-08) on chromosome
1. The minor allele frequency of these variants is respectively of 0.43
and 0.33 in the European population. The variants lie on an intergenic
region, however they show regulatory activity and the closest genes are
C1orf100 (chromosome 1 open reading frame 100) and ZBTB18/ZNF238
(zinc finger and BTB domain containing 18). On the same chromosome
(1), another signal was identified at rs12087686 (minor allele frequency=
0.14, P=1.92E-08) in high regulatory intergenic region close to BRINP3
(bone morphogenetic protein/retinoic acid inducible neural-specific 3)
transcript. BRINP3 is protein coding gene involved in neuronal cell
proliferation by negative regulation of the cell cycle transition. On
chromosome 14, I pinpointed a significant genetic signal at rs11625568
lying nearby DLK1 transcript. This gene encodes a transmembrane protein
containing six epidermal growth factor repeats, which is involved in
the differentiation of several cell types, including adipocytes. It is also
thought to be a tumor suppressor. Other interesting signals were found
on chromosome 10: rs1277751 and rs1277752 (respectively P= 5.04E-08
and P=5.54E-08) with a very consistent effects’ direction amongst all
cohorts. These SNPs are both lying within CACNB2 transcript (calcium
channel, voltage-dependent, beta 2). This gene encodes a subunit of
a voltage-dependent calcium channel protein that is a member of the
voltage-gated calcium channel super-family. Additionally,rs1966778 on
chromosome 17 was identified (P=6.63E-08) with again a high consistency
of direction of effects for all cohorts. This variant lies within PITPNM3 gene
(Phosphatidylinositol Transfer Protein, Membrane-Associated 3). This gene
encodes a member of a family of membrane-associated phosphatidylinositol
transfer domain-containing proteins. Other suggestive signal was found
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at rs12322558, located within BEST3 gene (vitelliform macular dystrophy
2-like 3 isoform), which belongs to the bestrophin family of anion channels.
Finally, rs11879136 was identified on chromosome 19 within LILRB5 gene
(leukocyte immunoglobulin-like receptor). This gene is a member of the
leukocyte immunoglobulin-like receptor (LIR) family, which is found in a
gene cluster at chromosomal region 19q13.4.
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Figure 6.8: Regional plot for rs7554059: the figure shows the regional information of
rs7554059 such as the strength of the association (y-axis) relative to genomic
position, local linkage disequilibrium, represented by the red colour and
recombination patterns (blue lines).
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Figure 6.9: Regional plot for rs11625568:the figure shows the regional information of
rs11625568 such as the strength of the association (y-axis) relative to genomic
position, local linkage disequilibrium, represented by the red colour and
recombination patterns (blue lines).
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Figure 6.10: Regional plot for rs1277751: the figure shows the regional information of
rs1277751 such as the strength of the association (y-axis) relative to genomic
position, local linkage disequilibrium, represented by the red colour and
recombination patterns (blue lines).
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Figure 6.11: Regional plot for rs1966778: the figure shows the regional information of
rs1966778 such as the strength of the association (y-axis) relative to genomic
position, local linkage disequilibrium, represented by the red colour and
recombination patterns (blue lines).
Given the relationship between RNFL thickness and POAG, the ten most
significant SNPs from RNFL thickness meta-analysis were checked for
magnitude of effects and significance in IOP and VCDR meta-analysis
(Chapter 3). For VCDR only rs12322558 (BEST3) reached significance in
the IGGC results (see Table 6.4). However, for IOP none of signal identified
in RNFL meta-analysis reached nominal significance in IGGC results (Table
6.5).
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Rs A1 Eaf Effect SE P
rs12087686 G 0.932 0.003 0.003 0.332603
rs6429459 C 0.944 0.003 0.004 0.424393
rs7554059 G 0.903 0.003 0.003 0.346288
rs11625568 A 0.957 -0.000 0.004 0.930275
rs1277752 A 0.829 -0.002 0.002 0.379816
rs1277751 C 0.219 0.000 0.002 0.937081
rs1966778 C 0.945 -0.002 0.003 0.582203
rs12322558 A 0.884 -0.007 0.002 0.000211
rs11879136 T 0.248 -0.000 0.002 0.873969
rs2913316 G 0.740 0.002 0.002 0.121232
Table 6.4: The most significant variants identified in the RNFL thickness meta-analysis in
the VCDR meta-analysis: Rs: marker name, A1: effect allele, SE: standard error,
P: p-value
Rs A1 Eaf Effect SE P
rs12087686 G 0.917 0.002 0.047 0.962
rs6429459 C 0.853 0.017 0.057 0.771
rs7554059 G 0.812 -0.075 0.051 0.135
rs11625568 A 0.951 -0.050 0.058 0.384
rs1277751 C 0.214 -0.002 0.032 0.957
rs1277752 A 0.777 0.007 0.031 0.827
rs1966778 C 0.940 -0.053 0.066 0.424
rs12322558 A 0.871 -0.040 0.037 0.278
rs11879136 T 0.244 -0.008 0.036 0.815
rs2913316 G 0.733 0.027 0.029 0.337
Table 6.5: The most significant variants identified in the RNFL thickness meta-analysis in
the IOP meta-analysis: Rs: marker name, A1: effect allele, SE: standard error, P:
p-value
To further elucidate potential mechanisms that cause RNFL thickness
variation in the general population, I carried out a gene-set enrichment
analysis of the results obtained after the GWAS meta-analysis. A total of
2,424 unique genes or transcripts were identified. With the exception of
the BioCarta pathways, in which no significant enrichment was observed,
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high level of entry enrichment were found in all other databases.
Amongst the most associated GO entries were cell and biological adhesion
(P=9.99E-11 and P=1.09E-10), plasma membrane (P=3.23E-06) and
voltage ion channel activity (p=2.87E-06) (Tables 6.6, 6.7, 6.8).
In addition, several KEGG pathways were identified, for instance
ECM-receptor interaction (P=1.50E04) and focal adhesion (P=5.65E-04)
(Table 6.9). These findings suggest that adhesion in the plasma membrane
and ion channels (i.e. calcium channels) may play a role in RNFL thickness
variation.
Category Term PValue Fold Enrichment Bonferroni
GOTERM BP FAT GO:0007155˜cell adhesion 9.99E-11 1.85 3.52E-07
GOTERM BP FAT GO:0022610˜biological adhesion 1.09E-10 1.84 3.85E-07
GOTERM BP FAT GO:0048568˜embryonic organ development 8.37E-08 2.57 2.95E-04
GOTERM BP FAT GO:0048562˜embryonic organ morphogenesis 1.19E-06 2.64 4.19E-03
GOTERM BP FAT GO:0030030˜cell projection organization 2.05E-06 1.88 7.20E-03
GOTERM BP FAT GO:0048598˜embryonic morphogenesis 6.86E-06 1.92 2.39E-02
GOTERM BP FAT GO:0000904˜cell morphogenesis involved in differentiation 8.03E-06 2.04 2.79E-02
Table 6.6: GO biological processes identified with gene-set enrichment analysis: the table
shows the GO biological processes significantly enriched for RNFL thickness
meta-analysis.
Category Term PValue Fold Enrichment Bonferroni
GOTERM CC FAT GO:0044459˜plasma membrane part 3.23E-06 1.30 1.74-03
GOTERM CC FAT GO:0005886˜plasma membrane 6.31E-06 1.20 3.39E-03
GOTERM CC FAT GO:0031224˜intrinsic to membrane 8.10E-06 1.14 4.35E-03
GOTERM CC FAT GO:0031012˜extracellular matrix 4.88E-05 1.77 2.59E-02
GOTERM CC FAT GO:0042995˜cell projection 5.43E-05 1.51 2.88E-02
GOTERM CC FAT GO:0016021˜integral to membrane 7.32E-05 1.13 3.86E-02
Table 6.7: GO cellular components identified with gene-set enrichment analysis: the table
shows the GO cellular component significantly enriched for RNFL thickness
meta-analysis.
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Category Term PValue Fold Enrichment Bonferroni
GOTERM MF FAT GO:0005244˜voltage-gated ion channel activity 2.87E-06 2.25 3.34E-03
GOTERM MF FAT GO:0022832˜voltage-gated channel activity 2.87E-06 2.25 3.34E-03
GOTERM MF FAT GO:0005509˜calcium ion binding 2.97E-06 1.50 3.46E-03
GOTERM MF FAT GO:0019198˜transmembrane receptor protein phosphatase activity 7.79E-06 6.24 9.05E-03
GOTERM MF FAT GO:0022843˜voltage-gated cation channel activity 3.30E-05 2.29 3.77E-02
Table 6.8: GO molecular functions identified with gene-set enrichment analysis:the table
shows the GO molecular functions significantly enriched for RNFL thickness
meta-analysis.
Category Term PValue Fold Enrichment Bonferroni
KEGG PATHWAY hsa04512:ECM-receptor interaction 1.50E-04 2.60 2.65E-02
KEGG PATHWAY hsa04510:Focal adhesion 5.65E-04 1.85 9.62E-02
KEGG PATHWAY hsa05412:Arrhythmogenic right ventricular cardiomyopathy (ARVC) 1.14E-03 2.44 1.84E-01
KEGG PATHWAY hsa05414:Dilated cardiomyopathy 1.41E-03 2.25 2.23E-01
KEGG PATHWAY hsa05410:Hypertrophic cardiomyopathy (HCM) 1.47E-03 2.31 2.32E-01
KEGG PATHWAY hsa04010:MAPK signaling pathway 1.04E-02 1.51 8.46E-01
KEGG PATHWAY hsa00534:Heparan sulfate biosynthesis 2.68E-02 2.94 9.92E-01
KEGG PATHWAY hsa04340:Hedgehog signaling pathway 2.85E-02 2.14 9.94E-01
KEGG PATHWAY hsa03410:Base excision repair 3.61E-02 2.49 9.99E-01
Table 6.9: KEGG pathways identified with gene-set enrichment analysis: the table shows
the KEGG pathways significantly enriched for RNFL thickness meta-analysis.
6.3.3 Investigating the genetic link between RNFL thickness and
Alzheimer’s disease
Given the epidemiological relationship between RNFL thickness and AD,
my interest was to investigate a possible genetic overlap between the RNFL
and the disease. A list of 435 genetic variants associated with AD was
compiled. Of these SNPs, 50 reached significance in the RNFL meta-analysis
(Table 6.10). Interestingly, some of the most important genes associated
with AD such as APOE, PVRL2, PICALM and CLU were also associated with
RNFL thickness.
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SNP Gene chr A1 rnfl eaf beta se p rnfl A1 ad OR p ad
rs2814022 C10orf107 10 A 0.371362 3.83E-03 1.01E-03 1.55E-04 A 0.96 3.11E-02
rs2787723 C10orf107 10 T 0.372088 3.83E-03 1.01E-03 1.56E-04 T 0.96 3.55E-02
rs2814020 C10orf107 10 T 0.371629 3.79E-03 1.01E-03 1.78E-04 T 0.96 3.55E-02
rs12357683 C10orf107 10 A 0.371204 3.71E-03 1.01E-03 2.38E-04 A 0.96 4.57E-02
rs12356284 C10orf107 10 T 0.371328 3.69E-03 1.01E-03 2.58E-04 T 0.96 4.34E-02
rs7250924 GEMIN7 19 C 0.594076 -3.59E-03 1.12E-03 1.31E-03 T 0.9 2.08E-06
rs7093099 LOC254312 10 C 0.807219 -4.17E-03 1.32E-03 1.60E-03 T 0.91 5.96E-04
rs17444979 LOC254312 10 C 0.81772 -4.11E-03 1.31E-03 1.71E-03 T 0.91 4.17E-04
rs11767557 EPHA1 7 T 0.796575 -3.62E-03 1.23E-03 3.23E-03 C 0.87 2.43E-07
rs3813498 FOXO3 6 T 0.817217 3.56E-03 1.27E-03 5.01E-03 C 0.92 8.87E-04
rs1469704 GEMIN7 19 T 0.534567 -2.67E-03 1.00E-03 7.73E-03 C 0.91 3.72E-06
rs2060250 GEMIN7 19 A 0.53726 -2.68E-03 1.01E-03 7.76E-03 G 0.91 2.11E-06
rs1871047 PVRL2 19 A 0.611251 -2.65E-03 1.02E-03 9.61E-03 G 0.85 1.08E-14
rs12416248 PRKCQ 10 C 0.347019 -2.69E-03 1.05E-03 1.01E-02 C 0.95 2.16E-02
rs519825 PVRL2 19 C 0.38486 -2.60E-03 1.01E-03 1.02E-02 C 1.17 6.49E-14
rs1898895 PICALM 11 C 0.67258 2.66E-03 1.06E-03 1.18E-02 T 0.87 5.68E-11
rs567075 PICALM 11 C 0.674696 2.67E-03 1.06E-03 1.19E-02 T 0.87 3.14E-11
rs377702 PVRL2 19 A 0.384104 -2.53E-03 1.01E-03 1.20E-02 A 1.17 3.36E-14
rs416041 PVRL2 19 G 0.384699 -2.54E-03 1.01E-03 1.20E-02 G 1.17 5.52E-14
rs659023 PICALM 11 G 0.62312 2.50E-03 1.02E-03 1.46E-02 A 0.88 2.78E-10
rs4803763 PVRL2 19 G 0.701436 2.89E-03 1.19E-03 1.48E-02 C 1.51 2.90E-67
rs1871046 PVRL2 19 T 0.615781 -2.50E-03 1.03E-03 1.52E-02 C 0.85 8.45E-15
rs542126 PICALM 11 G 0.610389 2.47E-03 1.02E-03 1.57E-02 A 0.89 5.02E-09
rs561655 PICALM 11 A 0.645149 2.47E-03 1.04E-03 1.75E-02 G 0.87 7.00E-11
rs10402271 BCAM 19 G 0.338378 -2.49E-03 1.05E-03 1.80E-02 G 1.33 8.72E-44
rs12703526 EPHA1 7 T 0.51799 -2.44E-03 1.04E-03 1.86E-02 G 0.91 1.02E-05
rs2927480 PVRL2 19 C 0.336457 -2.55E-03 1.09E-03 1.88E-02 C 1.36 2.69E-47
rs1237999 PICALM 11 A 0.640026 2.40E-03 1.03E-03 1.98E-02 G 0.88 3.29E-10
rs526904 PICALM 11 C 0.6397 2.39E-03 1.03E-03 2.00E-02 T 0.88 2.31E-10
rs497816 PICALM 11 T 0.639748 2.39E-03 1.03E-03 2.01E-02 C 0.88 2.41E-10
rs543293 PICALM 11 G 0.661299 2.39E-03 1.04E-03 2.23E-02 A 0.87 7.91E-11
rs7359852 BCAM 19 C 0.337846 -2.45E-03 1.08E-03 2.34E-02 C 1.36 3.86E-47
rs586274 PICALM 11 G 0.657823 2.33E-03 1.04E-03 2.53E-02 T 0.87 6.14E-11
rs9480861 LACE1 6 T 0.394723 -2.22E-03 1.01E-03 2.83E-02 T 0.92 1.22E-04
rs725206 PRKCQ 10 T 0.347032 -2.21E-03 1.03E-03 3.21E-02 T 0.95 1.72E-02
rs472486 PICALM 11 G 0.637036 2.20E-03 1.03E-03 3.22E-02 A 0.88 6.34E-10
rs573167 PICALM 11 A 0.655714 2.21E-03 1.04E-03 3.32E-02 G 0.87 1.31E-10
rs17125924 FERMT2 14 A 0.900731 3.46E-03 1.63E-03 3.36E-02 G 1.12 8.22E-04
rs1532278 CLU 8 C 0.620158 2.22E-03 1.05E-03 3.46E-02 T 0.89 8.34E-08
rs439401 APOE 19 C 0.649678 -2.39E-03 1.13E-03 3.47E-02 T 0.65 1.65E-73
rs17125944 FERMT2 14 T 0.901269 3.44E-03 1.63E-03 3.49E-02 C 1.12 7.61E-04
rs519961 PICALM 11 C 0.656701 2.15E-03 1.04E-03 3.92E-02 T 0.87 1.20E-10
rs1332027 LACE1 6 A 0.931492 4.07E-03 1.99E-03 4.08E-02 G 0.89 1.33E-03
rs846848 CEACAM22P 19 T 0.857897 3.23E-03 1.59E-03 4.17E-02 G 0.88 1.13E-05
rs7110631 PICALM 11 G 0.68077 2.14E-03 1.06E-03 4.33E-02 C 0.87 3.53E-10
rs7941541 PICALM 11 A 0.677676 2.12E-03 1.06E-03 4.57E-02 G 0.87 5.57E-10
rs12152750 LOC285627 5 A 0.751868 -2.28E-03 1.14E-03 4.66E-02 G 1.08 5.41E-04
rs2984 RPS6KA2 6 T 0.635023 -2.13E-03 1.08E-03 4.80E-02 C 1.06 1.07E-02
rs541458 PICALM 11 T 0.678247 2.08E-03 1.06E-03 4.95E-02 C 0.88 1.43E-09
rs17056877 LOC285627 5 G 0.754413 -2.24E-03 1.14E-03 4.98E-02 A 1.09 3.28E-04
Table 6.10: List of AD-associated SNPs that are significant in RNFL meta-analysis: A1 rnfl:
effect allele in the RNFL analysis, eaf: effect allele frequency, beta= effect in
RNFL analysis, SE: standard error, p rnfl: p-value of RNFL analysis, A1 ad:
effect allele in AD analysis, OR: odds ratio, p ad: p-value in AD analysis.
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Amongst these 50 SNPs, 16 SNPs were not in linkage disequilibrium.
The correlation between their effects size on AD and RNFL thickness
was examined (Figure 6.12). The correlation between AD and RNFL
thickness effect sizes was -0.25 (P=0.33). The negative sign suggests
that variants that increase RNFL thickness also diminished the risk of AD.
For example, the allele of the variant within APOE gene is protective for
RNFL thickness (effect size calculated on T allele is 0.002) and reduce
the risk of AD (the beta is -1.81, which is the -log10 of an odd ratio of 0.65).
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Figure 6.12: Plot of the β for RNFL thickness against AD: this figure shows the beta for
RNFL thickness (x-axis) plotted against those for AD (y-axis). Beta for AD
were calculated using the -log10 of the odds ratio.
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Polygenic score analysis was performed in the BMES cohort. From 435
SNPs, 37 independent SNPs (not in LD) were included with association
p<0.0001 in the AD joint meta-analysis and used to calculate the polygenic
score. The weighted score was not significantly associated with RNFL
thickness (β=-0.1955, SE=0.18, P=0.29) in the BMES cohort. The change
of RNFL thickness for the quantiles of the polygenic score are shown in
Figure 6.13. The overall r-square of the model was 0.014 (P= 0.003). The
model was compared with the null model where a linear regression was fit
only with age and sex (r-square =0.012) and the two models did not differ
(ANOVA P=0.29).
Figure 6.13: Quantile plot showing the effect of increasing score in RNFL thickness: the
plot shows the quantiles of the polygenic score created with 37 SNPs (x-axis)
plotted against the change in the phenotype
I also investigated whether the 50 AD SNPs identified as significant in
RNFL GWAS meta-analysis had a cumulative effect on RNFL thickness
variation. 16 of these 50 were independent and selected as shown in Table
6.11. The polygenic score created was still not significantly associated with
RNFL thinning (β=12.08, SE=10.46, P=0.24). The overall R-squared was
0.014 and still, this model did not significantly differ from the null model
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(ANOVA p=0.24).
SNP CHR BP GENE
rs17056877 5 159083691 LOC285627
rs9480861 6 108858459 LACE1
rs1332027 6 108798497 LACE1
rs2984 6 166826020 RPS6KA2
rs11767557 7 143109138 EPHA1/LOC285965
rs1532278 8 27466314 CLU
rs2814022 10 63360810 C10orf107
rs17444979 10 10994158 LOC254312
rs725206 10 6394994 PRKCQ
rs567075 11 85830156 PICALM
rs17125944 14 53400628 FERMT2
rs7250924 19 45585705 GEMIN7
rs377702 19 45362666 PVRL2
rs7359852 19 45336034 BCAM
rs439401 19 45414450 APOE
rs846848 19 45074176 CEACAM22P
Table 6.11: List of 16 independent SNP associated with both RNFL thickness and AD: the
table shows the list of 16 independent AD (non in linkage disequilibrium)
SNPs that are also significant in RNFL thickness meta-analysis and were used
to create the second polygenic score. CHR: chromosome; BP: base-position;
GENE: closest gene/transcript
Given the small sample size in the BMES cohort (960 individuals), a
multi-SNP score analysis, which allows summary results from both RNFL
thickness meta-analysis and AD meta-analysis, was used. The weighted
sum of the individual SNP coefficients leads also to an estimate of the
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explained variance. The risk score was weighted using the AD effects for
the 16 independent SNPs, previously selected to be associated with both
AD and RNFL thickness. This multi-SNP risk score explained 7% of the
variance of RNFL thickness. Then the association of this risk score with
RNFL thickness variation was tested. The multi-SNP genotypic risk score
was associated with a decrease of RNFL thickness (β=-0.0047, SE=0.001,
P=0.005), where β is the average effect of AD risk alleles on the β of RNFL
thickness (see Figure 6.14)
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Figure 6.14: Coefficients in the AD risk score versus estimated effect size for RNFL
thickness: this figure shows each SNP plotted by coefficient in the AD
risk score (x-axis) versus estimated effect size for RNFL thickness in the
meta-analysis (y-axis). Vertical grey lines show 95% confidence interval (CI)
for each individual SNP. The solid red line shows the effect size estimate for
the AD risk score on RNFL thickness, with red dashed lines representing the
95% interval.
6.4 Discussion
In this chapter the relationship between RNFL and POAG endophenotypes,
the genetic architecture of RNFL thickness, the genetic factors underlying
its variation and shared genetic effects between RNFL thickness and
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Alzheimer’s disease were investigated.
The relationship between RNFL thickness and POAG endophenotypes
was investigated in 960 individuals in the BMES cohort. Findings showed
that RNFL thickness was correlated with optic measurements. In addition,
using regression models, RNFL thickness was also linked with IOP and
refraction. RNFL has already been identified as a good indicator of POAG
and it has been used in the diagnosis and for checking the progression
(Jonas & Dichtl 1996). Also, increasing IOP has been shown to lead to
disrupted axonal transport and a decrease of the mean RNFL thickness in
rats (Abbott et al. 2014).
As other POAG quantitative traits, RNFL thickness is likely to be affected
by environmental and genetic factors. The latter were investigated in
the general population, first in the BMES and then in an extensive
meta-analysis including more than 10,000 individual of European ancestry.
Several common variants have been identified. The most significant
signal lies in proximity of two genes: C1orf100 and ZBTB18/ZNF238.
ZBTB18/ZNF238 is highly involved in neuronal activity, for example as a
key regulator of neural migration (Ohtaka-Maruyama et al. 2013). It is also
essential for the growth and organisation of the cerebellum and regulates
the development of both GABAergic and glutamarergic neurons (Baubet
et al. 2012). Finally, it is also been recognised as brain tumour suppressor
(Tatard et al. 2010).
Another gene identified playing a role in neurogenesis was BRINP3
which inhibits neuronal cell proliferation and it is involved since the
early phases of neural development during the mouse embryogenesis.
Chapter 6. Novel genetic loci and Alzheimer’s disease genes influence retinal nerve
fibre layer thinning: an European ancestry meta-analysis of 10,502 individuals 181
BRINP3-mRNA is expressed in the adult brain in the olfactory bulb,
cerebellum and neuronal layers in the hyppocampus (Kawano et al. 2004).
Another signal was identified close to DLK1 transcript. The protein is
involved in the differentiation of several cell types, including adipocytes;
it is also thought to be a tumor suppressor. Muller et al. found that it is
expressed by 30% of motor neurons. Dlk1 suppresses Notch signalling
and activates expression of the K(+) channel subunit Kcng4 to modulate
delayed-rectifier currents (Mu¨ller et al. 2014).
Another genetic signal was found within CACNB2 gene. The protein
encoded increases calcium current density by facilitating channel opening
and increasing the number of channels in the plasma membrane
(Sto¨lting et al. 2015). In addition, CACNB2 is a well-known gene
for neuropsychiatric disorders, in particular ADHD (attention deficit
hyperactive disorder), anxiety, bipolar disorder, major depressive disorder
and schizophrenia. Voltage-gated calcium signalling (calcium channel
activity) could be an important biological process in psychiatric disorders
(of the Psychiatric Genomics Consortium et al. 2013) and seems to be
implicated in postsynaptic density (Lotan et al. 2014). In addition, three
rare missense mutations of CACNB2 were found in autism spectrum
disorder where the calcium channel dysfunction is likely to play a role in
the disease (Breitenkamp et al. 2014). Xueying et al. identified a modest
risk for AD in a gene-gene interaction study investigating a broad region
on chromosome 10 in a Caucasian cohort of 506 cases and 558 controls
(Liang et al. 2009). The authors concluded arguing that calcium level
(controlled by calcium channels) may cause mitochondrial damage and
induce apoptosis. Also, the protein may affect prefrontal-hippocampal
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functional coupling in the human brain (Dixson et al. 2014). The gene
has been also associated with hypertension in several studies (Hong et al.
2013; Lin et al. 2011; Takeuchi et al. 2010; Levy et al. 2009).
PITPNM3 is a well-known gene in ophthalmology as associated with
retinal dystrophy. The gene encodes for calcium-binding protein and
two Swedish families have a mutation in this gene which causes visual
impairment from childhood, progressive decline in visual acuity, decreased
macular thickness and enlarged fovea (Reinis et al. 2013).
BEST3 gene belongs to the bestrophin family of anion channels, which
includes BEST1, the gene mutant in vitelliform macular dystrophy. It is
expressed in a variety of tissue (cardiac, smooth muscle and renal) and it
prevents apoptotic cell death induced by endoplasmatic reticulum stress
(Jiang et al. 2013).
Interestingly these genes are not shared with other POAG endophenotypes.
Only the variant in BEST3 gene reached nominal significance for VCDR,
suggesting that the genetic factors underlying RNFL thickness might be
different to those associated with other POAG phenotypes thus underlying
different processes of the disease.
To extrapolate biological meaning from the meta-analysis of GWASs
and thus elucidate possible mechanisms underlying RNFL thinning, a
gene-set pathway analysis was performed. Biological processes such as
biological and cell adhesion in plasma membrane have been identified.
In addition voltage-dependent ion channel, such as calcium, have been
found to be enriched in the result. Using KEGG database, I identified
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ECM-receptor interaction and focal adhesion to be overrepresented in
RNFL thickness genes.
Alzheimer’s disease has commonalities with POAG and RNFL thickness
has been proposed as a bio marker of the disease. In this chapter, the
shared genetics between RNFL thickness and AD was investigated. 50
variants out of 435 identified through AD meta-analysis were also
significant for RNFL thickness in the GWAS meta-analysis. This cluster of
genes includes CLU, PICALM, APOE and PVRL2, which are well-known
genes for AD (Naj et al. 2011). These genes are likely to be involved in
relevant mechanisms underlying RNFL thinning and POAG. CLU gene,
for example, play many roles in a variety of extracellular processes,
including apoptosis, lipid transport, cell-cell and cell-matrix interaction
and prevents protein misfolding (Wilson & Easterbrook-Smith 2000; Poon
et al. 2002). Interestingly, an increase of Clusterin protein has been found
in the aqueous humour of individuals with pseudo-exfoliative glaucoma
(PXG) (Padhy et al. 2014). It is also involved in the TGF-beta signalling
(Lee et al. 2008). Epigenetic factors may regulate Clusterin expression
of retinal pigment epithelial cells, affecting the pathogenesis of AMD via
the inhibition of angiogenesis and inflammation (Suuronen et al. 2007).
Finally, Clusterin produced and released by Muller cell may play a role in
the pathogenesis of ischemic injury in the rat retina, following increase of
IOP-muller cell die by apoptosis (Gwon et al. 2004). In addition, PVRL2
gene is highly involved in cell adhesion, it encodes Nectin, which is a
protein essential for adherens junction formation (Indra et al. 2013) and
cell-cell adhesion (Samanta et al. 2012). APOE gene is surely known for AD
and might be involved in RNFL thinning. Apolipoprotein E plays a role in
the human body as a carrier of cholesterol (Mahley 1988). In the nervous
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system, the main source of apoe synthesis are the astrocytes and microglia.
Secreted apoe binds to cholesterol and this complex is internalised into
the RGCs through the low density lipoprotein (LDL) receptors before being
transferred to the optic nerve (Amaratunga et al. 1996). Apoe-E4 is higher
in AD and also in glaucoma patients (Tamura et al. 2006). Several SNPs
in APOE locus have been associated with both POAG and NTG (normal
tension glaucoma) (Lam et al. 2006; Mabuchi et al. 2005; Ressiniotis T et al.
2004; Zetterberg et al. 2007; Guo et al. 2015). A study in mice showed
that apoe has a critical role in axonal damage-induced retinal ganglion
cell death and it is likely to involve cytotoxic KA pathway (Omodaka et al.
2014).
There was an inverse linear relationship between the effect sizes for
RNFL thickness and AD. For example, the variant in APOE gene had a
protective effect for AD and increase RNFL thickness. Vice versa the one
within PRVL2 gene increased the risk for AD and decrease RNFL thickness.
Two different polygenic risk scores were used to investigate the polygenic
effect of AD loci. The first score included 37 independent SNPs associated
with AD (Naj et al. 2011) and the second one included 16 independent
SNPs associated with AD and also associated with RNFL thickness variation
in the meta-analysis. Both scores were not significantly associated with
RNFL thickness in the BMES.
However, the BMES cohort only has 960 observations for RNFL thickness
leading to a lack of power. For this reason, summary statistics, such as
effect sizes and SE, from RNFL thickness and AD meta-analyses were used
to calculate a multi-SNP score including 16 variants associated with both
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phenotypes. Multi-SNP risk score analysis identified a weak but statistical
significant protective effect of thicker RNFL on AD risk.
There are a number of limitations to consider. Firstly, genetic associations
results for RNFL thickness need to be replicated and validated or assessed
for clinical importance in POAG case-controls cohort. Second, results are
generated in HapMap2 which covers common genetic variants at the
expense of rare variants. Third, results for polygenic risk analysis need
replication and to be validated in future studies.
6.5 Conclusion
This is the first study investigating RNFL thickness genetics in an extensive
European population and results suggest a role of several common
variants in RNFL variation. The genetic factors identified are mainly
involved in glutamate, calcium channels and cell adhesion, which were
also identified mechanisms through the gene-set enrichment analysis. The
study also showed a possible shared genetics between RNFL thickness
and AD underlying the importance of using RNFL measurements as a bio
marker for AD, but also the role of neuronal protection in RNFL thickness
and thus POAG. These findings might help to shed a light on POAG
mechanisms since a complete understanding of glaucoma pathogenesis
has not been achieved. At the moment the only therapy aims to lower IOP,
however, therapeutic approaches based on neuroprotection might be used.
Neuroprotection aims to protect retinal ganglion cell and their surrounding
microglia by targeting pathways involved in neurodegeneration. Emerging
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lines of investigation are examining neuroprotection therapies aimed to
halt retinal ganglion cell apoptosis. For example, glutamate excitotoxicity,
which leads to elevated intracellular calcium levels and thus triggering
RGC death, appear to be a promising target. Memantine, which is used for
AD, has shown protective properties in a rat glaucoma model by acting on
NMDA receptor (Danesh-Meyer 2011; Lagreze et al. 1998), blocking NMDA
channels normally opened by glutamate in glaucoma models (Osborne
2009).
CHAPTER 7
General discussion and conclusions
In this chapter I will summarise and discuss the research of this thesis.
The main purpose of the PhD course is to gain insight in the genetic
factors underlying POAG using GWAS techniques. My work shows that
GWAS methodology may still have the potential to unravel the genetics of
complex traits and disease.
My work includes several interests. In Chapter 3, I described GWAS
on POAG quantitative traits in the BMES cohort, such as VCDR and
IOP, including a candidate gene study on ATOH7 gene in optic disc
measurements, and consequent meta-analyses as part of the IGGC
consortium. I also investigated common mechanisms underlying IOP
variation using the GWAS results from the IGG meta-analysis through
gene-set enrichment analysis. In Chapter 4 I focused on genetic analysis
that can combine information from different POAG endophenotypes,
such as principal factor analysis, genetic correlation and multivariate
regression models. Then, in Chapter 5 I investigated epistatic interactions
in association with VCDR and IOP. Finally, in Chapter 6 I described
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association analyses on RNFL thickness, a POAG trait whose genetics has
not been fully investigated, and its genetic relationship with AD.
Here I will start with a summary and discussion of the main findings
for each chapter and then I will discuss what these results mean globally
and why these are important for understanding the genetic architecture of
POAG. As Griffith mentioned ”There is no hope of doing perfect research”
(Levi 2013) and I will describe how my work is not perfect, the main flaws
and limitations of my PhD project. Following this, I will consider a few
points for future research and studies.
7.1 Discussion
7.1.1 Which are the genetic variants underlying POAG endophenotypes in
the general population and the biological mechanisms underlying
them?
In chapter 3 the genetic architecture of POAG endophenotypes (VCDR and
IOP) was investigated using GWAS. Specifically, I performed GWAS in the
BMES cohort on VCDR and IOP and then meta-analysed the results with
other European and Asian populations from the IGGC. The findings suggest
a role of cellular stress response in VCDR variation involving DUSP1 and
HSF2 genes (Keyse & Emslie 1992; Kwong et al. 2006). In addition, cell
growth and differentiation may have an effect on VCDR (PLCE1 gene)
(Wang et al. 2010; Wang et al. 2014; Abnet et al. 2010). Results also
suggest that neuronal degeneration may be partially responsible of the loss
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of cells in the optic disc nerve (EXOC2 gene) (Lipschutz & Mostov 2002;
Coleman & Yao 2003). These results also confirm the association between
VCDR and variants within ATOH7 gene, which is a well-known gene for
disc size (Ramdas et al. 2010; Macgregor et al. 2010; Khor et al. 2011).
The findings corroborate the idea that ATOH7 gene affects VCDR variation
mainly through its effect on disc size. The role of disc size for POAG is
controversial (Crowston et al. 2004) and therefore whether ATOH7 gene
affects POAG susceptibility varying VCDR or merely the disc size has
clinical implication. In addition, findings in this thesis support the role
of cellular adhesion in the plasma membrane and cell junctions in IOP
variation, suggested also by loci near to CAV1/2 genes. In addition, calcium
ion binding may be partially responsible for IOP regulation.
Taken together, these results suggest that GWAS, especially supported
by extensive meta-analysis, were still able to identify novel variants for IOP
and VCDR and more important to investigate the biological and molecular
mechanisms that may be responsible for these traits, thus affecting POAG
susceptibility.
7.1.2 Are POAG endophenotypes correlated with each other and if so is it
possible to combine POAG endophenotypes in order to unravel novel
shared genetic loci?
Chapter 4 describes my work on pleiotropy within POAG endophenotypes
and to identify cross-phenotypes loci within POAG endophenotypes.
Firstly, epidemiological correlations between POAG quantitative traits was
investigated. The link between IOP and CCT measurements (Doughty &
Chapter 7. General discussion and conclusions 190
Zaman 2000) and between optic disc measurements, including disc size
and VCDR (Quigley HA et al. 1990) was confirmed. More interesting is
the link between IOP and VCDR, as the relationship between IOP and the
glaucomatous damage is not clear, however it is critical to understand
and treat the disease. To clarify whether phenotypic correlation was due
to pleiotropy genetic correlation was investigated. Interestingly, a genetic
correlation of 64% was identified for IOP and VCDR, showing a shared
genetic determination between the two traits and thus suggesting the
existence of pleitropic factors underlying both phenotypes.
To reduce the dimensions of POAG traits, principal factor analysis
was carried out and two factors were used for further analysis. GWAS using
the factors as outcomes were performed in the BMES and TwinsUK cohorts
and results were then meta-analysed. The findings suggested several loci
involved, for example nearby GLRX3 gene, which is involved in apoptosis
and cellular growth (Cheng et al. 2011) and close to RGS7 gene. The latter
plays a role in intracellular signalling (Rose et al. 2000) and it is expressed
in the eye and the retina (Cabrera et al. 1998).
Multivariate regression models that can accommodate multiple phenotypes
in one model were also investigated. Suggestive signals, such as near
SEC16B gene and and SYT14, were identified through MANOVA method.
These genes are involved in organisation of transitional endoplasmatic
reticulum sites and protein export (Watson et al. 2006) and synaptic
transmission, however these data must be interpreted with caution because
the correlation between IOP and VCDR is not taken into account. For this
purpose, another model using GEE was carried out and a signal within
CACNAD3 gene was identified. This gene modulates the expression and
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the function of the voltage-gated calcium channel complex and it may be
involved in pain sensitivity (Neely et al. 2010). Also, a locus in SNED1 gene
was identified. GO annotations for this gene include calcium ion binding
and its paralog is DLK2 gene, which is an epidermal growth factor and
involved as modulator of adipogenesis in vitro (Rivero et al. 2012).
The findings of applying multivariate models on POAG traits are far
from exhaustive. This work may suggest that, despite a few suggestive
genetic loci, mechanisms underlying IOP and optic nerve head are different.
The existence of normal tension glaucoma, where optic nerve damage is
present without an increase of IOP, provides evidence to this hypothesis.
Mechanisms that not involve IOP may play a role. For example, vascular
factors has been proven crucial where vascular dysregulation impacts the
optic disc without an increase of IOP (Mi et al. 2014). Other mechanisms
that contribute independently to death of retinal cells and optic disc fibres,
without high IOP, may be excessive stimulation of the glutamatergic system
(Dreyer et al. 1996), poorly functioning cellular pumps and glutamate
transporters, oxidative stress and aberrant immunity (Schwartz 2003).
7.1.3 Are genetic variants for POAG endophenotypes interacting with other
loci or between each other to determine IOP and VCDR?
In Chapter 5 I described the work on epistatic interactions between genetic
variation associated with POAG endophenotypes in order to identify novel
variants that interact with known ones to alter CDR and IOP. Several
suggestive genetic variants were identified for VCDR. For example, on
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chromosome 7 one genetic variation lying close to PDE1C gene interacted
with a variant in PLCE1, identified in the VCDR IGGC meta-analysis.
PDE1C gene plays a role in calcium-calmodulin complex (Repaske
et al. 1992), it regulates soluble adenylyl cyclase/ cAMP signalling and
lysosome-mediated collagen 1 protein degradation, in particular regulating
collagen homeostasis during pathological vascular remodelling (Cai et al.
2011). I identified also an interaction affecting VCDR variation between
variants located in DUSP1 transcript and PITX2 gene, which is involved
in early development, especially of the anterior segment of the eye (Gage
et al. 2005). Another interesting interaction was found between variants
located in CDC7/TGFBR3 and EFHB genes. The latter plays a role in
calcium-ion binding and it is associated with type 1 diabetes (Howson
et al. 2009). Another gene for VCDR SALL1 had a significant interaction
with a variant within PCDH7 gene, which encodes an integral membrane
protein, involved in cell-cell recognition and adhesion, calcium-ion binding
and axon guidance (Leung et al. 2013). Finally, I identified another novel
variant lying within C2CD5 gene, which had a significant interaction with
SIX1/6 gene. C2CD5 gene is an insulin-stimulated glucose transporter. I
also investigated the epistatic interactions between the 17 VCDR-associated
SNPs to study whether these variants interacted together to affect VCDR
variation. The locus within DUSP1 gene appeared to interact with genes
located in PLCE1, SSSCA1, RPAP3 and TMTC2 genes. TMTC2 gene is also
connected with CHEK2 gene. These interactions underline the role of cell
growth and cell differentiation in VCDR variation. Another group of genes
included RERE gene, which had significant interactions with variants lying
on SALL1, CDKN2BAS and CDC7/TGFBR3 genes, suggesting an influence
during embrionic development on VCDR variation. Indeed, RERE gene is
involved in eye and cerebellum development (Kim et al. 2013; Kim & Scott
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2014), SALL1 gene in neural tube development and CDC7/TGFBR3 gene in
cell growth.
Similarly, suggestive interactions were identified for IOP. Variants located
within PTPRJ gene had suggestive interactions with loci in SCAF4/SOD1
and SORBS2 genes. SCAF4 gene has been associated with diabetic
nephropathy (Alwohhaib et al. 2014). SOD1 is a well known gene for
amyotrophic lateral sclerosis (Rotunno et al. 2014) and the lack of the
protein increases the vulnerability to stress of motor neurons leading to cell
death and axon injury (Saccon et al. 2013). Interestingly, knock-out mice
exhibit a contractile vascular phenotype with impairment of endothelial
function during ageing (Didion et al. 2006). SORBS2 gene encodes a
adapter protein which is released from damaged cardiac tissue into the
bloodstream upon lethal acute myocardial infarction (Kakimoto et al.
2013) and it has been also associated with diabetic nephropathy (Nakatani
et al. 2011). I also identified an interaction between a locus within ABO
transcript with SLC3A1 gene, which is renal amino acid transporter
and involved in cystinuria (Miyamoto et al. 1996), and DOCK7 gene,
crucial for axon formation (Pinheiro & Gertler 2006), neural polarisation
(Watabe-Uchida et al. 2006) and encepholopathy and cortical blindness
(Perrault et al. 2014). Another suggestive interaction was between loci
located in TMCO1 and GNG2 genes. GNG2 gene may be important for
signalling mechanisms across membranes and loss of function of this
protein inhibits the ability of VEGF (vascular endothelium growth factor)
to promote the angiogenic sprouting of blood vessels in zebra-fish models
(Leung et al. 2006). Finally, I identified a suggestive interaction between
variants in CAV1 and TOX2 and TBC1D1 genes. TOX2 gene regulates human
natural killer cell development by controlling T-BET expression (Vong et al.
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2014) and it has been associated with diastolic blood pressure(Basson
et al. 2014). TBC1D1 gene is crucial for cell growth regulation and
differentiation. I also checked whether IOP associated variants interacted
with each other. PTPRJ’s variants had significant interaction with loci
within GAS7 and FNDC3B genes, suggesting a role of cell growth and
neuronal differentiation in IOP.
The evidence of these findings suggest that genetic factors interact between
each other to affect POAG endophenotypes. In particular, mechanisms
such as cell growth, neuronal differentiation, calcium channels activity and
axon guidance may affect VCDR variation and be the product of interaction
between genes. The role of neural development was confirmed also in
IOP variation, providing evidence for a link between increased IOP and
optic nerve defects in POAG. IOP is also affected by vascular and systemic
processes and conditions, including vascular endothelium mechanism,
blood pressure and diabetes.
7.1.4 Is RNFL thickness correlated with other POAG endophenotypes? Are
there genetic variants affecting RNFL thickness? Do RNFL thickness
and Alzheimer’s disease have a shared genetics?
Finally, Chapter 6 describes my work on retinal nerve fibre layer thickness,
its relationship with POAG endophentoypes, common genetic variants and
pathways underlying its variation and its relationship with Alzheimer’s
disease. RNFL thickness is used in clinic for diagnosis and evaluation of
progression of POAG (Jonas & Dichtl 1996) and epidemiological findings in
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the BMES cohort confirmed its relationship with other POAG quantitative
traits. Therefore RNFL thickness may be used as a quantitative traits for
POAG in genetic association studies.
RNFL thickness, as POAG endophenotypes, is a complex trait and it
is affected by genetic and environmental factors. Five novel genetic regions
associated with RNFL thickness variation were identified in this thesis. The
first signal lies on chromosome 1 nearby C1orf100 and ZBTB18/ZNF238
genes. The latter is highly involved in neuronal activity, such as neural
migration (Ohtaka-Maruyama et al. 2013), development of GABAergic
and glutamarergic neurons and cerebellum’s growth and organisation
(Baubet et al. 2012). Still on chromosome 1 another genetic variants was
found located near to BRINP3 transcript, which is involved in neuronal cell
proliferation inhibition, neural development, and it is expressed in the adult
brain (Kawano et al. 2004). Another signal was found on chromosome
14 nearby DLK1 gene that plays a role in cellular differentiation and
it is expressed in motor neurons (Mu¨ller et al. 2014). On chromosome
10 two signals were identified within CACNAB2 gene whose protein
increases calcium current density in the plasma membrane (Sto¨lting et al.
2015). This gene is known to be associated with psychiatric disorders
(ADHD, schizophrenia, depression, anxiety) (“Identification of risk loci
with shared effects on five major psychiatric disorders” 2013) as well as
autism (Breitenkamp et al. 2014) and may affect prefrontal-hippocampal
functional coupling in the human brain and induce apoptosis. Also, the
protein affects prefrontal-hippocampal functional coupling in the human
brain (Dixson et al. 2014). It has also been associated with hypertension
(Hong et al. 2013; Lin et al. 2011; Takeuchi et al. 2010; Levy et al. 2009).
On chromosome 17, I identified a suggestive signal within PITPNM3 gene,
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which is well known for its association with retinal dystrophy (Reinis
et al. 2013). Even though it did not cross genome-wide significance level,
on chromosome 12, I pinpointed an interesting genetic signal lying on
BEST3 gene whose protein prevents apoptotic cell death induced by
endoplasmatic reticulum stress (Jiang et al. 2013). This gene is also
interesting because it is the only one, among the most significance hits
for RNFL thickness, to reach significance also for another POAG trait, VCDR.
In Chapter 6, the shared genetics between RNFL thickness and AD
was also investigated. Findings showed that 50 AD-associated variants (Naj
et al. 2011) reached nominal significance in RNFL meta-analysis results.
For instance, a locus within CLU gene, which is involved in apoptosis,
cellular interaction (Wilson & Easterbrook-Smith 2000; Poon et al. 2002)
and interestingly in pseudo-exfoliative glaucoma (Padhy et al. 2014).
Another signal associated with both AD and RNFL thickness was identified
within PVRL2 gene that plays a role in cell adhesion (Indra et al. 2013;
Samanta et al. 2012). Interestingly, also a locus located within APOE gene
was associated with both phenotypes. APOE gene is a cholesterol carrier
and might play a role in axonal damage. Apoe-E4 is higher in AD and
interestingly in glaucoma patients (Tamura et al. 2006). There was an
inverse relationship between RNFL thickness’ effect sizes and AD ones,
showing that, for example, the APOE allele investigated had a protective
effect on AD and also increase the thickness of RNFL. Following this,
different polygenic score were built with AD risk loci in the BMES cohort. I
then investigated whether the scores were associated with RNFL thickness.
No score was associated with RNFL thickness variation. However, given
that these results may reflect the lack of power in the BMES cohort due to
a small sample size, a multi-SNP score was created using effect estimates
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of 16 SNPs from RNFL meta-analysis and AD study (Naj et al. 2011).
Multi-SNP risk score analysis identified a weak but statistical significant
protective effect of thicker RNFL on AD risk.
Taken together these findings provide evidence that the genetics underlying
RNFL thickness may involve glutamate, calcium channels and cell adhesion,
also confirmed by the gene-set enrichment analysis. The relationship with
AD suggests a possible role of neural protection in RNFL thickness and thus
POAG.
7.1.5 General discussion
A complete understanding on POAG pathogenesis has not been yet
achieved, however several hypotheses have been proposed. Genetic studies
such as GWAS can help to clarify POAG endophenotypes variation and may
provide an insight of mechanisms underlying the disease.
The first mechanism my work suggests is cellular adhesion, in particular
for IOP variation. Disruptions in cell adhesion mechanisms may lead to
an accumulation of extracellular protein within the trabecular meshwork,
restricting aqueous humour flow. The mechanism is in line with the
mechanical stress model where an increase in IOP creates a compression of
the optic disc causing death of the retinal ganglion cells. A pathway thought
to be involved in mechanical stress mechanisms involved in POAG is TGB-β
super-family of cell-signalling molecules. An increase of TGB-β can cause
an increase of tissue stiffness through expression of of other extracellular
matrix proteins such as fibronectin, collagen, and elastin (Wordinger et al.
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2014). TGB-β may affect the capacity of cell to withstand mechanical
pressure and/or restricting the flexibility of the trabecular meshwork cells.
In combination with IOP fluctuation, cell stiffness may increase cell death
over time, leading to the presentation of POAG (Wordinger et al. 2014).
Findings on VCDR have underlined a possible role of cellular stress
in the pathogenesis of POAG. Cellular stress might involve several cell
responses such as endoplasmatic reticulum stress response. Continuous
exposure of the trabecular meshowork to oxidative stress seems to be a
risk factor for POAG as the stress in the trabecular meshwork may induce
death of cells and increase of IOP (Babizhayev & Yegorov 2011).
The findings on RNFL thickness, but also on VCDR and IOP, have
potentially highlight the importance of calcium channels mechanisms
for POAG in support to excitotoxicity theory. Excitotoxicity is caused by
disruptions in glutamate transport that lead in abnormally high levels of
glutamate in the synapse. This increased level of glutamate can lead to
neurotoxicity through the N-methyl-D-aspartate (NMDA) receptor that
causes influx of calcium into the cell and activates apoptotic pathways
(Almasieh et al. 2012; Li et al. 1997; Masliah et al. 1996).
These findings have significant implications for the understanding
and developing of POAG therapies. Current therapies focus on lowering
IOP, however with limited effects as some patients have glaucoma despite
normal IOP and others continue to suffer retinal ganglion cell death
after medication (Group 1998; Shiose et al. 1990). It is also clear that
there are additional pathogenic mechanisms that are not related to IOP
variation. The current findings on cellular stress and calcium mechanisms
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add to a growing body of literature on another therapeutic approach
called neuroprotection (Tamm et al. 2013). Neuroprotection aims to
protect retinal ganglion cells and the surrounding microglia and help their
regeneration. Pathways targeted in this approach are oxidative stress and
excitotoxicity. For example, memantine acts on excitotoxicity that leads to
elevated levels of calcium as a non-competitive NMDA receptor antagonist.
Interestingly, memantine is a drug currently used in Alzheimer’s disease,
supporting the idea of shared mechanisms between the two diseases as
suggested by my work on RNFL and Alzheimer’s disease (Danesh-Meyer
2011; Lagreze et al. 1998).
The generalisability of these results is subject to certain limitations.
Firstly, POAG is a complex disease and it is a combination of genetic
and environmental factors. Several environmental factors are generally
considered to affect glaucomatous mechanisms and might interact with
genetic factors. For instance, Kang et al. found an interaction between
a a nitric oxide synthase gene variant and smoking (Kang et al. 2011).
Secondly, the potential of false-positive results is an important limitation
of GWAS. The balance between sensitivity and specificity, where false
positive rates are minimised while maintaining the power to identify
the true associations, is difficult to achieve. Due to the multiple tests
performed, Bonferroni correction was generally used, however it can be
very conservative if the independence assumption does not hold as for
SNPs in GWAS. On the other hand, the same efforts to reduce false-positive
results may results in overlooking a true association. Another limit of
GWAS designs is that most the variants identified have very modest effects
on the POAG endophenotypes, explaining only a small fraction of the total
estimated heritability. SNPs used in GWAS would not probably be the causal
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variants and might not be in LD with a causal variant rare allele. Selection
will drive one susceptibility allele to low frequency, thus the increase of
interest in the role of rare variants in complex diseases (Yang et al. 2010).
However GWAS data in this work were imputed to HapMap 2 which does
not guarantee an adequate covert of allele with a frequency less than 3-4%.
Another potential drawback of studying quantitative traits of POAG may
relate to their clinical relevance. In particular for RNFL thickness results
and the epistatic study, investigation on the importance of the results in
POAG onset and progression is needed. More precise phenotypes that
can also give information about the stage of the disease would provide
valuable insight in genetic studies. For example, longitudinal data could be
implemented in GWAS and would inform about the progression of POAG.
In addition, these studies are clearly far from actual clinical application.
GWAS results need functional confirmation to be translated into new
therapeutic targets. Gene-set enrichment analyses are surely useful in
identifying biological pathways, however more research is needed to clarify
the functional role of these variants and related genes.
7.2 Future studies and conclusion
The etiology of complex diseases, such as POAG, is still far from understood
and much more has to be elucidated. Future directions following from the
studies described in this thesis will need to clarify the functional role of
the genes identified and validate their clinical relevance for POAG. Firstly,
more research is needed to better understand whether combining multiple
phenotypes might be a useful tool to improve our understanding on POAG
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mechanisms. My first results are not encouraging, but larger sample size
and replication are needed. This research has thrown up many questions
on the link between POAG and Alzheimer’s disease. My results on RNFL
thickness and its implication on Alzheimer’s disease need replication and
validation. Further studies need to be carried out in order to validate
epistatic interactions identified in this thesis.
More broadly, research is also needed to determine the functional aspects
of the genes identified through my research and in general with association
genetic studies. These investigations include fine mapping, including also
rare variants investigation, genomic analysis of gene expression in human
tissues, possibly including ocular tissue and epigenetic analysis of human
tissue using the GWAS SNPs and their LD regions (Axton 2010). Once a
gene or genes have been securely implicated, other models could be used.
For instance, mouse knockouts, fish or cell knockdowns of a nearby gene
and in vitro expression studies (Axton 2010).
This research extends our knowledge of genetic architecture of POAG
endophenotypes and enhance our understanding of POAG onset and
progression mechanisms. A key strength of the present studies was to show
how GWAS can still help us to understand more on the genetics of complex
disease. This thesis will serve as a base for future studies on mechanisms
and future therapies on POAG.
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